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As healthcare expenditures keep rising and technological advances 
in healthcare continue, guiding and canalizing efforts aiming at 
improvement of effectiveness and efficiency of care remains high 
on the political agenda throughout the Western world. Particularly, 
the field of oncological care becomes more and more complex, with 
an increasingly multidisciplinary approach to cancer treatment, 
advances in staging methods, surgical- and multimodality treatment, 
and an ongoing centralization of care towards referral centers for 
many types of cancer treatment. One of the major challenges is the 
ageing population, leading to a higher proportion of cancer patients 
that is susceptible for complications secondary to cancer treatment, 
as a result of prevalent comorbid illnesses1,2. 
high-risk­surgery
A successful treatment for a patient consists of a right diagnosis, 
followed by a proper and adequately performed treatment, and the 
avoidance of adverse events associated with the treatment. Perhaps, 
the processes and outcomes of surgical treatment are the most 
straightforward to measure among oncological treatments. Postop-
erative clinical outcomes are important for both patients and caregiv-
ers, and adverse events like postoperative complications and mortal-
ity remain a major concern in intestinal oncological procedures. Of 
all intestinal surgical oncological procedures, colorectal resections 
are performed most commonly. They account for a disproportionate 
share (24%) of all adverse events within the spectrum of general 
surgery3.  For instance, anastomotic leakage after low anterior resec-
tion is reported in literature to be approximately 9%4 and 30-day 
postoperative mortality after colorectal cancer surgery is reported to 
be between 3-6% in larger series5-8. Oesophageal cancer surgery is a 
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classic example of high-complex, low-volume surgery with reported 
postoperative mortality rates as high as 9%9.  In esophageal cancer 
surgery, there is compelling evidence of better results and lower 
morbidity and mortality rates when surgery is performed in high-
volume referral centres10,11. Although esophageal cancer care is now 
centralized in the Netherlands12, postoperative morbidity and mor-
tality (4.5%) is still high and esophageal cancer patients still have an 
unfavorable prognosis13.
hospital­variation
With this background, hospital variation regarding quality of care 
received much attention in recent years. In the Netherlands, the 
2010 ‘Quality of Cancer Care’ report14,15 by the Signaling Committee 
of the Dutch Cancer Society described the marked presence of vari-
ability of treatment patterns, as well as outcomes, between hospitals 
in the treatment of bladder-, lung-, colorectal- and breast cancer. A 
major theme was the volume-outcome relationship. Centralization 
of highly complex, low volume care- treating patients in centers that 
are experienced in a certain treatments, with a high annual number 
of procedures, has been shown to improve outcomes and reduce 
adverse events13,16,17. However, according to the report, a higher an-
nual number of patients receiving a certain treatment per caregiver 
proved to be only a part of the explanation of variation in outcomes 
between hospitals. Several studies showed that centralization based 
on outcomes is more effective than volume-based referral13,18,19. The 
report highlighted the need for further defining quality of care and 
focusing research on the observed differences between hospitals, 
thereby appealing to the increasing demand of patients, policy 
makers and payers for transparency of treatment and outcome in-
formation. This paved the way for various Dutch clinical audits after 
international examples20,21. Not surprisingly, gastrointestinal cancers 
introduction and outline
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surgeons, especially colorectal surgeons, were among the first to 
embrace clinical registries in the Netherlands.
Clinical­registry
The Dutch Surgical Colorectal Audit (DSCA) was initiated in 2009 as 
a nationwide continuous quality improvement program, registering 
all patients undergoing resections for primary colorectal cancer in 
the Netherlands. One of its main focus points is reduction of adverse 
event rates through feedback to participants of results with the 
national average as a benchmark22. The Association of Surgeons of 
the Netherlands agreed on a process in which outcomes of the DSCA 
will become publicly available in a stepwise fashion throughout the 
years. With a high rate of case-ascertainment and participation of 
all Dutch hospitals performing colorectal cancer resections, it is a 
valuable source of information on outcomes of everyday practice of 
colorectal cancer surgery in the Netherlands. Risk factors for adverse 
outcomes can be identified, with inclusion of patients that are usually 
not enrolled in clinical trials because of advanced age or comorbidity. 
The DSCA dataset forms the basis for most chapters in this thesis. 
outlIne­of­thIs­thesIs
In this thesis, hospital variation concerning various outcomes is 
illustrated, thereby exploring the usability of these outcomes for hos-
pital comparisons, both from a clinical and methodological point of 
view. Moreover, the studies provide insight in risk factors for adverse 
events in colorectal and oesophageal cancer surgery, focusing on the 




When hospital-specific outcomes are made available for the public, 
explicit ranking of hospitals based on specific outcomes may be at-
tempted to compare quality of care, as is rather popular in the lay 
press23-25. Postoperative mortality may be considered one of the most 
delicate outcomes, and unjustly stigmatizing a hospital as having a 
high mortality rate may have great impact on its reputation. In rank-
ings, besides differences in casemix, chance variation may play a role. 
The study described in chapter 2 aims to determine to what extent 
chance variation and differences in casemix between hospitals have 
an impact on rankings; and whether postoperative mortality is an 
appropriate outcome to be used for hospital rankings in colorectal 
cancer surgery.
When comparing hospitals on outcomes, there is an important role 
for risk-adjustment, as observed variation between hospitals may 
be influenced by differences in patient- and tumor characteristics 
(casemix) between hospitals. It has been shown, for instance, that 
patients at high risk for postoperative mortality after colorectal 
cancer resections are not evenly distributed among hospitals26. It 
may be valuable to identify outcomes that accurately reflect actual 
differences in quality of care, but are not much influenced by patient 
characteristics. In chapter 3, it is explored to which extent hospital 
variation in anastomotic leak rates can be attributed to differences in 
casemix, in comparison with postoperative mortality.
Another well-known outcome measure in colorectal surgery is 
‘unplanned reoperations’. In the Netherlands, it has long been a com-
pulsory quality indicator for hospitals, traditionally collected by the 
Dutch Healthcare Inspectorate. On a patient level, reoperations are 
obviously associated with adverse outcomes such as complications, 
a prolonged length of hospital stay and postoperative mortality7,27,28. 
introduction and outline
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Less is known, however, about the correlation between reoperation 
rates and other outcomes on a hospital level. In fact, a low threshold 
for a reoperation in case of a suspected surgical complication may 
be part of an effective strategy to reduce postoperative mortality29. 
Chapter 4 studies the value of reoperation rate as a marker for qual-
ity of care in elective colorectal cancer surgery. 
As postoperative mortality is usually preceded by postoperative com-
plications, hospitals with high postoperative mortality rates will in-
tuitively have higher complication rates. However, there is increasing 
evidence that high postoperative mortality rates in certain centres 
is better explained by the way they recognize and rescue patients 
from postoperative complications once they emerge6,30 - reflected by 
the ‘failure to rescue’ rate: the postoperative mortality rate among 
patients with a postoperative complication31. The study described in 
chapter 5 investigates whether high-mortality centers are character-
ized by higher complication rates or by higher failure to rescue rates 
and explores its value for quality improvement programs.
Hospital type (e.g., academic or non-academic hospital) and annual 
hospital caseload (volume) are well-known proxies for surgical ex-
perience, perioperative care, and availability of resources. The envi-
ronment in which a surgical team works may influence the ability 
of the team to keep patients alive when severe complications occur. 
Another seemingly important hospital characteristic, the level Inten-
sive Care facilities available in a hospital, was not studied before in 
this context. Chapter 6 studies the association between these three 
hospital characteristics and failure to rescue rates after colorectal 
cancer resections.
The study presented in chapter 7 of this thesis concerns oesopha-
geal cancer resections. As mentioned above, there is a clear volume-
14
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outcome relationship in oesophageal cancer surgery and minimum 
volume standards are now introduced in various countries. In 
literature, usually arbitrary volume categories are compared and as 
a result, these minimums vary from country to country. In this study, 
the relationship between hospital volume and 6-month and 2-year 
mortality following oesophagectomy in a non-categorical, non-linear 
fashion was determined, exploring how far centralization should go to 
be most effective. The discussion in chapter 7, as well as the general 
discussion of this thesis elaborates whether this should be achieved 
through a higher volume standard or through another process.
In order to reduce morbidity and mortality, it is important to under-
stand the mechanisms behind the development of complications and 
the way they lead to fatal outcomes. Chapter 8 studied rates of anas-
tomotic leak and associated mortality in left-sided and right-sided 
colectomies, assessing the burden and impact of leaks in various 
types of colon cancer resections. Besides anastomotic leak, associ-
ated non-surgical complications may be an important determinant 
of postoperative mortality. The impact of these may be more related 
to patient factors. In the DSCA as well as the British National Bowel 
Cancer Audit Program32, postoperative complication- and reopera-
tion rates appear to be higher after rectal cancer resections than after 
colon cancer resections. However, postoperative mortality rates are 
higher in the latter22. This suggests the risk of dying once a postop-
erative complication has emerged is higher for patients undergoing a 
colon cancer resection. Chapter 9 investigates differences in failure 
to rescue associated with major complications between elective co-
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Objectives: To examine to what extent random variation and 
variation in casemix influence hospital rankings based on mortality 
rates; to determine the suitability of mortality for ranking hospitals 
in colorectal surgery.
Background: Comparing and ranking postoperative mortality rates 
between hospitals becomes increasingly popular. Differences in 
hospital case-mix, and chance variation related to caseload, may in-
fluence rankings. The suitability of mortality for rankings remains 
unclear.
Methods: Data were derived from the Dutch Surgical Colorectal 
Audit. Hospital rankings based on fixed (FE) and random effects 
(RE) logistic regression models, unadjusted and adjusted for case-
mix were compared with the percentile expected ranks (PCER; the 
chance that a hospital performs better than a random hospital). 
Rankability, measuring which part of variation between hospitals 
is not due to chance, was calculated. 
Results: Some 25,591 patients undergoing colorectal resections in 
92 hospitals were evaluated. Postoperative mortality rates ranged 
between 0 and 8.8%. Adjustment for casemix with an FE model 
caused large changes in rankings. A smaller additional effect on 
changes in rankings occurred after adjusting with an RE model, 
with lower volume hospitals moving towards the mean. PCERs 
ranged between 10% and 85%. Rankability was 38%, meaning that 
62% of hospital variation in mortality was due to chance. 
Conclusions: Hospital ranks changed after casemix adjustment and 
random effect models, compared to unadjusted analysis. A large 
proportion of hospital variation in mortality was due to chance. 
Caution should be warranted when interpreting hospital rankings 
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based on postoperative mortality. Percentiles of expected ranks 




Colorectal cancer surgery is performed commonly, but colorectal re-
sections remain associated with morbidity and mortality, accounting 
for 24% of all adverse events in general surgery1. Hence, complica-
tions and mortality are widely used outcomes in colorectal surgery2-5. 
At the same time, society focuses increasingly on effectiveness and 
efficiency in healthcare. Variations in hospital performances have be-
come subject to research6 and various quality improvement projects 
aim at reducing adverse event rates7.
The Dutch Surgical Colorectal Audit (DSCA) is a nationwide con-
tinuous quality improvement program. One of its main focus points 
is reduction of postoperative mortality rates by providing feedback 
of results to participating hospitals, with the national average as a 
benchmark8. The Association of Surgeons of the Netherlands agreed 
on a process in which outcomes of the DSCA will become publicly 
available in a stepwise fashion throughout the years. 
With outcomes made available for the public, explicit ranking of 
hospitals based on specific outcomes may be attempted to compare 
quality of care, as is rather popular in the lay press9-11.  Postoperative 
mortality may be considered one of the most delicate outcomes, and 
unjustly stigmatizing a hospital as having a high mortality rate may 
have great impact on hospital reputation. It is therefore crucial that 
hospital comparisons, especially rankings, are based on sound meth-
odology and should be reliable. After all, when information becomes 
public, allocation of reimbursements by insurers and certification by 
policy makers might be based on such rankings. 
Two issues have to be addressed when comparing hospital perfor-
mances. First, the occurrence of postoperative death may depend on 
the patient’s age, preoperative condition and disease severity. There 
is an increasing body of evidence that case-mix of different hospitals 
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varies12,13. Second, chance variation may play an important role. For 
hospitals with a small number of cases, it is difficult to know whether 
extremely high or low mortality rates are due to chance or caused by 
actual differences in quality of care. Random Effect (RE) regression 
models can be fitted to account for the fact that part of the variation 
in outcomes between hospitals is due to chance14-16. 
Previous studies have examined the influence of random variation 
and differences in casemix on hospital variation and ranking in per-
formance indicators for various types of treatments13,17,18, including 
wound infections and reoperation rates in colorectal surgery. Only 
one study investigated the effect of adjustment for chance variation 
on 30-day mortality after colectomy15, finding a large impact on rank-
ings.
With this background, we aimed to determine to what extent ran-
dom variation and differences in casemix between hospitals have an 
impact on hospital comparisons in mortality rates after colorectal 
cancer resections in the context of the DSCA; and to explore whether 
postoperative mortality is an appropriate outcome to be used for 
hospital rankings in colorectal cancer surgery.
Methods
data­source
Data were derived from the Dutch Surgical Colorectal Audit (DSCA), 
a continuous national quality improvement project in which many 
variables concerning patient and disease-specific details, diagnostics, 
treatment, and outcomes are collected prospectively. Since part of 
the dataset of the DSCA was designed with the objective of perform-
ing casemix adjustment for postoperative mortality, variables were 
determined as risk factors for postoperative mortality at an early 
ranking and rankability
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stage of development of the dataset. These factors were based on 
existing evidence concerning potential risk factors for mortality and 
determined by an expert panel using a Delphi method8,12.
The DSCA contains data registered by all 92 Dutch hospitals per-
forming colorectal cancer surgery8. The dataset shows a high level 
of completeness on most items and a case-ascertainment of approxi-
mately 95% when compared to the Netherlands Cancer Registry 8,19. 
All information concerning individual patients and hospitals are 
made anonymous, making it possible to compare hospitals without 
identifying them.
Primary outcome
The primary outcome was 30-day and/or in-hospital postoperative 
mortality (death within 30 days after the operation, or during the 
index admission).
Statistical methods
To assess hospital’s performance with respect to mortality, patient- 
and treatment characteristics (casemix) were included in the logistic 
regression analysis. Both fixed effect (FE) and random effect (RE) 
models were investigated. The case-mix factors age, gender, Ameri-
can Society of Anaesthesiologists (ASA) score, Charlson comorbidity 
index, body mass index, TNM stage, preoperative conditions related 
to the tumor, tumor location, procedure, preoperative (chemo/
radio)therapy, urgent operations, additional resections and multiple 
synchronous colorectal tumors were included in the models. Details 





The FE logistic regression model is a classical regression model 
in which hospitals were included as a categorical variable by con-
sidering the situations without and with adjustment for case-mix. 
From these two models the log odds of mortality, with and without 
adjustment for differences in casemix between hospitals, and related 
standard errors for each hospital were estimated. Results from the 
FE models are referred to as FE estimates in this article.  
random­effect­model
Random effect (RE) models were used to represent the different 
source of variation in observed hospital-specific mortality rate. These 
models were employed to evaluate to what extent hospital variation 
in postoperative mortality can be attributed to chance. The estimated 
log odds adjusted for casemix between hospitals were computed 
along with a model parameter that describes the between-hospital 
variance (also called heterogeneity). As for the FE model, results from 
the RE are denoted as RE estimates, also known as Empirical Bayes 
(EB) estimates. The Bayesian approach, as introduced by Laird and 
Lewis and Thomas et al., produces shrinkage estimates of individual 
hospital mortality rates towards the national average and produces 
a more stable estimator21,22. In hospitals with a small number of 
cases, shrinking is bigger. The confidence intervals produced by the 
Bayesian methods account for the multiple comparisons problem 
that arises when identifying hospitals with an exceptional outcome 
among all hospitals. The variation in hospital-specific mortality rates 
not due to small sample fluctuations or measureable differences in 
severity of casemix can be quantified. Previous studies have also 




To account for the effect of chance variation on rankings, the ex-
pected rank (ER)21 was used. The ER represents the probability that 
the performance of a specific centre is better than a randomly chosen 
hospital. The ER can be transformed in percentiles based on expected 
ranks (PCER) to scale them between 0% and 100%. 
By fitting a RE model, an estimation of the variability between 
hospitals can be obtained while the FE model provides an estimation 
of the variance for each hospital as it has been described in the Fixed 
Effects section. These quantities can be compared to measure which 
part of the variation between the hospitals is due to true differences. 
This leads to the measure called rankability, which indicates which 
part of variation between hospitals is due to true difference, and 
which part is due to chance24. Rankability is computed by relating 
heterogeneity between hospitals to uncertainty between and within 
centres. From this definition it follows that rankability can be used to 
express how reliable the ranking procedure is. 




A total of 25,591 patients that underwent colorectal cancer resec-
tions in 92 Dutch hospitals between January 1st, 2009 and December 
31st, 2011 were evaluated.  The average hospital case volume in the 
study period was 278 patients (standard deviation 125,2). Patient, 
tumor and treatment characteristics are displayed in table 1. 
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table­1:­aatient-, tumor- and treatment cCaracteristics. 
Characteristic­ n %
Gender Male  4072 55%
Age Mean (standard deviation) 70   
Body Mass Index Kg/m2, mean (standard deviation) 26 4,8
­Carlson co-morbidity index 0  4 89 55%
  5555 22%
 2 34 9  3%
 3 or CigCer 2428  0%
ASA classification I 5 32 20%
 II  3968 55%
 III 5389 2 %
 IV 48  ,90%
 V  5 0, 0%
 Unknown 606 2%
PatCological TNM stage X 943 4%
 I 5270 2 %
 II 8472 33%
 III 7934 3 %
 IV 2972   %
Preoaerative tumor conditions Perforation 409 2%
 Obstruction 2507  0%
 Anaemia/blood loss  389 5%
Location of tumor RigCt Cemicolon 8207 32%
 Left Cemicolon 302  2%
 Sigmoid colon 7 04 28%
 Rectum 7259 28%
Preoaerative treatment SCort course radiotCeraay 34 7  3%
 ­CemoradiotCeraay 2067 8%
 OtCer 564 2%
Procedure Ileocaecal resection 267  %
 RigCt Cemicolectomy 8026 32%




The average mortality was 4.3% (range 0 - 8,8%). The individual 
hospital effects are displayed as a sequence of 95% confidence inter-
vals (95% CI) (figures 1a-1b). The 95% CI’s represent the estimated 
range in which the true effect size for each hospital lies with a likeli-
hood of 95%. Similarly, in figure 1c, posterior probability intervals 
(estimated from the RE model) for the true hospital effects are 
shown. In these three figures, one specific hospital with no mortality 
cases is not shown due to the extreme effect sizes and corresponding 
confidence interval. Although not shown, this hospital was included 
in the analyses. 
Figure 1a shows unadjusted log odds for mortality of all hospitals, 
ranked from the lowest to the highest mortality rate. In this unad-
justed analysis, five hospitals had significantly lower (low outliers) 
and nine hospitals had significantly higher (high outliers) mortality 
rates than average (figure 1a). These are hospitals of which the 95% 
CI’s do not cross 0 (horizontal black line). For illustrative purposes, 
ten arbitrarily chosen hospitals with unadjusted ranks 1, 11, 21, 31 
table­1:­aatient-, tumor- and treatment cCaracteristics. Continued
Characteristic­ n %
 Left Cemicolectomy  854 7%
 Sigmoid colectomy/low anterior 
resection
  092 44%
 Subtotal colectomy 400 2%
 Abdominoaerineal resection 2240 9%
 Panaroctocolectomy 245  %
 OtCer 622 3%
Urgency of arocedure Urgent/emergency arocedure 3840  5%
Additional resections Locally advanced tumor 2448  0%
 Metastasectomy 82 3%
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etc. up to 91 are marked with a specific colour and letter (A through 
J). 
After adjustment for case-mix by fitting a FE model, hospitals 
changed ranks, as can be seen by tracking the positions of hospitals 
A-J in figure 1b compared to figure 1a. Only two hospitals remained 
low (significantly lower mortality than average) and five hospitals 
remained high outliers (figure 1b). Hospital A appeared to perform 
better than the average in the unadjusted analysis (figure 1a), but this 
proved to be partly due to a favourable casemix as the hospital was 
not a low outlier after fixed effect adjustment for casemix (figure 1b). 
After adjustment using a RE model with hospitals as a random effect, 
confidence intervals shrunk and only three high and one low outlier 
remained (figure 1c). Hospital J consistently remained a high outlier 
(significantly higher mortality than average) in all three models.
ranking
Table 2 shows a quantification of change in ranks between unadjusted 
analysis and after adjustment for casemix with a FE model (A), and 
the extent of change in ranks between the FE and RE model analysis 
(B). 
After adjustment for casemix in the FE model, 4 hospitals moved 
more than 30 places in the ranking. One of these hospitals moved 
from the lowest 20% (rank 79) to the middle 20% (rank 44), and 
two hospitals moved from the middle 20% to the bottom 20% (i.e. 
from the 51st to the 78th place, and from the 56th to the 85th place, 
respectively). One specific hospital moved from the 57th to the 15th 
rank.  Four other hospitals changed between 21 and 30 ranks, and 23 
hospitals changed between 11 and 20 ranks. Overall, three of the 18 
‘best’ hospitals (top 20% in rank) moved out of the top 20%, and six 
of the 18 ‘worst’ (lowest 20% in rank) moved out of the bottom 20%. 
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By fitting a RE model, three top-20% hospitals moved out of this 
group, and three of the bottom-20% hospitals moved out of this 
group. One hospital moved down 45 ranks from the 43rd place to the 
88th place; one changed from the 4th to the 29th place; and another 
one from the 89th to the 68th rank. Eventually three hospitals changed 
between 11 and 20 ranks, and for 11 hospitals the rank remained as 
in the FE model analysis.
For illustrative purposes, table 3 shows the respective ranks for 
postoperative mortality for hospitals A – J with the three differ-
ent models as used in figure 1a-1c. In addition, the PCER for these 









>30 ranks CigCer 3 0
2 -30 ranks CigCer   
  -20 ranks CigCer    
6- 0 ranks CigCer 9  2
 -5 ranks CigCer 24 32
same rank 3   
 -5 ranks lower  7 20
6- 0 ranks lower 8   
  -20 ranks lower  2 2
2 -30 ranks lower 3  
>30 ranks lower   
table­2:­­Cange of ranks a) between results from unadjusted analysis and analysis witC 




probability that a specific hospital has a better performance than a 
randomly selected hospital i. 
Hospital A was highest in rank in unadjusted analysis, but moved to 
the 6th and 19th place in adjusted analysis and in the RE model analy-
sis. Hospital A had PCER equal to 66%; this means that there is 66% 
probability that hospital A would have better mortality rates than 
a randomly selected hospital. Hospitals A, C, and D, in unadjusted 
analysis ranked 1, 21, and 31 had quite similar PCERs (64%-68%). 
The distribution of the PCERs for all hospitals is shown in figure 2. 
As Figure 2 shows none of the hospitals could be classified as the 
worst or the best hospital (0% or 100%). Hospitals’ percentiles of all 
hospitals ranged from 10% to 85%. PCER for hospital B was 74%, im-
plying that there is 74% probability that hospital B performs better 
than a randomly selected hospital. On the other hand, hospital J with 
a PCER of 10% still had a 10% chance of not being the worst perform-
table­3
hospital unadjusted­rank fe­adjusted­rank re­adjusted­rank er percentile­er
A   6  9 3 .3 65,6%
B     3 7 24. 73,8%
­ 2  23  8 30.2 67,6%
D 3  20 22 33. 64,2%
E 4 36 35 40.6 56,2%
F 5  4  38 4 .5 55,4%
G 6  8  82 67.3 27,3%
H 7  72 72 60.2 35,2%
I 8  89 68 57.3 38, %
J 9  90 90 83. 9,9%
table­3:­ranks on aostoaerative mortality of Cosaitals A-J (ranked  st,   tC, 2 st, 3 st and 
so on in unadjusted analysis) based on results from different models. FE= fixed effect; 
RE=random effect; ER= exaected rank. 
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ing hospital. The hospital with the highest PCER of all 92 hospitals 
was ranked 12th in unadjusted analysis (not shown in table 2). 
rankability
 Rankability without and with adjustment for case-mix was equal to 
44% and 38% respectively. Rankability can be interpreted as part of 
Hospitals ranked








figure­2:­aercentiles exaected rank (P­ER) on aostoaerative mortality for all Cosaitals. 
Hosaitals A tCrougC J, in unadjusted analysis ranked  st,   tC, 2 st, 3 st etc., are marked for 
illustration auraoses. 
* Hosaital witC no mortality cases.
ranking and rankability
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the observed differences between centres not due to chance; while 
the rest is due to natural variations or chance. A value of rankabil-
ity equal to 38% implies that 62% of the variation in postoperative 
mortality between hospitals was due to chance while 38% may be 
considered due to true differences in hospital performance. 
dIsCussIon
Our study is the first to look at the rankability concept of postopera-
tive mortality in colorectal surgery. In our study we estimated that 
62% of the variation in postoperative mortality between hospitals 
was due to chance. We found that the differences in hospitals’ ranks 
between unadjusted and FE adjusted analysis were considerable. 
To a lesser extent, rankings changed again after fitting RE models. 
Finally, we illustrated the differences between rankings on mortality 
rates based on FE and RE models and compared these rankings to 
result from the PCER measure, which estimated the probability that a 
hospital has a better mortality rate than a randomly chosen hospital.
Dimick et al., assessing mortality rates in 18,454 colectomy patients 
from 181 hospitals participating in the American National Surgical 
Quality Improvement Program (NSQIP), found large differences be-
tween hospital rankings based on FE and RE models15. In our study, 
we also detected effect of the RE model on rankings, although in our 
study, drastic relevant changes in rank (e.g. moving from the top or 
bottom 20% in comparison with ranking based on FE modelling) 
only occurred in 3 of the bottom-20% and 3 of the top-20% hospitals 
when comparing ranks based on the FE model with the RE model 
results. Dimick et al. found that the FE model ranking potentially mis-
classified 25% of the top-20% hospitals and 25% of the bottom-20% 
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hospitals when comparing with the RE model ranking. Our dataset 
might be more homogenous in terms of variation in hospital volumes 
and mortality rates between hospitals, which could be a possible 
explanation for the different findings. Both studies suggest the use 
of EB methodology when ranking hospital outcomes and this method 
should still be preferred over the more traditional FE models. 
The novelty of our work concerns the use of rankability, as intro-
duced by van Houwelingen et al.24, for postoperative mortality in 
colorectal surgery. Rankability gives an idea of how a specific out-
come accurately reflects hospitals’ performance. Previous studies 
have looked at rankability in different outcomes. Van Dishoeck et al. 
studied seven performance indicators18. For the performance indi-
cator ‘unplanned reoperations after colorectal surgery’, rankability 
was relatively high (71%), but for all the other remaining indicators 
rankability was lower (e.g., 58% for in-hospital mortality following 
myocardial infarction, 38% for pressure ulcer incidence). Unfortu-
nately, the authors were unable to perform adjustments for casemix 
in this study. In a similar study, looking at surgical site infections for 
various procedures in 34 Dutch hospitals, the same authors found a 
rankability of only 8% for this outcome when all procedures were 
combined; however for colectomies, the rankability for surgical site 
infections was 80%. An exact rule that can be used to assess the reli-
ability of a specific ranking does not exist.  Lingsma et al. suggest that 
any ranking is meaningless when rankability is smaller than 50%, 
and that ranking can be used if rankability is bigger than 75% 25. In 
our study, the rankability for postoperative mortality after colorectal 
surgery was rather low, 38%, suggesting that this measure is not 
appropriate for ranking hospitals. Should it be attempted, the PCER 
can be used. The PCER can be interpreted as an estimate of the prob-
ability that the mortality rate of a specific hospital is smaller than 
ranking and rankability
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the mortality rate of a randomly selected hospital. In this study the 
PCERs ranged from 10% to 85%.
The necessity of adjusting for casemix factors when comparing 
outcomes between hospitals is well established13,26. Kolfschoten at 
al. showed differences in patient characteristics between hospitals 
in the DSCA dataset, leading to different expected mortality rates12. 
Siregar et al. showed that hospital rankings on mortality following 
cardiac surgery are greatly influenced by adjustment for casemix 
with an RE model.
 We came to the same conclusion for colorectal cancer surgery. We 
furthermore showed that outlier status (ie. hospitals having a sig-
nificantly lower or higher mortality rate than average) changes after 
adjusting for case-mix factors. 
Our study has some limitations. Firstly, although many casemix 
variables were available, there may have been unknown confound-
ing variables not available in the dataset that may have influenced 
variation in outcomes between hospitals. However, colorectal cancer 
surgery experts constructed the DSCA dataset, and special attention 
was given to case-mix variables necessary for fair hospital compari-
sons8,27. 
 One specific hospital had no observed cases of mortality. In un-
adjusted and adjusted FE analysis this hospital had an enormous 
(negative) effect size with extraordinarily large confidence intervals. 
For this reason, the estimates for this hospital were not displayed 
in the figures. This example illustrates the shortcomings of a FE 
model when there are no observed events in a hospital, which is not 
unlikely to happen in a sample with many hospitals. Arguably this 
hospital may perform well since there were no postoperative deaths 
in three years. Nonetheless, it is difficult to draw statistically valid 
conclusions from this observation in FE analysis. The EB methodol-
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ogy overcomes this problem and an estimated hospital effect can be 
found in hospitals with no events. The PCER for this specific hospital 
was equal to 83% with an ER of 16.7.
In this study, we used pooled data from three registration years 
of registration. The longitudinal aspect of the data is beyond the 
scope of this manuscript, but in a future work it will be investigated 
whether results based on correlation across years might be used to 
make predictions about center effects. 
There is an on-going debate whether outcome measures such as 
postoperative mortality adequately reflect quality of care. Some 
advocate using process measures (e.g. guideline adherence) in 
measuring quality of care, because these factors can be improved 
more concretely by hospitals with poor performance. However, what 
counts for patients are outcomes. Most probably, quality of care is 
best expressed as a combination of process and outcome measures, 
or even composite measures comprising both28. For this study, 
postoperatively mortality was chosen because it is well defined and 
may be considered quite delicate: unjustly stigmatizing a hospital 
as having high postoperative mortality may have a dramatic impact 
on hospital reputation and reimbursements. We found that 62% 
of variation in mortality between hospitals is due to chance, which 
implies that great caution should be used when interpreting hospital 
comparisons and rankings on this outcome. However, since this is 
an important outcome for patients, it seems worthwhile to continue 
measuring postoperative mortality rates. Another important reason 
to continue collecting and reporting postoperative mortality infor-
mation is that evidence shows that feedback of surgical outcomes 
to physicians can lead to improvement29,30.  Recently, in the UK, 
postoperative mortality data per surgeon has become publicly avail-
able on the Internet. Presumably, the influence of chance variation is 
ranking and rankability
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even greater in that situation, since the number of patients for each 
surgeon is rather small.
Measuring quality of care may have internal and external purposes. 
The DSCA is used as a system for benchmarking: surgical teams from 
the participating hospitals can compare results and improve in re-
lation to the national average. This is an internal purpose. With an 
increasing demand for transparency of quality information, however, 
more information becomes public. Eventually, (risk-adjusted) out-
come information will become public too. In this situation, third par-
ties may compare outcomes between hospitals. Payers have limited 
resources and want to allocate them to the best performers. Ranking 
can be used in this context and therefore people should be aware of 
the reliability of such lists. The magnitude of differences between two 
hospitals is lost: one hospital is simply higher in rank than the other. 
Moreover, a hospital can move down on a ranking list as a result of 
another one moving up, even when performance remains the same. 
The advantage of the PCER measure is that it can be interpreted on its 
own, and it can be very useful in helping payers and patients to make 
decisions.  The uncertainty concerning the outcome is included in the 
percentage ascribed to each hospital: the chance that the selected 
hospital has a better outcome than a randomly selected hospital. We 
suggest that when outcome information such as postoperative mor-
tality becomes public, PCERs should be published with them. Reliable 
information on specific performance indicators may be extremely 
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Introduction: When comparing mortality rates between hospitals to 
explore hospital performance, there is an important role for adjust-
ment for differences in casemix. Identifying outcome measures that 
are less influenced by differences in casemix may be valuable. The 
main goal of this study was to explore whether hospital differences 
in anastomotic leakage (AL) and postoperative mortality are due to 
differences in casemix, or to differences in treatment factors. 
Methods: Data of the Dutch Surgical Colorectal Audit were used. 
Casemix factors and treatment related factors were identified 
from the literature, and their association with anastomotic leak-
age and mortality were analyzed with logistic regression. Hospital 
differences in observed anastomotic leakage and mortality rates; 
and adjusted rates based on the logistic regression models were 
shown. The reduction in hospital variance after was adjustment 
was analyzed with a Levene’s test for equality of variances.
Results: 17 out of 22 case-mix factors and 4 out of 11 treatment fac-
tors related to anastomotic leakage derived from literature were 
available in the database. Variation in observed AL rates between 
hospitals was large with a maximum rate of 17%. This variation 
could not be attributed to differences in casemix, but more to differ-
ences in treatment factors. Hospital variation in observed mortality 
rates was significantly reduced after adjustment for differences in 
casemix.
Conclusions: Hospital variation in anastomotic leakage is relatively 
independent of differences in casemix. In contrast to ‘postopera-
tive mortality’ the observed anastomotic leakage rates of hospitals 
evaluated in our study were only slightly affected after adjustment 
for case-mix factors. Therefore, anastomotic leakage rates may be 
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Nowadays there’s a growing public interest in quality of medical and 
surgical care, with an increasing urge for outcome measures that rep-
resent hospital performance. The outcome measure postoperative 
mortality is often used to benchmark surgical performance.1-3 When 
comparing mortality rates between hospitals, there is an important 
role for risk adjustment.4, 5 Observed variations in mortality may be 
caused by differences in patient and tumor characteristics (casemix), 
and high risk patients may not be evenly distributed between hospi-
tals.6 
However, valid casemix adjustments require a substantial amount 
of reliable data collected on a patient level. These data are rarely 
available and require a substantial registration effort. Therefore, it 
may be valuable to identify outcome measures that are less influ-
enced by differences in casemix and represent the actual differences 
in quality of care processes.
Colorectal cancer is a significant source of mortality with nearly 
10,000 new cases diagnosed in the Netherlands each year.7 The 
cornerstone of this treatment is surgical resection. Patients under-
going surgical resection have a considerable risk for postoperative 
complications, which can lead to significant morbidity, mortality and 
large costs. Internationally, several quality improvement programs 
have therefore been initiated to reduce postoperative complications 
after colorectal surgery. 
Anastomotic leakage is one of the most feared complications after 
colorectal surgery, often causing prolonged hospital stay, morbidity, 
mortality and possibly worse oncological outcomes.8 The percentage 
of patients developing anastomotic leakage depends on multiple 
factors. In literature, several elements have been identified as risk 
factors. These can be patient- or tumor-related, often referred to as 
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casemix, such as height of the anastomosis, a malnourished status, 
steroid use and male gender.9-13  Treatment related factors such as 
surgeons’ experience, operative duration, blood loss, preoperative 
radiation and a defunctioning stoma have also demonstrated to be 
associated with the occurrence of anastomotic leakage.9-13 
The aim of this study was to explore whether hospital differences 
in anastomotic leakage rates are related to differences in casemix. 
We compared the role of casemix adjustment for anastomotic leak-
age and postoperative mortality. With this objective, the following 
research questions were drawn: 
1. Which casemix and treatment related risk factors are associ-
ated with anastomotic leakage and postoperative mortality after 
colorectal surgery? 
2. What are differences in anastomotic leakage and mortality rates 
between hospitals and are these due to differences in casemix or 
due to differences in treatment-patterns? 
Methods
patients
Data was derived from the Dutch Surgical Colorectal Audit (DSCA), 
a national quality improvement project in which over 200 variables 
concerning the patient, comorbidity, diagnostics, disease-specific 
details, treatment, and outcomes are collected prospectively. The 
DSCA contains data of patients registered by 92 hospitals (all hospi-
tals performing colorectal cancer surgery). The data set is disease-
specific for colorectal cancer and shows a nearly 100% accordance 
on most items, including anastomotic leakage on validation against 
the National Cancer Registry (NKR) data set.14 All patients under-
anastomotic leakage
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going resection for primary colorectal cancer between the 1st of 
January 2009 and 31st of December 2011 and registered in the DSCA 
before March 15th 2012 were evaluated. Minimal data requirements 
for inclusion in analyses were information on tumor location, date of 
surgery and mortality. Patients with metastases at time of primary 
surgery and resections for multiple synchronous colorectal tumours 
were excluded, because these represent subgroups of patients with 
other treatment perspectives and subsequent different expected 
outcomes. Also, patients in which a primary end-colostomy was 
constructed were excluded from analysis.  
risk­factors­
Since part of the dataset of the DSCA was designed with the objec-
tive of performing casemix adjustment particularly for postop-
erative mortality, variables have been determined as risk factors 
for postoperative mortality in an early stage of conduction of the 
dataset. These factors were based on existing evidence on potential 
risk factors for mortality and determined by an expert panel using 
a Delphi method.6 To assess whether there are additional casemix 
and treatment related risk factors that need to be taken into account 
when adjusting for anastomotic leakage, we performed a systematic 
search for literature published between 1990 and 2012 on biomedi-
cal bibliographical databases Pubmed and the Cochrane Library. The 
search headings “anastomotic leak and colorectal surgery” were used 
in combination with the keyword “risk factor”. The “related articles” 
function was used to expand the search. References from the articles 
were also used when appropriate. Letters, reviews without original 
data, non-English language papers, overlapping patient populations 
and animal studies were excluded.  From the articles retrieved from 
the literature search, different risk factors for anastomotic leakage 
were selected. A distinction was made between patient and tumor 
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related factors (casemix factors) and treatment related factors. We 
selected risk factors with a statistical significance of p <0.05, which 
were analyzed with multivariate logistic regression.
outcomes
Various definitions of AL have been previously presented.15 The defi-
nition of anastomotic leakage in this study was ‘a clinically relevant 
anastomotic leak requiring a re-intervention’. Both radiological and 
surgical re-interventions were included.  Postoperative mortality 
was defined as ‘death during postoperative hospital stay or within 30 
days after the date of surgery’. 
analyses
The association of casemix and treatment factors and both anasto-
motic leakage and mortality were tested with multivariate logistic 
regression models. Separate models were used for each outcome. 
To analyze the differences in anastomotic leakage and mortality 
between hospitals and investigate whether these were due to dif-
ferences in case-mix or due to differences in treatment-patterns we 
applied 3 different models. model 1: unadjusted (observed) variation 
in outcome; model 2: adjusted for patient (casemix) characteris-
tics; model 3: ‘adjusted’ for casemix and treatment characteristics. 
Adjustment was performed by calculating expected outcomes (E) 
using casemix (model 2) and both casemix and treatment (model 3) 
coefficients from the regression analysis. Next, for each hospital, the 
observed percentage (O) was divided by the expected value (E) and 
multiplied by the overall mean (observed/E * mean) to obtain the 
adjusted percentages.
Hospital differences in anastomotic leakage and mortality rates 
before and after adjustment were plotted in a graph; a summary 
measure of the between hospital variance was given with ranges 
anastomotic leakage
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and standard deviations. The reduction in between center variance 
after adjustment for (model 2) casemix and (model 3) casemix and 
treatment factors was analyzed with a Levene’s test for equality of 
variances.  A p-value <0,05 was considered statistically significant. 
Furthermore, a mixed logistic regression model with hospitals as 
random effects was performed A likelihood ratio test was used to test 
whether the variance of the random effects was statistically signifi-
cant after adjustment for casemix and treatment factors. Hospitals 
with more than 15% missing casemix factors were excluded from 
multivariate analyses.  All statistical analyses were performed in 
PASW Statistics, Rel. 18.0.2009. Chicago: SPSS and R version 2.14.16 
results
On March 15th 2012, 92 hospitals (8 university, 47 teaching and 37 
non-teaching hospitals) registered a total of 25,555 eligible primary 
colorectal cancer patients with a date of surgery between January 
1st 2009 and December 31 2011 in the DSCA. Nine hospitals had 
more than 15% missing case-mix factors in total, and were therefore 
excluded (n=1,460). After additional exclusion of patients with mul-
tiple synchronous tumors (n=598), distant metastases (n=2,032) and 
without an anastomosis (n=5,480), a total of 15,236 patients were 
included in the analysis. Characteristics of the included patients are 
shown in Table 1.
Of all patients, 1207 patients (8%) developed anastomotic leak-





The literature search gave a total of 39 studies describing risk fac-
tors for anastomotic leakage.8, 10-13, 17-49 In total, 22 casemix factors 
and 11 treatment related factors for were identified. Table 1 shows 
the results. Casemix factors described most frequently were gender, 
American Society of Anesthesiologists (ASA) score and location of 
the tumor and/or anastomosis. Treatment factors often described 
were blood loss/transfusion, duration of the operation and the use of 
a defunctioning stoma.
Of the 22 casemix factors for anastomotic leakage identified in 
literature, 17 were available in the DSCA. The database had no in-
formation on the factors weight loss, nutrition status, alcohol abuse, 
smoking and leukocytosis. Treatment factors were less often avail-
able; 4 out of 11 were available in the dataset. 
The casemix and treatment related risk factors that were found 
for anastomotic leakage in literature were similar to those that have 
been used for risk adjustment for postoperative mortality in the 
DSCA dataset.
A multivariate analysis has been performed to investigate the as-
sociation of casemix and treatment factors with anastomotic leakage 
and postoperative mortality; results of the analysis are shown in 
table 2. 
Individual casemix factors predicting anastomotic leakage were 
male gender, urgency of the resection, renal disease and tumor loca-
tion. Treatment related factors associated with anastomotic leakage 
were short preoperative radiotherapy, the absence of a defunctioning 
stoma and postoperative blood transfusion. For postoperative mor-
tality the case-mix factors age, gender, ASA score, pulmonary disease, 
tumor location sigmoid, urgency of the resection were individual pre-
dicting factors. Treatment related factors were chemo-radiotherapy 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































table­2:­­asemix and treatment factors included in tCe multivariate logistic regression 
model for AL and mortality after colon and rectal carcinoma resections. Age and BMI were 
analyzed as continuous variables. AL= anastomotic leakage; ­I= confidence interval; OR= 
odds ratio; ASA= American Society of AnestCesiologists score; BMI = Body Mass Index. Bold 
arinted numbers are significant odds ratios (a < 0.05).
­ ­ al Mortality




Age 0.99 0.98  .02 2.65 2.33 3.04
Gender male 1.31 1.11 1.55 1.82 1.39 2.37
ASA 2  .0 .84  .22 3.09 1.54 6.17
 3+  .00 .80  .24 6.44 3.46 13.12
BMI .9 .74  . 3 .99 .97  .02
2 or more comorbidities .88 .70  . 0  . 7 .82  .67
­ardiovascular disease .85 .70  .04  .2 .90  .62
Pulmonary disease .92 .7  .20 1.44 1.06 1.97
Diabetes .99 .77  .28  . 2 .8  .55
­roCn’s disease  .06 .43 2.60  .35 .36 4.98
Preoaerative blood loss .72 .42  .25 .68 .23 2.00
Steriod treatment  .27 .8 2.00  .25 .72 2. 5
Renal disease 1.34 1.01 1.78 .9 .62  .34
Abdominal surgical 
Cistory
 .03 .87  .22 .87 .67  . 4
T-stage T3  .03 .87  .2  .05 .8  .36
 T4  . 3 .78  .64  .22 .7 2. 0
Additional resection  .20 .88  .64 .96 .59  .55
Urgent resection 1.32 1.01 1.73 2.18 1.60 2.98
Tumor location Transverse colon 1.93 1.49 2.50  .25 .89  .76
 Sigmoid 1.68 1.33 2.11 .70 .50 1.00
 Rectum 2.22 1.49 3.29  .04 .52 2.04
Treatment factors
Neo-adjuvant tCeraay 5x5 1.70 1.13 2.54 .88 .42  .85
 ­CemoradiotCeraay  .33 .84 2.09 .30 .09 .98
Defunctioning Stoma .54 .42 .70  . 5 .69  .89





Unadjusted hospital variation in anastomotic leakage rates was large: 
the hospital with the lowest percentage had an anastomotic leakage 
rate of 0% (n=0/166); the hospital with the highest percentage had 
an anastomotic leakage rate of 18% (n=12/70) (SD 0.036,, Figure 1a). 
After adjustment for casemix, there was still a large variation be-
tween hospitals: the adjusted anastomotic leakage rates per hospital 
ranged from 0 to 17% (SD 0.033). The reduction in variation after 
adjustment for casemix was not statistically significant (p=0.52). 
The variance in anastomotic leakage rates significantly decreased 
after including treatment factors in the adjustment model (p<0.01). 
Casemix and treatment adjusted anastomotic leakage rates varied 
from 0 to 12% (SD 0.024). 
For 60% of the hospitals (50/83), the unadjusted anastomotic 
leakage rate was similar to the casemix adjusted anastomotic leakage 
rate. In 36% of the hospitals, anastomotic leakage rates slightly in-or 
decreased with 1%, and in 4% of the hospitals with 2% (Figure 2a). 
For 75% of the hospitals (63/83), unadjusted anastomotic leakage 
rate altered after adjustment for treatment factors with at least 1%; 
for 32% of the hospitals, the unadjusted rate altered with more than 
3% and for 10% with more than 5%. 
Although hospital variance decreased after adjustment for casemix 
and treatment factors, there was still variability between hospitals as 
a likelihood ratio test showed that the variance of the random effects 













































figure­1:­Boxalots aresenting tCe range in Cosaitals’ anastomotic leakage rates (A) and 
mortality rates (B). TCe unadjusted range (left), tCe range after adjustment for case-mix 
(center), and tCe range after adjustment for case-mix and treatment factors (rigCt) are 
sCown. P-values describe tCe statistical significance of tCe reduction in variance (Levene’s 













































































































































































































































































































Hospitals’ unadjusted mortality rates ranges from 0 to 10% (SD 
0.017). The variance in postoperative mortality significantly de-
creased after casemix adjustment (p<0.01) (range 0-6%, SD 0.012, 
Figure 1b). 
The variance in postoperative mortality rates slightly increased 
(range 0-6%, SD 0.013)  after including treatment factors in the ad-
justment model, although not statistically significant (p=0.81). 
For 84% of the hospitals (70/83), the unadjusted postoperative 
mortality rate altered after adjustment for treatment factors with at 
least 1%; for 24% of the hospitals, the unadjusted rate altered with 
more than 3% and for 6% with more than 5% (Figure 2b).  
Adjustment for treatment factors had a slight effect on two hospi-
tals when compared to the casemix adjusted mortality rate. In these 
hospitals, case-mix adjusted mortality rate altered with 1% after 
adjustment for treatment factors. 
Hospital variability in postoperative mortality was still significant 
after adjustment for casemix and treatment factors, as a likelihood 
ratio test showed that the variance of the random effects was statisti-
cally significant in all models.
dIsCussIon
The present study suggests that ‘anastomotic leakage rate’ is an 
outcome indicator for measurement of surgical quality of care that is 
relatively independent of differences in casemix between hospitals. 
We found a large variation in anastomotic leakage rates between 
Dutch hospitals, which confirm the ability of this outcome indica-
tor to be discriminative. In contrast to ‘postoperative mortality’ the 
observed anastomotic leakage rates of hospitals evaluated in our 
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study could not be explained by differences in casemix.  In addition, 
we found that the influence of treatment factors on the variation in 
anastomotic leakage rates was substantial. These findings imply that 
anastomotic leakage rates may be much more related to treatment 
factors and in hospital care processes, than to characteristics of the 
patient population treated in a certain hospital. Anastomotic leak-
age rates may therefore be a good reflection of the quality of care 
provided. 
outcome­measures
Optimizing surgical outcomes can be seen as ‘the bottom line’ of what 
surgeons do, and outcome indicators have the advantage that they 
have ‘face validity’ for surgeons as well as for their patients. Also, 
measurement in itself may improve surgical outcomes – as suggested 
by the so-called Hawthorne effect. 4 As shown in our study, outcome 
indicators can present meaningful differences between hospitals. 
However, there was still significant variability in both anastomotic 
leakage and mortality rates, after adjustment for case mix factors 
and treatment factors in our study. This suggests that there are other 
characteristics of the hospital, its staff and the care they deliver, which 
may explain the observed differences. Although outcomes of care are 
important, process and structure information is essential to identify 
which area is susceptible for innovation. Therefore, adopting to the 
Donabedian paradigm50, a balanced indicator set needs to include 
information on structures, processes and outcomes. 
limitations­
The results presented in this study should be interpreted in the 
light of some important limitations. First, despite the fact that most 
patient-related risk factors were available in the database of the 
DSCA, it lacked data on some important host-related factors, such 
anastomotic leakage
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as smoking, alcohol consumption, nutrition status and preoperative 
leukocytosis. Although unlikely, it is possible that a strong casemix 
adjustment model for AL could have been made when exactly those 
four missing factors would have been available from the data set. 
Also, high risk patients according to the surgeons’ preoperative risk 
judgment or patients with impaired continence at baseline may 
not have been selected for a primary anastomosis, and therefore 
excluded which may have caused a potential selection bias. It is not 
exactly clear how these differences in patient selection might affect 
the between hospital comparisons.  Moreover, due to a lack of clear 
agreements on definitions, the factors we used may not have been 
identical to the ones we found in literature. 
Although we found that casemix adjustment does not seem to play 
a large role when comparing hospitals’ anastomotic leakage rates, 
there are some limitations of using it as an outcome indicator that 
deserve mentioning. It may unintentionally lead to the perverse 
incentive of aiming for the lowest possible anastomotic leakage rate 
by constructing more end-colostomies or defunctioning stomas. This 
defensive attitude would not immediately contribute to a higher 
quality of care, as a surgeon or clinic that has zero AL rates at the 
cost of constructing defunctioning stomas or end-colostomies in all 
patients will not be regarded as the best practice. Obviously, anas-
tomotic leakage rates are only calculated over patients in whom an 
anastomosis has been created.  Therefore hospitals, with lower rates 
of patients with anastomoses could automatically have better scores, 
without immediately better quality of care, as the stoma itself may 
cause morbidity, lead to a higher need for readmissions51, 52 and may 
be associated with morbidity at the time of surgical removal of the 
stoma.53 In reality, there is probably an optimum percentage of de-
functioning stoma’s and end-colostomies to be created, and AL rates 
should always be seen in the light of these percentages. However, the 
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exact optimum is unclear and it may vary between different surgeons 
or clinics. Auditing programs like the DSCA may help to clarify in 
what range this optimum should be. A composite quality measure 
might be a solution, that is a metric which includes whether or not 
AL occurred, creation of a defunctioning stoma or end-colostomy, 
readmissions or mortality. Patient reported outcomes are of additive 
value in this context. The choice between an anastomosis with or 
without a defunctioning stoma or an end-colostomy can and should 
always be influenced by patient preferences.
Improvement­of­outcomes­
When anastomotic leakage is used in hospital comparisons, it should 
be under the condition that practices with higher anastomotic 
leakage rates have the opportunity to improve their performance. 
Unfortunately, the actual cascade of factors resulting in anastomotic 
leakage still remains a ‘black box’. Our findings suggest that this black 
box consists of factors that represent multiple elements of the care 
processes taking place within a hospital. Per-operative factors, such 
as blood loss and duration of the operation have been described as 
important predictors for AL by several authors.9-13 Longer duration, 
more blood loss than anticipated, an increased anastomotic strain 
and limited vascular supply at the anastomotic sites may be a proxy 
of a more complicated procedure, suggesting that anastomotic leak-
age rates might be related to surgical technical skill and experience. 
Additionally, factors more related to perioperative care than to surgi-
cal skill, such as oliguria during the operation, are are also said to 
enhance the risk for leakage.54 
The ultimate challenge for outcome researchers is to understand 
the complex clinical mechanisms that lead to success or failure, so 
that the excellence of best practices can be transferred to all hospitals 




Comparison of AL between hospitals also requires the use of stan-
dard definitions and methods of measurement of AL. It has however 
been stated before that the definition of AL varies; a systematic re-
view done by Bruce et al. found 56 separate definitions for AL used 
in literature.15 A valuable feature of an audit registration system is 
that it applies one definition that is used by all participants. In the 
DSCA; only clinical apparent leaks requiring re-intervention have 
been registered, and a distinction has been made between radiologi-
cal and surgical re-intervention. Further (international) agreement 
on a standard definition that is valid and reliable, and can distinguish 
between clinical minor and major anastomotic leaks are explicitly 
important when using anastomotic leakage as an outcome indicator. 
Conclusions
Hospital variation in anastomotic leakage rates is relatively inde-
pendent of differences in case-mix. Differences in treatment factors 
contributed more to the variation of anastomotic leakage rates. 
Further exploration of in-hospital factors may give insight in further 
improvement possibilities and understanding the multifactorial pro-
cess that underlies anastomotic leakage. Audit programs may provide 
data for targeted visitation of clinics with bad outcomes, as well as 
best practices, aiding in identification of the most important areas 
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Background: “Unplanned reoperations” has been advocated as a 
quality measure in colorectal cancer surgery as it is correlated 
with complications and postoperative mortality at a patient level. 
However, little is known about the relation between reoperation 
rates and postoperative mortality rates at a hospital level.
Methods: Data were derived from the Dutch Surgical Colorectal 
Audit 2009-2012 database. Hospitals with significantly higher and 
lower reoperation rates than average were identified and grouped 
accordingly. Postoperative mortality rates were compared between 
the groups.
Results: Some 28,667 patients who underwent elective colorectal 
cancer resections in 92 hospitals were analyzed. Fourteen hospitals 
had significantly higher (mean 14.6%) adjusted reoperation rates 
than average (10%), 20 had lower (5.3%) rates than average. Ad-
justed mortality rates were similar in groups with high reoperation 
rates and the majority cohort (3,5-3,2%) and significantly lower in 
hospitals with low reoperation rates (2,3%). However, individual 
hospitals with relatively high reoperation rates had low mortality 
rates and vice versa. 
Conclusions: Reoperation rates after elective colorectal cancer 
resections varied. Hospitals with significantly higher reoperation 
rates than average did not have higher mortality rates. The group 
with lowest reoperation rates also had lower postoperative mortal-
ity rates; however, this did not apply to all hospitals in the group. In 
conclusion, ‘reoperations’ seems suitable as benchmark informa-
tion to hospitals but less suitable to detect poor performers. Best 
practices should be identified as hospitals with both low reopera-




There is an increasing demand for transparency of information that 
aids in rating hospitals’ performance, both from policy makers and 
patients. At the same time, clinical outcome registries are becoming 
more widespread, helping caregivers to improve by generating bench-
mark information1. As a result, measuring and comparing quality of 
surgical care has become increasingly important in the last decades, 
and in several quality improvement projects, quality indicators have 
been defined2. Quality indicators measure a certain aspect (structure, 
process, or outcome3) of care and are compared against a standard 
or average. They may be used for internal purposes (feedback and 
quality improvement) as well as external purposes (making public of 
information on hospital performance).
Colorectal surgery is associated with relatively high surgical post-
operative morbidity rates4 and accounts for a disproportionate share 
of reoperations within the spectrum of general surgery5. “Unplanned 
reoperation” is a well-accepted quality measure for colorectal 
surgery. In the Netherlands, it is a compulsory quality indicator col-
lected by the Dutch Healthcare Inspectorate. Many publications have 
concluded that the measure is suitable as a quality measure because 
it is a factor independently associated with other adverse outcomes 
such as prolonged hospital stay and postoperative mortality5-7. Obvi-
ously, this is because of the close relationship between reoperations 
and surgical complications such as anastomotic leak or haemor-
rhage. An advantage over postoperative mortality as an outcome 
indicator would be that in elective surgery, postoperative mortality 
is less frequent and may therefore not discriminate worse perform-
ing hospitals from better performing hospitals. On the other hand, 
timely reoperations in case of complications may save the patients’ 
life and higher reoperation rates may in fact be associated with lower 
reoaeration rates
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postoperative mortality rates8. Although on a patient level the as-
sociation between reoperations and postoperative mortality is well 
established, little is known about the relation between reoperation 
rate and postoperative mortality rate at a hospital level. 
This study aims to investigate the value of reoperation rates as a 
marker for quality of care in elective colorectal cancer surgery by 
exploring hospital variation, the presence of hospitals with signifi-
cantly lower or higher reoperation rates than average (low and high 
outliers) and the association with postoperative mortality rates.
MaterIals­and­Methods
data
Data was derived from the Dutch Surgical Colorectal Audit (DSCA), 
a nationwide clinical registry and continuous quality improvement 
project in which a wide range of variables concerning patient and 
disease-specific details, diagnostics, treatment, and outcomes are 
collected prospectively. The dataset is disease-specific for colorectal 
cancer and shows a case ascertainment of >95% and high accuracy 
level on comparison against the Netherlands Cancer Registry (NCR) 
dataset9,10.
patients
For this study, no ethical approval or informed consent was required 
under Dutch law. All patients undergoing a surgical resection for pri-
mary colorectal cancer between the 1st of January 2009 and 31st of 
December 2012, and registered in the DSCA before March 15th 2013, 
were evaluated. Minimal data requirements to consider a patient 
eligible for analyses were information on tumor location, date of 
surgery, and mortality. In total, 35,749 patients were eligible.
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Patients undergoing non-elective surgery (n=5546), local tumor 
excisions (n=393), and surgery for multiple synchronous colorectal 
tumors (n=1122) were excluded from analysis. The total number of 
patients diagnosed with stage I-IV colorectal cancer in the Nether-
lands during the study period was 52,046; increasing from 12,423 in 
2009 to 13,408 in 201211. 
Outcomes
Primary outcomes
Reoperations were defined as unplanned operations within 30 days 
from the primary operation. Postoperative mortality was defined as 
death within 30 days from the primary operation and/or during the 
index admission.
Statistical analysis
 Categorical variables were compared using a chi-square test, and 
continuous variables using the independent samples t-test.  A 2-sided 
p ≤ 0.05 was considered statistically significant. 
Potential, clinically relevant risk factors for adverse events were se-
lected from the dataset and logistic regression models were employed 
to estimate expected outcomes. The variables age, gender, ASA score, 
Charlson comorbidity index, BMI, TNM stage, neoadjuvant therapy, 
type of index procedure and extended resections were incorporated 
in the model. Data were aggregated at a hospital level and observed-
to-expected rates were multiplied with the average outcome in the 
study population in order to obtain casemix-adjusted outcomes for 
each hospital.
Hospital variation in adjusted reoperation rates is illustrated in 
a funnel plot, showing the overall average reoperation rate with its 
95% confidence limits, based on a Poisson distribution, varying in 
reoaeration rates
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relation to the population size. The funnel plot was used to identify 
hospitals with reoperation rates that were significantly higher or 
lower than the national average (high and low outliers, hospitals that 
are outside the 95% confidence limits). Hospitals were grouped ac-
cordingly (higher reoperation rate than average; lower reoperation 
rate than average; and the majority cohort with reoperation rates 
within the 95% confidence limits). Outcomes were compared be-
tween these groups.
Also after aggregating the data on a hospital level, comparison of 
outcomes between the three hospital groups was performed. This 
was done by applying the analysis of variance (ANOVA). Pairwise 
comparisons between the hospitals groups were carried out by us-
ing one-way multiple comparisons with Bonferroni correction. All 
statistical analyses were performed in PASW Statistics, version 20 
(Chicago, IL, USA). 
results
Some 28,667 patients undergoing elective colorectal cancer resec-
tions were included in the analysis. Patient characteristics are dis-
played in table 1. The average reoperation rate was 9.7%, ranging 
from 0.7% to 20.9% among the 92 hospitals.
outlier­hospitals­concerning­reoperation­rates
Adjusted reoperation rates for all hospitals are shown in figure 1. 
Fourteen hospitals had adjusted reoperation rates that were higher 
than average (two hospitals had similar caseloads and reoperation 
rates and cannot be distinguished from each other in this figure). 
Twenty hospitals had adjusted reoperation rates that were lower 
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table­1.­Patient-, tumor- and treatment cCaracteristics.
characteristic n %
gender male  5,839 55.3%
Age mean, SD 70   





0  5,584 54.4%
 6,295 22.0%
2 3,954  3.8%
3 or CigCer 2,834 9.9%
ASA score I - II 22,3 4 77.8%
 III 5,687  9.8%
 IV - V 3 4  . %
 unknown 352  .2%
TNM stage X/missing  ,049 3.7%
  6,738 23.5%
 2 9,566 33.4%
 3 8,629 30. %
 4 2,685 9.4%
tumor location rigCt colon 8,9 2 3 . %
 transverse/left colon 2,889  0. %
 sigmoid colon 7,48 26. %
 rectum 9,385 32.7%
neoadjuvant tCeraay none 20,655 72. %
 sCort course RT 4,390  5.3%
 ­RT 3,0 4  0.5%
 otCer 608 2. %
arocedure ileocecal resection 233 0.8%
 rigCt Cemicolectomy 8,937 3 .2%
 transverse colectomy 574 2.0%
 left Cemicolectomy  ,79 6.2%
 LAR/sigmoid colectomy  3,2 2 46. %
 subtotal colectomy 396  .4%
reoaeration rates
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table­1.­Patient-, tumor- and treatment cCaracteristics. (continued)
characteristic n %
 APR 2,923  0.2%
 aanaroctocolectomy  63 0.6%
 otCer 438  .5%
extended resection locally advanced tumor 2,4 9 8.4%
 metastasectomy 849 3. %
BMI: body mass index; SD: standard deviation; ASA: American Society of AnestCesiologists; TNM: 
tumor, node metastasis classification (5tC edition); RT : radiotCeraay; ­RT: cCemoradiotCeraay; 


























Number of elective colorectal cancer resections 2009-2012
national average reoperation rate
hospitals with average
reoperation rate
upper 95% conidence limit
lower 95% conidence limit
hospitals with lower reoperation
rate than average
hospitals with higher reoperation
rate than average
figure­1:­Funnel alot of risk-adjusted reoaeration rates in 92 Cosaitals in tCe NetCerlands
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table­2.­stoma rates and outcomes for aatients oaerated in Cosaitals witC CigC, average 
and low reoaeration rates (as identified in figure  ). * aercentage in relation to all aatients 












aatients 469  74 0 6566  
   
anastomosis witCout fecal 
diversion
30 2 (65.4%)   298 (67.2%) 432  (66.8%) 0.094
 witC fecal diversion 678 ( 4.7%) 2232 ( 3.3%) 899 ( 3.9%)
 no anastomosis 9 4 ( 9.9%) 3279 ( 9.5%)  246 ( 9.3%)
   
reoaerations any 685 ( 4.6%)  743 ( 0%) 350 (5.30%) <0.00 
anastomotic leak 325 (6.9%) 83  (4.8%)  58 (2.4%) <0.00 
bleeding 35 (0.7%) 98 (0.6%) 25 (0.4%) 0.034
ileus 75 ( .6%)  64 (0.9%) 37 (0.6%) <0.00 
fascial deCiscence 82 ( .7%)  94 ( . %) 42 (0.6%) <0.00 
iatrogenic bowel injury 23 (0.5%) 62 (0.4%) 9 (0. %) 0.003
bladder/uretCral injury 6 (0. %)  7 (0. %) 2 (0%) 0. 7 
otCer 98 (2. %) 29  ( .7%) 62 (0.9%) <0.00 
negative relaaarotomy  2 (0.3%)  4 (0. %) 3 (0.0%) <0.00 
   
aostoaerative mortality  60 (3.4%) 559 (3.2%)  55 (2.4%) 0.00 
   
aercutaneous reinterventions * 92 (2.0%) 206 ( .2%) 74 ( . %) <0.00 
aroaortion of aercutaneous 
reinterventions**
92/777 (  .8%) 206/ 945 ( 0.6%) 74/424 ( 7.6%) <0.00 
   
blood transfusion aostoaeratively 658 ( 4.8%) 2540 ( 5.8%) 684 (  .5%) <0.00 
   
lengtC of stay >  4 days 98  (2 .2%) 3430 (20. %)  023 ( 5.8%) <0.00 
reoaeration rates
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than average. The remaining hospitals had reoperation rates that 
were within the 95% confidence limits (the ‘majority cohort’).
Table 2 compares outcomes between the groups (high and low rates 
and the majority cohort as identified in the funnel plot in figure 1). 
As reoperation rates may be influenced by the construction of a an 
anastomosis and/or a defunctioning stoma, anastomosis- and stoma 
rates are displayed as well. The proportion of patients receiving an 
unprotected primary anastomosis, an anastomosis with a diverting 
stoma, or an end-colostomy did not differ significantly between the 
groups. The majority cohort had slightly but significantly lower rates 
of laparoscopically completed procedures.
Most reoperations were performed for anastomotic leaks. For all 
indications except bladder- or urethral injury, reoperation rates were 
different between the groups. The number of registered negative 
reoperations was very small, but did differ between the groups and 
was highest in the group with high reoperation rates.
Postoperative mortality
Unadjusted postoperative mortality rates were 3,4% in hospitals 
with high reoperation rates, 3,2% in the majority cohort and lower 
(2,4%) in hospitals with lowest reoperation rates. Figure 2 displays 
postoperative mortality rates, adjusted for case-mix, for the three 
hospital groups, based on the aggregated data on a hospital level. The 
group of hospitals with high reoperation rates had an adjusted mor-
tality rate of 3,5%. The majority cohort had an adjusted postopera-
tive mortality rate of 3,2% and the group with low reoperation rates 
had an adjusted postoperative mortality rate of 2,3%. The ANOVA 
showed a significant difference between the groups (p=0.009). The 
group with low reoperation rates had significantly lower mortality 
rates than the group with high reoperations (p=0.022), and also than 
the majority cohort (p=0.019). Mortality rates were not significantly 
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different when comparing hospitals with high reoperation rates and 
the majority cohort. 
postoperative­mortality:­individual­hospitals
The funnel plot in figure 3 displays postoperative mortality rates, ad-
justed for casemix, for all 92 hospitals marked with different colours 
corresponding with high or low reoperation rates or the majority 
cohort. It shows a variation between 0,5% and 7% postoperative 
mortality around the average of 3%. Figure 2 showed that the hos-
pitals with low reoperation rates have lowest mortality rates when 
compared as groups of hospitals, figure 3 shows that individual hos-
pitals with low reoperation rates had mortality rates that were higher 
than some hospitals with high reoperation rates. Also, some hospitals 
with high reoperation rates had postoperative mortality rates that 
Higher than average Average Lower than average






























figure­2:­Risk-adjusted aostoaerative mortality in Cosaitals grouaed according to reoaera-
tion rates (CigCer tCan average, average and lower tCan average). P values are derived from 










































































































































































































































































































































were as low as 2%. Nine hospitals had postoperative mortality rates 
that were significantly lower than average, 5 of which were hospitals 
with reoperation rates within the 95% confidence limits.  
The low reoperation group also had significantly lower rates of 
percutaneous re-interventions than the other groups (table 2). 
However, the ratio between percutaneous re-interventions and all 
re-interventions (reoperations and percutaneous procedures alto-
gether) was significanlty higher in the low reoperation group, with 
17.6% of all re-interventions being a percutaneous procedure.
The high reoperation group had a relatively high percentage of 
laparoscopy in case of a reoperation (10.7% of all reoperations, vs. 
6.0 and 6.6% in the majority cohort and the low reoperation rate 
groups).
dIsCussIon
This study evaluated the value of reoperation rates as a marker of 
surgical quality of care in colorectal cancer surgery. A large hospital 
variation was found, with many hospitals having significantly higher 
or lower reoperation rates than the national average. The group of 
hospitals with high reoperation rates had similar outcomes as the 
majority cohort with reoperation rates within the 95% confidence 
limits. The group of hospitals with low reoperation rates had a lower 
rate of postoperative mortality. However, when comparing all hos-
pitals on an individual basis, lower reoperation rates than average 
could go together with relatively high mortality rates, although no 
hospitals had mortality rates that were significantly higher than 
average. Merkow et al., analyzing over 20,000 elective colorectal 
surgery cases from the American College of Surgeons NSQIP dataset, 
found a large hospital-by-hospital variation (ranging from 0% to 
reoaeration rates
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38%) in reoperation rates with the presence of many high and low 
outlier institutions12. Because of this hospital variation, the authors 
conclude that reoperation rates are valuable as mirror information 
for institutions participating in a quality improvement project. Burns 
et al. report national reoperation rates after colorectal resections 
in England derived from the Hospital Episode Statistics database7. 
These authors found a large variation in reoperation rates between 
hospitals/trusts, using a database with various pathologies and 
indications for colorectal resections, both emergent and elective. 
One study demonstrated the correlation between reoperation- and 
mortality rates after colorectal resections on a hospital level13. 
This study found a weak correlation between reoperation rate and 
mortality rate on the whole. Importantly, for individual hospitals the 
performance on reoperation rate could be the exact opposite of the 
performance on postoperative mortality: one high mortality outlier 
trust had a lower reoperation rate than average and one low mortal-
ity unit had a reoperation rate above the 2 standard deviation limit. 
Our study builds on these publications, confirming the large hospi-
tal variation and the presence of outlier institutions. We showed that 
lower reoperation rates than average are, on the whole, associated 
with a lower postoperative mortality. However, hospitals with higher 
reoperation rates than the national average perform similarly to the 
institutions with average reoperation rates when it concerns postop-
erative mortality. We confirm the findings of Almoudaris et al13 that 
group outcome patterns do not apply to all individual hospitals in the 
group (in this case, reoperation rate outlier status). 
The 30-day reoperation rate we found in this study is relatively 
high when compared to the rates in the abovementioned American 
and English cohorts. Differences in patient populations may prohibit 
direct comparison, however the reoperation rate of 5.9% in the sub-
set of elective colorectal cancer resections that Burns et al. describe 
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still compares favourably to the 9.7% we found. The single-centre 
series of van Westereenen et al., reporting a 12.5% reoperation rate, 
is the only publication from the Netherlands we can use as a refer-
ence, but this study included benign indications as well14. Perhaps the 
differences between our findings and the English publication reflect 
differences between a clinical registry and administrative data. 
The present study focused on elective surgery. We also did a sub 
analysis on the patients undergoing urgent/emergency resections 
(n=5546). In this group, the reoperation rate was slightly higher than 
in the elective group (12.2% vs 9.8%), but postoperative mortality 
was three times higher in this group (9.3% vs 3%). Although hos-
pital variation in reoperation rates and mortality rates proved wide 
(reoperations: range 0-27%; mortality: range 0-29%), it is hard to 
draw conclusions concerning individual hospital performance and 
correlation between each other, as numbers break down quickly and 
confidence intervals become extremely wide in this relatively small 
cohort. Future research on a larger (international) database may 
focus on this subject.
There are some limitations to this study. The data is self-reported, 
so selection bias cannot be completely excluded. However, the data-
set is highly detailed and validated against data from the Netherlands 
Cancer registry. Moreover, the relatively high registered reoperation 
rates do not suggest under-reporting of this outcome. Unfortunately, 
our database only contains information concerning patients who 
underwent surgical resection of colorectal cancer. The percentage 
of patients selected for surgery may vary per region or hospital. In 
future research, requiring linkage of Cancer Registry data to Audit 
data, it would be interesting to study whether differences in the 




Another limitation concerns the risk adjustment. The DSCA dataset 
was designed with the objective of performing adjustment for differ-
ences in casemix between hospitals, and relevant risk factors were 
included in the dataset at an early stage of development of the da-
taset based on a Delphi method by an expert panel15,16. The included 
variables are therefore mainly risk factors for mortality which may 
or may not be the same as risk factors for reoperations- although 
from a clinical point of view they seem relevant for this outcome, 
too, and compare with the confounders adjusted for in other publi-
cations6,7,12,17. Although adjustment was made for many variables, a 
large variation in outcomes between hospitals remains after adjust-
ment; which may be due to true differences in performance as well 
as possible limitations of the adjustment model. Thirdly, we conclude 
that high outliers have mortality rates similar to hospitals with reop-
eration rates within the 95% confidence limits. This only concerns 
30-day and/or in-hospital mortality, whereas reoperations may be 
associated with a higher risk of 1-year mortality14. It is unknown to 
what extent hospital reoperation rates correlate with longer-term 
mortality rates. 
Hospitals with lowest reoperation rates had a relatively high rate 
of percutaneous reinterventions compared to the two other groups. 
This may be due to less severe complications or due to other factors 
such as improved radiological support or a better selection for percu-
taneous solutions for surgical complications in these hospitals.
“Reoperation” is a measure that reflects many factors in the postop-
erative process. There are, however, no guidelines concerning return 
to the operating room. Decisions regarding postoperative manage-
ment remain at the surgeon’s discretion and surgeons may differ 
in their threshold for performing a reoperation on a patient with a 
suspected surgical complication. As a timely reoperation may be an 
effective measure to rescue a patient with a postoperative complica-
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tion, a low threshold for a reoperation is not necessarily a reflection of 
a low quality of surgical care. A problem that may be associated with 
this outcome, is that the threshold for reoperation may rise when it 
is being used as an outcome indicator. For the individual patient, it 
may have dramatic results when the surgeon does not re-operate 
or waits too long, as a timely intervention may result in better out-
comes18.  Our study shows that some individual hospitals with high 
reoperation rates have relatively low postoperative mortality rates, 
well below the national average. Some majority cohort hospitals 
even had mortality rates that were significantly lower than average. 
Apparently, the surgical teams in these hospitals have a good ability 
to rescue patients with a surgical complication. On the other hand, a 
high reoperation rate puts a low mortality rate in perspective: clearly 
the low mortality comes at a high cost. Conversely, some hospitals 
with significantly lower reoperation rates than the national average 
had quite high postoperative mortality rates. Best practice should be 
sought in hospitals with both low reoperation and mortality rates. 
Another valuable outcome indicator relating to both complications 
and postoperative mortality is “failure to rescue (FTR)”, defined as 
the mortality rate among patients with a serious complication19. 
Almoudaris et al. introduced the outcome measure “failure to rescue-
surgical (FTR-S)” : the mortality among patients that underwent a 
reoperation20, reflecting the ability of a surgical team to effectively 
manage surgical complications. They found that high-mortality hospi-
tals were characterized by high FTR-S rates rather than high reopera-
tion rates. For the DSCA, FTR is defined as the mortality rate among 
patients with a serious complication (leading to a reintervention or 
a prolonged in-hospital stay)21. Regardless of the definition, such a 
FTR measure takes away possible hesitations to intervene in case of a 
surgical complication, as a successful intervention will merely lower 
reoaeration rates
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FTR rates. In our opinion, this is an important outcome measure to 
consider alongside the outcome indicator reoperation rate.
In conclusion, the results of this study show a wide hospital varia-
tion in reoperation rates after colorectal cancer resections in the 
Netherlands. Although several high outlier institutions could be 
identified, this could not be linked to worse mortality rates. Con-
versely, hospitals with low reoperation rates did perform better on 
other outcomes and it can be concluded that the outcome is suitable 
as feedback information to hospitals in quality improvement projects 
but not to stigmatize hospitals with high reoperation rates as poor 
performers. Best practices with regard to clinical outcomes should 
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Background: Postoperative mortality is frequently used in hospital 
comparisons as marker for quality of care.  Differences in mortality 
between hospitals may be explained by varying complication rates. 
A possible modifying factor may be the ability to let patients with a 
serious complication survive, referred to as failure to rescue (FTR). 
Purpose of this study is to evaluate how hospital performance on 
postoperative mortality is related to severe complications or to FTR 
and to explore the value of FTR in quality improvement programs.
Methods: All patients operated for colorectal cancer from 2009-
2011, registered in the Dutch Surgical Colorectal Audit, were 
included. Logistic regression models were used to obtain adjusted 
mortality- complication- and FTR rates. Hospitals were grouped 
into 5 quintiles according to adjusted mortality. Outcomes were 
compared between quintiles. 
Results: 24 667 Patients were included. Severe complications ranged 
from 19% in the lowest to 25% in the highest mortality quintile 
(OR=1,5; 95% CI 1,37-1,67). Risk-adjusted FTR rates showed a 
marked difference between the quintiles, ranging from 9 to 26% 
(OR=3.0; 95% CI 2,29-3,98). There was significant variability in 
FTR rates. Seven hospitals had significantly lower FTR rates than 
average.
Conclusions: High-mortality hospitals had slightly higher rates of 
severe complications than low-mortality hospitals. However, FTR 
was three times higher in high-mortality hospitals than in low-
mortality hospitals. In quality improvement projects, feedback to 
hospitals of FTR rates- along with complication rates- may illus-
trate shortcomings (prevention or management of complications) 




Increasingly, society focuses on effectiveness and efficiency in health-
care, and differences in hospital performances have become subject 
to research. Recent studies have shown great differences in hospital 
(surgical) mortality rates1,2 even after adjustment for differences in 
case-mix3. One of the explanations of these differences is sought in 
the handling of postoperative complications, eg. ‘failure to rescue’ 
(FTR). 
The term, introduced by Silber et al.4 is defined as “the mortality rate 
among patients with complications”. These authors found that hospi-
tal rankings based on adjusted complication rates did not correlate 
with rankings based on adjusted mortality rates. Ghaferi et al. defined 
FTR as “mortality among patients with serious complications” and 
found that hospitals with high mortality rates had higher FTR rates 
rather than higher complication rates5-7. Almoudaris et al. introduced 
the term “failure-to-rescue-surgical”, defined as death among patients 
that underwent reoperation. These authors found that hospitals with 
high mortality rates had higher death rates among patients that un-
derwent reoperation after colorectal surgery, while reoperation rates 
were the same in high- and low-mortality hospitals8.
Colorectal surgery is considered high-risk surgery as it brings 
along a relatively high risk of complications. Patients that experience 
a complication have a substantial increase in risk of dying9. Hence, 
mortality and complication rates are considered important outcome 
measures in colorectal surgery. 
Many publications on FTR used administrative data, in which the 
risk of identifying preoperative conditions as a postoperative compli-
cation is substantial10,11. The valuable insight into “failure to rescue” 
that the publication based on the National Surgical Quality Improve-
failure to rescue
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ment Program (NSQIP) clinical dataset provided, lacked details on 
procedure-specific complications such as anastomotic leak5. After 
the example of the NSQIP and other international audits, in 2009 the 
Dutch Surgical Colorectal Audit (DSCA) was introduced12, in which 
approximately 95% of patients undergoing surgery for colorectal 
cancer in the Netherlands are included.  By clarifying the hospital 
variation of FTR on a national level, its potential value in quality 
improvement programs is explored.
The aims of this study are to evaluate: 
1. to what extent mortality rates after colorectal surgery vary be-
tween Dutch hospitals, when adjusted for casemix
2.  whether, and to what extent, hospitals with higher mortality rates 
have higher severe complication rates 
3. whether, and to what extent, hospitals with higher mortality rates 
have higher FTR rates 
4. the variability in FTR after colorectal surgery between Dutch 
hospitals and the presence of positive and negative outliers
Methods
Data was derived from the DSCA, a national quality improvement 
project in which over 200 variables concerning patient and tumor 
characteristics, treatment, and outcomes are collected prospectively. 
All 92 hospitals performing colorectal cancer surgery participate. The 
dataset shows a high level of completeness on most items, including 
anastomotic leakage on validation against the National Cancer Reg-
istry (NKR) dataset13,14. Information concerning individual patients 
and hospitals are made anonymous, making it possible to compare 




For this study, no ethical approval or informed consent was required 
under Dutch law.
All patients (n=26 410) undergoing surgical resection for primary 
colorectal cancer between the 1st of January 2009 and 31st of De-
cember 2011, and registered in the DSCA before March 15th 2012, 
were evaluated. 
Minimal data requirements to consider a patient eligible for 
analyses were information on tumor location, date of surgery, com-
plications and mortality (25 591 eligible patients).  To minimize the 
risk of selection bias, patients from hospitals that failed to register 
more than 10 patients in a year were excluded (36 patients from nine 
hospitals in 2009, none in 2010 and 2011).  To analyze a clinically 
homogenous patient cohort, patients with multiple synchronous 
tumors (n=888) were excluded.
From the subset of patients operated in 2011 (n=8885), a detailed 
description of both surgical and non-surgical complications was 
available.
Mortality
The definition of mortality is shown in panel 1. Potential patient- and 
disease-specific risk factors (casemix) for mortality were selected 
from the dataset. The methods used to calculate the expected mor-
tality have been described in an earlier publication by the Dutch 
Surgical Colorectal Audit group3. In univariate analysis, categorical 
variables were compared by χ2 tests, while 2-sample t tests were used 
for continuous variables. A 2-sided P ≤ 0.05 was considered statisti-
cally significant, but casemix factors were selected for multivariate 
analysis when reaching a significance of p<0.10. Backward stepwise 
logistic regression models were employed to estimate the final model 
and calculate expected rates of mortality. The casemix factors age, 
failure to rescue
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sex, American Society of Anesthesiologists (ASA) classification, 
Charlson co-morbidity index, body mass index (BMI), emergency 
surgery, tumor location, preoperative complications from the tumor, 
oncologic stage and neoadjuvant therapy proved to be contributing 
to the correction model. Data were aggregated on hospital level and 
observed-to-expected rates were multiplied with the average mor-
tality in the study population in order to obtain casemix-adjusted 
mortality rates. Hospitals were grouped into five equally sized, risk-
adjusted quintiles of mortality according to previous publications5,8.
severe­complications
With the same methods, adjusted severe complication (see panel 1 
for definitions) rates were calculated for each hospital. The casemix 
factors sex, ASA classification, Charlson co-morbidity index, BMI, 
emergency surgery, tumor location, pre-operative complications, 
oncologic stage and additional resections for extended disease were 
significant contributors to the model. Adjusted severe complication 
rates were compared between the mortality quintiles. 
failure-to-rescue
For FTR, the casemix factors age, sex, ASA score, Charlson co-mor-
bidity index, emergency surgery, oncological stage and neoadjuvant 
therapy contributed to the model. Adjusted FTR rates were compared 
between the mortality quintiles. 
hospital­variation­and­outliers­in­ftr
A mixed logistic regression model with hospitals as random effects 
was employed to account for the presence of variability between 
hospitals. 
The fixed effects predictors in the model are the same as employed 
in the first model for FTR described before. The variance in the ran-
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dom effects model quantifies the degree of variation in the outcome 
between hospitals after adjustment for case mix. The likelihood ratio 
test was used to assess whether the variance of the random effect 
was significant.
The adjusted FTR rates per hospital are presented in a funnel plot, 
showing the overall average FTR rate with its 95% confidence limits, 
based on a Poisson distribution, varying in relation to the population 
size. The plot allows to identify hospitals with FTR rates that are 
significantly higher or lower than average.
Statistical analyses were performed in PASW Statistics, Rel. 20.0.2012 
(SPSS inc., Chicago, Il) and R 2-14 (http://cran.r-project.org/).
results
patient­characteristics
A total of 24 667 patients, registered by 92 hospitals met the inclu-
sion criteria and were included in the study. Hospitals were grouped 
according to adjusted mortality rates and the total group of hospitals 
was divided into quintiles. Patient characteristics are displayed in 
table 1. There was no evidence of systematic differences in case mix 
across hospital quintiles, as reflected by quite similar overall expected 
rates of death per quintile, based on casemix. Average mortality was 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































After adjustment for casemix, a marked variation in mortality rates 
between hospitals was observed ranging from 1 to 9 %. Figure 1 
shows the hospitals grouped in risk-adjusted mortality quintiles (left 
series).
Each quintile represents a group of hospitals with a different (ad-
justed) mortality rate, the first mortality quintile having the lowest 
casemix-adjusted mortality (2 %), with adjusted mortality increasing 
stepwise per quintile to 6.6% in the 5th (highest) quintile. The OR for 
mortality of the highest quintile was 3,5 (95% confidence interval 









mortality   severe complications  FTR


















figure­1:­risk-adjusted mortality, severe comalication, and FTR rates aer quintile. Odds 
ratios are  given, comaared to quintile   (reference). RR=relative risk; Q= mortality quintile; 
FTR= failure to rescue
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quintiles had significantly higher adjusted mortality rates than the 
first quintile as well.
severe­complications
An increase in adjusted percentage of patients with a severe compli-
cation was observed when comparing the lowest to the highest mor-
tality quintile (figure 1, middle series).  The percentages ranged from 
19% in the lowest to 25 % in the highest mortality quintile- with the 
OR for severe complications of the highest being 1,5 (95% confidence 
interval 1,37 – 1,67; p<0,001) compared to the lowest quintile. The 
table­2:­details of tCe severe comalications in tCe subset of aatients oaerated in 20  .
total­no.­of­patients­(2011) ­ 8885­(100%)
Any severe comalication   882 (2 ,2%)
Surgical comalications   
anastomotic leak 440 (5,0%)
intra-abdominal abcess  39 ( ,6%)
aostoaerative CaemorrCage 5  (0,5%)
ileus  06 ( ,2%)
fascial deCiscence 99 ( , %)
iatrogenic bowel injury 34 (0,4%)
iatrogenic injury to ureter/bladder    (0, %)
otCer  87 (2, %)
General comalications
  







OtCer 367 (4, %)
failure to rescue
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other quintiles had significantly higher adjusted severe complication 
rates than the lowest quintile as well. 
Details of the severe complications in the subset of patients operated 
in 2011 are displayed in table 2.
failure-to-rescue
The OR of FTR in the highest mortality quintile was 3.0 (95% confi-
dence interval 2,29 – 3,97, p<0.001) compared to the lowest mortal-
ity quintile, with an incremental increase per quintile (figure 1, right 
series). The difference in FTR rate was also significant for the other 
quintiles when compared to the lowest quintile.
hospital­variation­and­outliers
The variance in the random effects model quantified the degree of 
variation in FTR between hospitals; this was 0.09 with a standard 
error of 0.038.  A likelihood ratio test showed that the variance of the 
random effects was statistically significant.
Figure 2 shows that the adjusted FTR rates of the 92 hospitals varied 
between 0 and 39%. For 85 hospitals (92%), results were within the 
95%-confidence limits of the average. Seven hospitals showed sta-
tistically significant lower percentages than average. Each hospital 
is colored according to mortality quintile: the hospitals in the lower 
mortality quintiles fill the lower regions of the funnel plot, and the 
hospitals in the higher mortality quintiles are displayed on the higher 




Colorectal surgery is not without adverse events. This study ac-
knowledges the fact that postoperative casemix-adjusted mortality 
rates after colorectal surgery vary by hospital.  Our study shows that 
higher mortality rates seem to be only partially explained by higher 
rates of severe complications: the 1,5-fold increase in severe com-
plication rate seems insufficient to explain the 3-fold increase in 
mortality between the first and fifth quintile. Failure to rescue  seems 
to play a role as modifying factor, with a vast increase in failure to res-
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demonstrated that there was variability in FTR between individual 
hospitals, after adjusting for casemix.
High- and low-mortality hospitals were distinguished by their ability 
to treat and save patients with severe complications. These findings 
are consistent with recent literature5-8. 
Our study adds that in a specific, homogeneous group of surgical 
procedures, colorectal cancer surgery, failure to rescue plays an 
important role in explaining the variability in hospital mortality. The 
dataset we used was disease-specific and did, unlike some other stud-
ies, include anastomotic leak. Therefore we were able to accurately 
characterize the impact of failure to rescue on mortality in patients 
that underwent colorectal surgery. Secondly, this paper is the first 
from the European continent that describes hospital variation in 
FTR, whereas most publications concerning FTR originate from the 
United States4-7 or United Kingdom8. Despite differences in health 
care systems, FTR seems to be the main determinant of differences 
in hospital mortality after colorectal surgery in populations from dif-
ferent countries. Moreover, we found that FTR rates vary significantly 
between hospitals, with some hospitals having a significantly lower 
FTR rate than average (“best practices”).  
The study has some limitations. Firstly, since data are self-reported, 
registration bias cannot be excluded. However, the dataset is vali-
dated against the independently collected data of the Dutch National 
Cancer Registry, showing a very high rate of case-ascertainment, 
completeness and accuracy in terms of patient demographics, tumor 
stage, comorbidity, treatment and mortality14. The dataset consists 
of detailed, prospectively collected clinical data, registered by or 
under direct responsibility of colorectal surgeons. This avoids the 
problem that the use of administrative data brings along: difficulties 
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in correctly distinguishing a comorbid illness from a postoperative 
complication11. 
The definition of a severe complication used in this study is arbi-
trary but it is believed to exclude the minor complications such as 
simple urinary tract infections or minor wound problems not hinder-
ing the postoperative course. However, it cannot be ruled out that 
some patients with a minor complication, who spent more than 14 
days in the hospital due to other reasons, were incorrectly identified 
as having a severe complication. On the other hand, with the defini-
tion used in this study, a small number of mortality cases were not 
covered by our definition of a severe complication. Therefore we 
performed additional analyses using alternative definitions of severe 
complications (1. with all mortality cases included in the “severe 
complication” measure; 2. with exclusion from the data set of the 62 
mortality cases with no postoperative complication), showing very 
similar results. However, the severity of illness associated with com-
plications like anastomotic leak may vary widely. These differences 
may level out in larger groups of patients treated per hospital. How-
ever, we cannot exclude that differences in severity of complications 
between hospitals may have influenced the variation in FTR rates. 
A possible form of bias may have emerged from complicated 
patients transferred to another hospital, dying after transfer. How-
ever, as a minimum of facilities (e.g. ICU) is mandatory for hospitals 
performing colorectal surgery in the Netherlands, patients with 
complications are rarely transferred. In this uncommon situation 
the mortality is ascribed to the hospital that performed the initial 
operation.  
A drawback of using FTR is that it is a short-term outcome, whereas 
patients that experienced a complication following colorectal surgery 
are known to have a higher risk of mortality up to a year after the 
failure to rescue
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procedure15-17. The post-discharge period may be just as important 
as the immediate postoperative period, when aiming at improving 
mortality rates. 
Nonetheless, the hospital variation in FTR rates may reflect dif-
ferences in the postoperative care process. What these differences 
are, is beyond the scope of this study. Probably, FTR is affected by 
many factors including the usual postoperative care at each hospi-
tal, availability of resources like interventional radiology or a high 
level of Intensive Care facilities, staffing factors and equipment. 
Suggested factors related to FTR are nurse-to-patient ratios18-19, high-
technology status of a hospital (i.e., does the hospital perform organ 
transplant surgery open-heart surgery)19, higher case-volume6 and 
teaching status6. Probably as important as these structural factors 
are preoperative risk-assessment and appropriate case-selection, 
multidisciplinary treatment of patients with comorbid illnesses and 
timely recognition of complications. An active surveillance protocol 
has been shown to reduce the delay in diagnosis of anastomotic 
leak20. Whether the hospitals with lower FTR rates had a shorter 
delay between the onset of symptoms and the start of treatment of 
the complication is unknown and should be subject of further re-
search- ideally not only focusing on anastomotic leakage but also on 
non-surgical complications. In the context of quality improvement, 
feedback of complications and FTR rates to hospitals illustrates 
shortcomings (management or prevention of complications), allow-
ing targeted improvement efforts. Based on the results of this study, 
the DSCA started using FTR as feedback information to participating 
hospitals, enabling surgeons to evaluate detection and treatment of 
complications. Best practices can be identified and knowledge can be 
shared between surgical teams from different hospitals. 
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In conclusion, although the incidence of severe postoperative compli-
cations differed slightly across mortality quintiles, the adjusted rate 
of death in patients with a severe complication (failure to rescue) 
was markedly higher in hospitals with higher overall mortality. The 
chance that a patient dies once a severe complication has emerged 
was three times higher in a high-mortality hospital than in a low-
mortality hospital. FTR rates show a wide, significant variation 
between hospitals, with seven hospitals having a significantly lower 
FTR rate than average. More research is needed to identify the under-
lying mechanisms and structural factors that account for differences 
in FTR rates between hospitals. 
defInItIons­
Severe complication: a complication leading to a surgical, 
endoscopic or radiological reintervention or to a in-hospital 
stay of more than 14 days, or to death.
Mortality: A patient that died within 30 days after the operation 
or within the same admission. 
Failure to rescue: The percentage of patients with a severe 
complication that dies. (Number of patients that died second-
ary to a severe complication) / (total number of patients that 
experienced a severe complication)
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aBstraCt
Background:  Evidence suggests that a large hospital variation in 
failure to rescue (FTR) in colorectal surgery is causing hospital 
differences in mortality rates. Which structural hospital factors 
are associated with better FTR rates remains largely unclear. The 
purpose of this study is to evaluate the association between FTR 
and hospital volume, teaching status and level of Intensive Care 
facilities, in colorectal cancer surgery.
Methods: All patients undergoing colorectal cancer surgery from 
2009 through 2011 in 92 Dutch hospitals were analysed. Univari-
ate and multivariate logistic regression models including casemix, 
hospital volume, teaching status and different levels of ICU facilities 
were used to analyse risk-adjusted FTR rates. 
Results: 25591 patients from 92 hospitals were included. The aver-
age failure-to-rescue rate was 17% [0-39]. In univariate analysis, 
high hospital volume (>200 patients/year versus <=200/year), 
teaching status (academic versus teaching versus non-teaching 
hospitals) and high level of ICU facilities (highest level 3 versus 
lowest level 1) were associated with lower FTR rates. Only the 
higher levels of ICU facilities (2 or 3 compared to level 1) were 
independently associated with lower FTR rates (OR 0.72 (95% CI 
0.65 – 0.88) in multivariate analysis.
Conclusions: Hospital type and annual hospital volume were not 
independently associated with FTR rates in colorectal cancer sur-
gery. Instead, the lowest level of ICU facilities was independently 
associated with higher rates. This suggests that a more advanced 
ICU may be an important factor that contributes to better FTR rates, 




Hospital differences regarding quality of care have received much 
attention in recent years. Complications and mortality are outcomes 
frequently used to compare hospital performance in colorectal can-
cer surgery. Failure to rescue (FTR) is another outcome measure that 
indicates the ability of a surgical team to keep patients alive when 
severe complications occur.  The term, introduced by Silber et al.1 is 
defined as “the mortality rate among patients with complications”. 
These authors found that hospital rankings based on complication 
rates did not correlate with rankings based on mortality rates. Re-
cent literature suggests that high hospital mortality after colorectal 
surgery is best explained by higher FTR rates rather than by higher 
complication rates2,3. Hence it may be considered an outcome that is 
actionable, reflecting the ability of a surgical team to timely recognize 
and treat major complications once they emerge.
The fact that higher FTR rates, and not higher complication rates 
are the main determinant of higher mortality rates was recently 
confirmed by the Dutch Surgical Colorectal Audit (DSCA) group4. 
Dutch hospitals showed variability between 0 and 40% in FTR rates. 
It remains largely unclear which factors account for this variation. 
Some potential factors have been suggested. Surgical teams may vary 
in the ability to adequately and timely recognize and treat postopera-
tive complications by differences in expertise, experience with the 
procedure, and by more advanced resources. 
The number of procedures performed annually, might be a proxy 
for the experience of a surgical team with a specific procedure and 
its perioperative care. Increasing hospital volume is associated with 
better outcomes in many surgical procedures including colorectal 
surgery5. An American study using Medicare data showed that lower 
postoperative mortality rates after gastrectomy, esophagectomy and 
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pancreatectomy in higher volume hospitals were strongly related to 
lower FTR rates6. Yet, the association between hospital volume and 
FTR in colorectal surgery remains largely unexplored.
Another hospital-related factor that has been associated with dif-
ferences in outcome, is its teaching status. University hospitals have 
been associated with favorable outcomes compared to non-teaching 
hospitals for many procedures and conditions like prostatectomy7, 
cystectomy8 and cardiovascular events9,10. Teaching status has been 
mentioned as a factor inversely related to FTR11. It has been suggested 
that this association may be related to more advanced resources in 
university hospitals. A logical next step is to explore the relation be-
tween intensive care (ICU) capacity and outcomes. The relationship 
between level of care in ICU facilities and FTR after colorectal cancer 
surgery has not been investigated yet but higher ICU staffing has been 
associated with lower mortality in critically ill medical, surgical and 
pediatric patients12. In the Netherlands, ICU units are classified into 
three levels according to capacity, staffing and resources13 (table 1), 
making it possible to study the influence of enhanced ICU facilities 
on outcomes.
This study looks at the association between three major structural 
hospital factors and failure-to-rescue rates in colorectal cancer sur-
gery:
1. Annual hospital volume in colorectal cancer procedures
2. Teaching status (Academic-, teaching- and non-teaching hospi-
tals)
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Methods
Data was derived from the DSCA, a nationwide, continuous quality 
improvement project in which a wide range of variables concern-
ing patient and disease-specific details, diagnostics, treatment, and 
outcomes are collected prospectively. The dataset is disease-specific 
for colorectal cancer and shows a nearly 100% completeness on most 
items, and high accuracy level on comparison against the Netherlands 
Cancer Registry (NCR) dataset. The latter is constructed with data 
retrieved from chart review by independent, trained researchers14,15. 
patients
For this study, no ethical approval or informed consent was required 
under Dutch law.
All patients (n=26 410) undergoing surgical resection for primary 
colorectal cancer between the 1st of January 2009 and 31st of De-
cember 2011, and registered in the DSCA before March 15th 2012, 
were evaluated. Minimal data requirements to consider a patient 
eligible for analyses were information on tumor location, date of sur-
gery, complications and mortality.  For calculation of average annual 
hospital volume, no cases were excluded. 
definitions
Hospital volume
Hospital volume was divided into five groups: <51 cases/year, 51-100 
cases/year, 101-150 cases/year, 151-200 cases/year and more than 
200 cases/year. Subsequently, we used five different cutoff points for 
volume (0-50 versus more than 50 cases/year; 0-100 versus more 
than 100 cases/year, and so on). The groups were formed around 100 
cases per year, as the average hospital volume was 99 cases per year, 
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with most hospitals performing between 50 and 200 procedures an-
nually.
Hospital type
Hospitals were categorized as either academic hospitals, teaching 
hospitals or non-teaching hospitals. In the Dutch healthcare system 
there are eight university hospitals, which function as referral centers 
for high-complex, low-volume care like surgery for locally advanced 
tumors and synchronous metastasectomies16. Each university hos-
pital is affiliated with a number of teaching hospitals, providing the 
surgical residency programs together. The remaining hospitals were 
defined as non-teaching hospitals.
ICU facilities
According to the guidelines “organization of ICU departments for 
adults in the Netherlands”17, three levels of ICU facilities are defined. 
Table 1 displays the main differences per level, as described by the 
guideline.
The level of ICU facilities is a quality indicator that hospitals must 
provide to the Dutch healthcare inspectorate on a yearly basis. For 
this study, the level of ICU facilities for each hospital was derived 
from the website with the databank of these quality indicators13. If 
a hospital had changed levels within the study period of 2009-2011, 
the category noted in most of these years was used. 
Failure to rescue
The definition of FTR is displayed in panel 1 and was formulated in 
accordance with the definition in a previous study4. Unadjusted FTR 
rates were compared between different hospital volumes, hospital 
types and between hospitals with different levels of ICU facilities with 
the X2 test. Subsequently, multivariate logistic regression analysis was 
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used for risk adjustment and to determine whether the structural 
hospital factors were independently associated with differences in 
FTR rates. Risk adjustment was done for age, sex, ASA score, location 
of the tumor, Charlson co-morbidity index, urgency of the operation, 
TNM stage, additional resections, multiple synchronous colorectal 
tumours and neoadjuvant therapy. 
A 2-sided P ≤ 0.05 was considered statistically significant. Statistical 
analyses were performed in PASW Statistics, version 20 (SPSS inc., 
Chicago, Il, USA) and R 2-14 (The R Project for Statistical Comput-
ing and The Comprehensive R Archive Network; http://cran.r-
project.org/).
defInItIons
Mortality: A patient that died within 30 days after the operation 
or during the index hospital admission.
Severe complication: a complication leading to a surgical, 
endoscopic or radiological reintervention, to an in-hospital 
stay of more than 14 days, or to death
Failure to rescue: The pecentage of patients with a severe 
complicaion that died in-hospital or within 30 days after the 
resection; (Number of patients that died secondary to a severe 
complication ) / (total number of patients that experienced a 
severe complication)







































































































































































































































































































































































































































































































































































































































































































































































































































































































A total of 25591 patients, registered by 92 hospitals were included 
in this study.  Patient, tumor and treatment characteristics are dis-
played in table 2. Average mortality was 4.3% and the percentage of 
patients with a severe complication was 23%, with an average FTR 
rate of 17%. University hospitals treated a higher proportion of pa-
tients with rectal cancer. Patients treated in university hospitals were 
younger, but had slightly more comorbidity and more often stage IV 
disease. Consequently, additional resections and metastasectomies 
were performed more often in university hospitals, and patients in 
these hospitals were treated with preoperative chemoradiotherapy 
more frequently. Non-elective surgery was slightly less common in 
university hospitals, compared to other hospital types.
hospital­volume
The average annual number of colorectal cancer resections per hos-
pital was 99 and ranged between 20 and 206 procedures per year 
(table 2). 
In univariate analysis, there was no difference in FTR rate between 
the five hospital volume groups, especially not between the lowest 
(<50 patients/year) and highest volume (more than 200 patients/
year) group (data not shown). With the cutoff at 0-200 cases/year 
versus more than 200/year there was a significantly lower FTR rate 
in the higher volume group (table 3).  Four hospitals had an aver-
age annual volume of more than 200 colorectal cancer resections. 
Adjusted for casemix, the difference in FTR between hospitals with 
more than 200 cases/year and the lower volume hospitals was 17% 
versus 14%; p=0.07 (figure 1).





















































































































































































































































































































































































































All Dutch hospitals performing colorectal cancer surgery were in-
cluded in the study: eight university hospitals; 46 teaching hospitals 
and 38 non-teaching hospitals.
In 43 hospitals only basic (level 1) ICU facilities were available, 25 
hospitals had a level 2 ICU, and 24 hospitals had an ICU of the highest 
level 3. Hospital characteristics are displayed in table 2.
Differences in FTR rates between the different hospital types and 
levels of ICU facilities, derived from univariate- and multivariate 
analysis are displayed in table 3.  Unadjusted FTR rates were sig-
nificantly lower in university hospitals and significantly higher in 







AcademicTeaching Non-teaching Level 1 Level 2 Level 3<=200/year>200/year
Average annual hospital
 volume
Hospital type ICU level
Case-mix adjusted FTR rate
figure­1:­failure to rescue (FTR) rates, adjusted for casemix, aer volume groua, Cosaital tyae 
and I­U level.
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Also, level 1 ICU hospitals had significantly higher FTR rates than 
hospitals with level 2 ICU capacity; there was no difference in FTR 
rates between level 2 and 3 ICU hospitals.
Adjusted for casemix, FTR rates were 19% (0-39%) in non-teaching 
hospitals, 17%  (2-26%) in teaching hospitals and 13% (6-20%) in 
university hospitals. When stratified according to ICU level, casemix-
adjusted FTR rates were 19% (0-39%) in level 1 ICU hospitals, 
16% (8- 26%) in level 2 and 16% (6-23%) in level 3 ICU hospitals 
(figure 1). 
As can be seen in table 4, the relation between teaching status and 
FTR lost its statistical significance when the factors hospital volume, 
hospital type and ICU level were entered as variables in the logistic 
regression model. Only ICU level proved to be independently related 
to FTR rates, with level 1 (lowest) ICU level being associated with sig-
table­4:­incidence of and failure-to-rescue (FTR) from various comalications aer level of I­U 
postoperative­








anastomotic leak  3 5 (5%)  7%  4%  6% ns  
abscess 606 (2,4%) 9% 6% 7% ns  
CemorrCage 205 ( %) 23%  7%  0% 0.05*  
ileus 380 (2%)  5% 5% 4% 0.006* / 0.003 **
fascial deCiscence 409 (2%)  2% 6% 9% ns  
iatrogenic bowel injury  09 (0%) 29%  3% 22% ns  
otCer surgical 
comalications
759 (3%)  8%  4%  2% ns  
non-surgical comalications 2330 (9%) 27% 22% 22% 0.02 * / 0.0 6**
* I­U level   vs level 3
** I­U level   vs level 2
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nificantly lower FTR compared to a level 2 ICU (reference category). 
When level 2 and 3 ICU hospitals were combined in one group, the 
OR for FTR was 0,72 (95% CI 0,65 – 0,88; p<0,001) when compared 
to level 1 ICU hospitals.
Complication­types
A characterization of FTR per complication type is displayed in 
table 4. Anastomotic leak, intra-abdominal abscess and non-surgical 
complications occurred most often. FTR rates were lower for all 
complications in ICU level 2 and level 3 hospitals when compared to 
hospitals with level 1 ICUs. This difference was significant for FTR 
from postoperative haemorrhage, ileus, and non-surgical complica-
tions.
dIsCussIon
This study is the first to directly evaluate the association between 
FTR and hospital characteristics in colorectal cancer surgery. FTR 
was lower in patients operated in high volume hospitals, in univer-
sity hospitals and in hospitals with higher levels of ICU facilities in 
univariate analysis. A higher level of ICU facilities was the only factor 
associated with lower FTR rates in multivariate analysis. Differences 
in level of ICU facilities might be a part of the explanation of the dif-
ferences in FTR rates between hospitals.
Ghaferi et al. found higher hospital volume to be significantly 
associated with favourable FTR rates6, however this association 
concerned patients undergoing surgery that may be considered 
more challenging than colorectal cancer surgery (pancreatic and 
upper gastrointestinal surgery). In another study, teaching hospitals 
and overall hospital size of >200 beds were independently associ-
FTR and Cosaital factors
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ated with lower FTR rates after pancreatic resections11. In this study, 
“high technology” (transplantation and cardiac surgery performed 
in the hospital) was also associated with lower FTR. Arguably, “high 
technology” may be a proxy for better ICU facilities. Almoudaris et al. 
describe a higher number of high-dependency unit beds in the quan-
tile of hospitals with lowest postoperative mortality after colorectal 
surgery; however the number of ICU beds did not differ between 
quantiles3. 
Colorectal cancer surgery is performed in the majority of Dutch 
hospitals, typically in a medium-volume setting (average 99 cases/
year), though with many lower volume centers being present as well. 
Only a small number of hospitals perform more than 200 procedures/
year, which may make it hard to reach significance.
Although we found that unadjusted FTR rates were lower in 
university hospitals and higher in non-teaching hospitals, these dif-
ferences lost statistical significance when casemix factors and the 
three hospital characteristics were analyzed together in multivariate 
analysis. The availability of at least a level 2 ICU was the only struc-
tural hospital factor independently associated with better FTR rates. 
Patients operated in hospitals with level 2 ICUs had a similar risk 
of FTR as patients from level 3 ICU hospitals. The differences in char-
acteristics between ICUs of level 2 and 3 (table 1) appear relatively 
modest whereas differences between level 1 and 2 ICUs seem more 
distinct. The biggest differences between level 1 ICUs and level 2 or 
3 ICUs are the exclusive 24 hours a day availability of an intensivist, 
the transfer of responsibility for the patient to the intensivist, and 
more intensive care staffing (table 1).  Our findings suggest that these 
staffing factors of an ICU may be important factors that contribute to 
better FTR rates in colorectal surgery. Surgical complications such as 
anastomotic leak may lead to single or multiple organ dysfunction. 
Non-surgical complications may carry an additional risk of mortal-
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ity in this relatively old and frail patient group. Therefore, adequate 
availability of ICU support seems essential in management of patients 
with severe complications after colorectal surgery.
The positive effects of higher ICU staffing and 24-hour coverage 
by an intensivist on ICU- and hospital mortality have been described 
before12,18,19. Our study builds on this, showing an association be-
tween these staffing factors and lower FTR rates in a specific surgical 
population. 
Many Dutch hospitals with lower-level ICUs have regional agree-
ments with hospitals with higher levels of ICU care on, for instance, 
teleconferencing. Although regional collaboration undoubtedly has 
a positive impact on outcomes, our study shows that despite these 
initiatives a lower level of ICU facilities was associated with higher 
FTR rates.  However, some hospitals with low level ICUs performed 
well.  
There are some limitations in this study. The data is self-reported, 
so selection bias cannot be completely excluded. However, the 
dataset is highly detailed and validated against data from the Neth-
erlands Cancer registry (see methods). Secondly, the definition of 
severe complications (complications followed by a reintervention, a 
prolonged in-hospital stay of more than 14 days or to death) may 
be considered arbitrary. However, this definition distinguishes major 
complications from less severe complications that do not hinder the 
postoperative course20.
The variability of FTR rates within each group of hospitals’ struc-
tural factors suggest that there must be other factors as well playing a 
role in explaining hospital differences in FTR rates. Firstly, these may 
be factors associated with timely recognition of complications21.  For 
instance, higher nurse-to-patient ratios have been associated with 
lower FTR rates22. An in-depth study concerning factors reflecting 
differences concerning in-hospital processes should be conducted, 
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evaluating the daily ward rounds, responsibility for the ward patients, 
staffing outside office hours, vital sign collection and reporting, the 
level of experience in a surgical team, team communication, guideline 
adherence and quality of care from nurses. Secondly, hospital differ-
ences in FTR rates may be sought in differences in delay until the start 
of treatment of complications. For instance, early reintervention for 
anastomotic leak may prevent clinical deterioration and death. Alves 
et al. found lower mortality after reoperations performed before 
postoperative day five, although this difference was not significant23. 
With identification of specific care processes that account for dif-
ferences in hospital FTR rates, quality improvement initiatives can 
aim at reducing postoperative mortality by addressing the most 
important factors in the postoperative care process.  Safeguarding 
adequate ICU capacity to support patients with complications after 
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aBstraCt
Objective: To define a statistically sound and clinically meaningful 
cutoff point for annual hospital volume for esophagectomy.
Background: Higher hospital volumes are associated with improved 
outcomes after esophagectomy. However, reported optimal vol-
umes in literature vary, and minimal volume standards in different 
countries show considerable variation. So far, no research was 
done on studying the non-categorical, non-linear volume-outcome 
relationship in esophagectomy.
Methods: Data were derived from the Netherlands Cancer Registry. 
Restricted cubic splines were used to investigate the non-linear 
effects of annual hospital volume on 6-month and 2-year mortality 
rates. Outcomes were adjusted for year of diagnosis, case-mix and 
(neo)adjuvant treatment. 
Results: Between 1989 and 2009, some 10,025 patients underwent 
esophagectomy for cancer in the Netherlands. Annual hospital 
volumes varied between 1/year to 83/year, increasing over time. 
Increasing annual hospital volume showed a continuous, non-
linear decrease in HR (Hazard Ratio) for mortality along the curve. 
Increasing hospital volume from 20/year (baseline, HR = 1.00) 
to 40/year and 60/year was associated with decreasing 6-month 
mortality, with a HR of 0.73 (95% Confidence Interval (0.65-0.83) 
and 0.67 (0.58-0.77) respectively. Beyond 60/year, no further de-
crease was detected. Higher hospital volume was also associated 
with decreasing 2-year mortality until 50 esophagectomies/year 
with a HR of 0.86 (0.79-0.93).
Conclusions: Centralization of esophagectomy to a minimum of 20 
resections/year has been effectively introduced in the Netherlands. 
Increasing annual hospital volume was associated with a non-
linear decrease in mortality up to 40-60 esophagectomies/year, 
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Surgical resection is the cornerstone of curative treatment for 
esophageal cancer. Postoperative mortality remains a challenge with 
reported mortality rates as high as 8.9% in the Western world1, with 
a 5-year survival rate after esophagectomy of around 50%2. 
There is compelling evidence that patients have better short- and 
long-term outcomes when operated in hospitals with a high annual 
caseload of esophagectomies3,4,5.  
To improve outcomes after esophagectomy, many countries intro-
duced minimum hospital volume standards 1,6,7, but it remains un-
clear, how high this minimum volume standard should be. Many dif-
ferent definitions of a ‘high-volume hospital’ have been proposed in 
the recent literature, ranging from more than 5 to over 86 esophageal 
cancer resections annually1,3,8-34. Consequently, there is no consensus 
what should be considered a ’high-volume‘ hospital and minimum 
volume standards for esophagectomies vary per country or region. 
The American Leapfrog group set the standard at a minimum of 13 
esophagectomies per hospital annually35,36, whereas in the Neth-
erlands, the minimum was recently set at 20 esophagectomies per 
year37. In Great Britain and Ireland, AUGIS advises at least 60 esopha-
gogastric cancer resections per unit per year38. 
The majority of volume-outcome studies in esophagectomy ana-
lyze hospital volume as a categorical variable. Hospitals are grouped 
in volume categories and casemix adjusted outcomes are compared 
between the highest and the lowest group. Therefore, the definition 
of a ‘high-volume’ hospital is based on the predefined hospital vol-
ume categories, based on the available data or are chosen arbitrarily. 
Non-linear statistical modeling techniques allow analysis of annual 
hospital volume as a continuous variable, thus providing support in 
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defining a meaningful cutoff point. So far, these statistics have not 
been used for volume-outcome studies in esophagectomy.
The purpose of this study is to define a meaningful cutoff point for 
annual hospital volume for esophagectomy, using non-linear statis-




Data were derived from the Netherlands Cancer Registry (NCR), which 
routinely collects information on all newly diagnosed malignancies 
in all Dutch hospitals 6-18 months after diagnosis. Topography and 
morphology were coded according to the International Classification 
of Diseases for Oncology (ICD-O)39. ICD-O morphology codes were 
used to classify tumors as adenocarcinoma (8140-8145, 8190, 8201-
8211, 8243, 8255-8401, 8453-8520, 8572, 8573, 8576), squamous 
cell carcinoma (SCC) (8032, 8033, 8051-8074, 8076-8123), and 
other/unknown histology (8000-8022, 8041-8046, 8075, 8147, 
8153, 8200, 8230- 8242, 8244-8249, 8430, 8530, 8560, 8570, 8574, 
8575). Staging was according to the International Union Against Can-
cer (UICC) Tumor Node Metastases (TNM) classification in use in the 
year of diagnosis. Vital status was initially obtained from municipal 
registries, and from 1994 onwards from the nationwide population 
registries network, which provides complete coverage of all deceased 
Dutch citizens. Follow-up was complete for all patients until 31st 




Between January 1989 and December 2009, 37,560 patients with 
esophageal or gastric cardia cancer were diagnosed in the Nether-
lands. Esophagectomies were defined as resections for cancers of 
the esophagus (C15.0-15.9) and gastric cardia (C16.0). Patients who 
did not undergo surgery (N = 26,521) were excluded, leaving 11,039 
resections available to calculate annual hospital volumes. Annual 
hospital volumes, defined as the number of esophagectomies per 
hospital per year, were determined for each year of surgery and may 
have changed per year for individual hospitals. 
Subsequently, patients with in situ and M1 disease (N = 1,014) 
were excluded, leaving 10,025 patients with non-metastatic invasive 
carcinoma available for volume–outcome analyses.
statistical­analyses
Differences in baseline characteristics between hospital volume 
categories were calculated with the Chi-square test. The main out-
comes were 6-month and 2-year overall mortality (OM). These were 
calculated using Cox regression, adjusted for sex, age, socioeconomic 
status, tumor stage, morphology, preoperative therapy use, postop-
erative therapy use (only for 2-year mortality) and year of diagnosis. 
To adjust for possible correlation due to clustering of patients in 
hospitals, robust standard errors were obtained using sandwich 
estimators. Frailty models with random hospital effects were used 
as sensitivity analysis. OM was calculated from the day of diagnosis 
until death, because the date of surgery was not available before 
2005. Six-month OM was calculated unconditionally, while 2-year 
OM was calculated conditionally on surviving the first 6 months after 
diagnosis.
The relationship between annual hospital volume and outcomes 
was calculated using Cox regression with annual hospital volume 
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modeled through restricted cubic splines40, adjusted for the above-
mentioned patient and treatment factors. Restricted cubic splines 
statistics allow investigation of non-linear effects of continuous 
covariates and have been described as a method for threshold 
identification 41,42.  The current Dutch minimum volume standard of 
20 esophagectomies per year was taken as a reference and given a 
hazard ratio (HR) of 1.




Patient, tumor, and treatment characteristics are displayed in table 1. 
The majority of patients were males (76%). The median age was 64 
years. Hospitals in the higher volume categories (>40/year) operated 
a slightly lower percentage of patients aged 75 years and older. Pre-
operative therapy use was significantly different between the volume 
categories.
hospital­volumes
From 1989 to 2009, the annual number of esophagectomies per-
formed in the Netherlands doubled from 352 to 723. The percentage 
of esophagectomies performed in hospitals with an annual volume of 
more than 20 esophagectomies per year increased from 7% to 64%. 
From 1998 on, 18.2% of patients were operated in hospitals perform-
ing more than 60 esophagectomies per year. Overall, throughout the 
study period the mean hospital volume was 20.7 esophagectomies 

















































































































































































































































































































































































































































































































































































































































































The results of the cubic splines analyses are shown in Table 2 and in 
Figures 1 and 2. In Figure 1, the volume-outcome curve for 6-month 
mortality showed a steep decrease in HR in volumes above 20. At 
40 resections per year, the HR was 0.73 (95% confidence interval 
0.65-0.83). From this point, the curve became less steep but the 
HR decreased to 0.68 (0.60-0.78) at 50 resections per year and to a 
HR of 0.67 (0.58-0.77) at 60 per year. Beyond this point, no further 
decrease in HR was observed.  Figure 2 displays the volume-outcome 
curve for 2-year conditional mortality. The curve was similar to 
Figure 1: the HR for death after 2 years strongly decreased between 
20 and 40 esophagectomies per year, with a HR of 0.88 (0.83-0.93) 
at 40 resections per year. At 50 resections per year, the HR was 0.86 
(95% CI 0.79-0.93)- similar to the HR at 60 resections per year (HR 
0.85 (0.75-0.97)). Sensitivity analyses using frailty models did not 











20  REFEREN­E 20  REFEREN­E
30 0.83 (0.76-0.9 ) 30 0.92 (0.89-0.96)
40 0.73 (0.65-0.83) 40 0.88 (0.83-0.93)
50 0.68 (0.60-0.78) 50 0.86 (0.79-0.93)
60 0.67 (0.58-0.77) 60 0.85 (0.75-0.97)
70 0.67 (0.54-0.83) 70 0.86 (0.7 - .05)
80 0.68 (0.49-0.94) 80 0.88 (0.66- . 6)
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figure­1:­Volume-outcome curve for 6-montC mortality (black line) witC 95 aercent confi-
dence intervals (dotted line). Note tCat tCe vertical axis Cas a logaritCmic scale. 
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figure­2:­Volume-outcome curve for conditional 2-year mortality (black line) witC 95 aer-




In the current study, the volume-outcome relationship in esopha-
gectomy was assessed in a non-categorical fashion, using non-linear 
statistical modeling techniques on a large dataset with reliable case-
mix information. It was found that further centralization of esopha-
gectomy beyond the current Dutch minimum volume standard of 20 
resections per year can have a beneficial effect on mortality rates.  A 
continuous decrease in HRs for 6-month and 2-year mortality was 
observed until hospital volumes of up to 40-60 esophagectomies per 
year. Beyond this point, no further improvement was detected.
Increasing annual hospital volume is associated with better out-
comes after esophagectomy1,3,4,5,34,43.  So far, little research has been 
performed on defining the optimal hospital volume threshold for 
esophagectomy. In an American study, analyzing 4080 esophagec-
tomy patients from the Nationwide Inpatient Sample, a cutoff point 
of 15 resections per year showed the largest difference in postopera-
tive mortality between hospitals with a volume below and above this 
threshold44. However, mean and maximum hospital volumes were 
small with 4 and 33 esophagectomies per year respectively. 
Another study, investigating 1634 esophagectomies from the 1999-
2000 UHC clinical database found the greatest difference in mortality 
between hospitals at the volume threshold of 22 esophagectomies 
per year 45. However, this analysis did not go beyond a threshold of 
25.
A meta-analysis of relevant literature available between 1990 
and 200346 showed that differences in postoperative mortality after 
esophagectomy were best discriminated using a volume threshold of 
at least 20 esophagectomies. However, no analyses were performed 
for hospital volumes above 20.  In contrast to the abovementioned 
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studies, the current study aimed to define the annual hospital volume 
above which no further improvement in outcomes can be detected. 
A potential bias when analyzing outcomes over a long period is that 
preoperative staging and (perioperative) care generally improved 
over time, while at the same time most high-volume resections were 
performed in the more recent years. Therefore, high volume resec-
tions may be intrinsically associated with better outcomes. To offset 
this effect, we adjusted for year of diagnosis among other covariates. 
The surgery hospital was not available for part of the patients treated 
before 2005. Instead, the hospital of diagnosis was used in this case. 
Although referral of esophageal cancer patients to another hospital 
for surgery was uncommon in the earlier years of the study period, 
it may have influenced the analyses in the time period between 2000 
and 2004. 
The results of the current study are representative for the entire 
population as case ascertainment of the Netherlands Cancer Registry 
is high47. 
Due to the high number of registered variables, case-mix adjust-
ments could be made, in all survival analyses, although it is possible 
that some confounding factors not available in the dataset may have 
influenced differences in outcomes between hospitals. However, 
after adjusting for age, tumor stage and SES, the added value of other 
confounding factors like comorbidity may be limited, especially in 
more aggressive types of cancer.
Worldwide, programs to concentrate esophageal cancer surgery to-
wards high-volume hospitals take place, which has led to decreasing 
mortality rates in, for instance, the United States,1, 35,  and the United 
Kingdom 9, 43. 
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Because of the minimum volume standard in the Netherlands (10 
per hospital per year as of 2006, 20 per year as of 2011), the major-
ity of Dutch patients are currently operated in centers performing 
20 or more resections per year48.  The current results suggest that 
further centralization up to 40-60 esophagectomies per hospital per 
year may further improve both short-term mortality and long-term 
survival. T he recent increase in hospital volumes can mainly be at-
tributed to hospitals performing 20-40 procedures per year as of 
2005, whereas the highest volume category remained the same size 
since approximately 2000. Therefore, the learning curve of the hos-
pitals that became referral centers after 2005 might have influenced 
results: it may have taken some time for these hospitals to arrange 
care in such a way that they could achieve results similar to the 
higher volume centers (performing >60 resections/year) that existed 
already a longer time. However, by adjusting for year of diagnosis, 
there is also adjusted for the potential presence of learning curves. 
Moreover, it is possible that a greater effect of volumes above 60 
resections/year would have been detected with more hospitals in 
this higher end of the spectrum. 
In the Netherlands, a small country with a good infrastructure, fur-
ther centralization will not likely lead to unreasonable travel burdens 
or problems in continuity of post-surgical care. The right number for 
a small, densely populated country might differ from that of larger 
countries with less densely populated areas. 
Hospital volume may be a reflection of a variety of factors in the 
process of care, such as multidisciplinary approach, patient selec-
tion, and protocols; as well as resources. Arguably, lower volume 
hospitals may achieve excellent results with a similar approach 
and environment. Volume-based referral carries the risk that high-
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volume hospitals with unfavorable outcomes are selected as referral 
centers34,36 but identification of the processes and structural factors 
that account for superior results remains challenging 49.  Outcome-
based referral avoids this problem by selecting referral centers based 
on outcomes50.  Identification of centers of excellence requires valid, 
reliable, complete, and adequate risk-adjusted registration of out-
comes through audits51,52, which provide insight in care patterns, and 
allow clinicians to benchmark their hospital on outcomes, thereby 
stimulating improvement53.
In conclusion, the current study showed a continuous, non-linear 
decrease in HRs for 6-month and 2-year mortality, until hospital 
volumes of up to 40-60 esophagectomies per year, implicating that 
centralization of esophageal cancer resections to hospitals perform-
ing 40-60 resections per year may lead to an improved 6-month 
mortality and 2-year survival. These findings may guide national and 
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Background: Surgical resection with restoration of bowel continuity 
is the cornerstone of treatment for colon cancer patients. The aim 
of this study is to identify risk factors for anastomotic leakage (AL) 
and subsequent mortality in colon cancer surgery.
Methods: Data were retrieved from the Dutch Surgical Colorectal 
Audit. Patients undergoing a colon cancer resection with creation 
of an anastomosis between January 2009 to December 2011, were 
included. Outcomes were AL requiring a re-intervention and post-
operative mortality following AL.
Results: AL occurred in 7.5 per cent of a total of 15 667 included 
patients. Multivariate analyses identified male gender, high ASA 
classification, extensive tumour resection, emergency surgery and 
surgical resection types as transverse resection, left colectomy and 
subtotal colectomy, as independent risk factors for anastomotic 
leakage. In a small group of patients a defunctioning stoma was 
created, leading to a lower leakage risk. Overall mortality was 4.1 
per cent, and mortality was significantly higher in patients with 
AL compared to patients without leakage (16.4 vs 3.1 per cent 
P<0.001). Multivariate analyses showed a higher age, high ASA 
classification, high Charlson score and emergency surgery, as inde-
pendent risk factors for mortality after AL. Moreover, the adjusted 
risk of mortality after AL was twice as high in right colectomy 
compared to left colectomy.
Conclusions: Elderly and patients with comorbidity have higher 
mortality after anastomotic leakage. Despite a lower adjusted risk 
of AL after right colectomy compared to left colectomy, the risk of 
mortality after AL was higher after right colectomies. Of importance 
is accurate preoperative patient selection, intensive postoperative 
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surveillance for AL and early and aggressive treatment of AL once 




Surgical resection is the cornerstone of treatment for colon cancer 
patients. Generally, restoration of bowel continuity with a primary 
anastomosis is pursued in uncomplicated colon resections. The most 
serious complication of colonic surgery with restoration of bowel 
continuity is anastomotic leakage (AL)1, which is associated with the 
possible need for reinterventions, increased mortality2,3 and possibly 
a worse oncological outcome4,5. The reported incidence of AL in 
colonic anastomosis varies between 3 and 6.4 per cent, depending 
on patient and tumor characteristics, definition criteria, site of the 
anastomosis and possibly by case-load per surgeon6-9. Several risk 
factors including co-morbidity, higher American Society of Anes-
thesiologists (ASA) classification, stage of disease, type of surgery, 
surgery in emergency setting and intraoperative complications have 
been associated with AL7,10-12. Furthermore, concentration of surgery 
in high-volume centers has been considered as a strategy to improve 
quality of care, surgical outcomes and mortality13,14. Therefore, 
hospital procedural volume could also be a possible risk factor for 
AL. Although AL has long been subject of debate, the prediction for 
the risk of AL for the individual patient remains difficult. The Dutch 
Surgical Colorectal Audit (DSCA), a clinical outcome registry in which 
all Dutch hospitals participate, was initiated in 2009 to monitor and 
improve outcome of surgical care for colorectal cancer patients. The 
DSCA facilitates individual hospitals in quality improvement projects 
but is also used to identify treatment and outcome patterns for dif-
ferent patient groups. In the DSCA, AL after colorectal resections 
was appointed as an outcome indicator for surgical quality of care15. 
In rectal cancer surgery, the practice of routine construction of de-
functioning stomas may play a large role in measuring this outcome 
and determining risk factors16. Stoma construction may be of lesser 
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importance in colon cancer resections. Moreover, among all colorec-
tal surgical procedures, patients undergoing colon cancer resections 
may be considered a specifically vulnerable patient group, being at 
risk for morbidity and mortality because of advanced age and co-
morbidity17. Risk factors for AL and related postoperative mortality 
have not yet been investigated in this particular group. The aim of 
the present study is to identify risk factors for AL after colon cancer 
resection and factors influencing mortality associated with AL with 
patient information from a national audit database.
Methods
study­population
The dataset was retrieved from the DSCA, a web-based national data-
base, in which all patients undergoing surgical resection for colorec-
tal cancer were entered18. Data on patient and tumor characteristics, 
diagnostics, treatment and outcome, were collected. The dataset 
contained data registered from 92 hospitals with a high concordance 
on validation against the National Cancer Registry (NKR). In 2009, 
89 per cent of the Dutch hospitals participated, increasing to 99 per 
cent in 2010 and 201119. Medical ethics committee approval was not 
required for this study as all patients and hospital information in the 
DSCA was de-identified. Individual patient data was collected in the 
treating hospital and encrypted transferred to the database of the 
DSCA.
Inclusion­and­exclusion­Criteria
All Dutch patients who underwent a colon cancer resection in the 
Netherlands from January 2009 to December 2011, were included 
in this study. Rectal cancer patients, patients with multiple synchro-
leak-related mortality
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nous tumors, patients without a primary anastomosis or with an un-
known surgical resection type, were excluded from analysis. Surgical 
resections were categorized in ileocecal resection, right colectomy, 
transverse resection, left colectomy, sigmoid resection and subtotal 
colectomy.
outcome
Primary outcome measures were AL, defined as clinically significant 
AL requiring surgical or radiological re-interventions, and mortality 
after AL, defined as in-hospital mortality or within 30 days after pri-
mary surgery. Potential risk factors for postoperative complications 
including patient factors (age, gender, Body Mass Index (BMI), Charl-
son co-morbidity Score20,21, ASA classification, previous abdominal 
surgery), tumor factors (tumor stage, tumor location, preoperative 
tumor complications) and treatment factors (preoperative surgical 
procedures (stoma or other), type of surgical resection, emergency 
surgery, extensive resections, fashioning of a defunctioning stoma) 
were extracted from the database. Hospitals were categorized as 
low- (< 50), medium- (51 -100) or high-volume (>100) center, based 
on the number of surgically treated colon cancer patients per year 
for the years 2010 and 2011 (in 2009 not all hospitals completed 
registration). These categories reflect the present situation in the 
Netherlands with 50 percent of the clinics performing between 50-
100 colon cancer resections annually22.
statistical­analysis
Univariate analyses were performed to test the association between 
the above-mentioned patient, tumor, treatment and hospital factors 
and the occurrence of AL and mortality after AL, with a Chi-square 
test. Logistic multivariate analyses were performed to correct for 
possible confounders. A manual stepwise model was used for the vari-
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ables with a P-value <0.05 in univariate analysis. Clinically relevant 
variables were added to the statistical model. The variables ‘timing 
of surgery (elective/emergency)’ and ‘preoperative tumor complica-
tions’ were assumed to indicate the same clinical situation. To check 
for colinearity when both variables (‘timing of surgery (elective/
emergency)’ and ‘preoperative tumor complications’) were incorpo-
rated in the model, the variance inflation factor was computed. To 
check our model, we repeated the multivariate analysis with outcome 
AL, first without the variable ‘preoperative tumor complications’ 
and including ‘time of surgery’. Thereafter we performed the same 
analysis conversely (including ‘preoperative tumor complications’ 
and without ‘timing of surgery’). Results are reported as odds ratios 
(OR) and 95 per cent confidence intervals (95 per cent c.i.). Analyses 
were considered to be statistically significant with a 2-sided P-value 
<0.05. All data was analyzed using PASW Statistics, Release 20.0.0.1 
(SPSS inc, Chicago, IL).
results
From 2009 to 2011 data from 27 259 patients were included in 
the database of the DSCA (Figure 1). After exclusion of 7614 rectal 
cancer patients and 943 patients with multiple synchronous tumors, 
18 702 colon cancer patients were eligible. After excluding another 
2581 patients without a primary anastomosis and 454 patients who 
underwent another surgical resection (total colectomy or unknown 
resection type), 15 667 colon cancer patients were included for anal-
ysis (tables 1-3). From all included patients there were 240 ileocecal 
resections, 7788 right colectomies, 527 transverse resections, 1601 
left colectomies, 5354 sigmoid resections and 157 subtotal colecto-
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table­1:­Patient cCaracteristics of aatients oaerated for colon cancer, and univariate 
analyses of aossible variables associated witC anastomotic leakage and witC mortality after 
anastomotic leakage
patient­Characteristics anastomotic­leakage Mortality­after­al
 Patient factors N % N % P-Value N % P-Value
 5667    76 7.5  45  5.7  
Gender     
Female 7605 48.5 477 6.3 <0.00 80  6.8 0.783
Male 8062 5 .5 699 8.7   3  6.2  
Age (years)     
<65 4825 30.8 386 8.0 0.284 20 5.2 <0.00 
 65-80 76 6 48.7 55 7.2  0  8.3  
>80 32  20.5 239 7.4 72 30.  
BMI     
<20 623 5.0 54 8.5 0.643   20.4 0.535
20-25 4922 39.0 366 7.4 59  6.  
25-30 4986 49.5 389 7.8 54  3.9  
>30 2079  6.5  69 8. 29  7.2  
ASA      
I -II   638 74.3 822 7. <0.00 94   .4 <0.00 
III-IV 37 3 23.7 249 9.2 96 28.2  
Unknown 3 6 2.0  0 4.4 3 2 .4  
­Carlson Score     
0 8335 53.2 583 7.0 0.032 56 9.6 <0.00 
I 3579 22.8 285 8.0 59 20.7  
≥II 3753 24.0 308 8.2 78 25.3  
Previous abdominal surgery     
Yes 5309 33.9 425 8.0 0.090 8  9. 0.065
No  0358 66. 75 7.3    2  4.9  
BMI= Body Mass Index; ASA= American Society of AnestCesiologists
leak-related mortality
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table­2:­Tumour cCaracteristics and univariate analyses of aossible variables associated 
witC  anastomotic leakage and witC mortality after anastomotic leakage
patient­Characteristics anastomotic­leakage Mortality­after­al
 N % N % P-Value N % P-Value
Tumour factors      
Preoaerative tumour comalications    
None   968 76.4 820 6.9 <0.00  30  5.9 0. 00
Perforation 356 2.3 43  2. 8  8.6  
Obstruction  557 9.9  75   .2 30  7.  
Blood loss 95 6. 65 6.8 6 9.2  
OtCer 835 5.3 73 8.7  9 26.0  
TNM Stage    
0  53  .0  3 8.5 0. 76 3 23. 0.782
 28   7.9  80 6.4 3  7.2  
2 5769 36.8 46 8.0 67  4.5  
3 49 8 3 .4 376 7.6 67  7.8  
4  784   .4  3 7.3 23  7.6  
Unknown 232  .5  5 6.5 2  3.3  
Tumor Location     
­aecum 35 3 22.4 2 6 6.  <0.00 45 20.8 0.225
Ascending colon 3085  9.7  99 6.5 35  7.6  
Heaatic Flexure  064 6.8 70 6.6  5 2 .4  
Transverse colon   68 7.5  22  0.4 20  6.4  
Salenic Flexure 448 2.9 54  2. 9  6.7  
Descending colon 887 5.7 93  0.5     .8  
Sigmoid colon 5502 35. 422 7.7  58  3.7  
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table­3:­Treatment cCaracteristics and univariate analyses of aossible variables associated 
witC anastomotic leakage and witC mortality after anastomotic leakage. Hosaital Volume: 
low: <50 aatients aer year, medium: 5 - 00 aatients aer year, CigC: > 0  aatients aer year.
patient­Characteristics anastomotic­leakage Mortality­after­al
 N % N % P-Value N % P-Value
Treatment factors
Preoaerative surgical arocedures 
None  5285 97.6   33 7.4 0.0 5  88  6.6 0.383
Stoma formation   8 0.8  5  2.7 3 20.0  
OtCer 264  .7 28  0.6 2 7.  
Surgical Resection
RigCt colectomy 7788  .5 495 6.4 <0.00  0 20.4 0.029
Ileocecal resection 240 49.7  8 7.5 3  6.7  
Transverse resection 527 3.4 57  0.8  0  7.5  
Left colectomy  60  0.2  72  0.7 20   .6  
Sigmoid resection 5354 34.2 4 3 7.7 58  4.0  
Subtotal colectomy  57  .0 2  3.4  4.8  
Time of surgery
Elective  3 39 83.9 925 7.0 <0.00  45  5.7 0.028
Emergency  625  0.5  59 9.6 37 23.3  
Unknown 869 5.5 92  0.6    2.0  
Stoma    
No stoma  506 96.   37 7.5 0.308  87  6.4 0.860
Defuncioning stoma 606 3.9 39 6.4 6  5.4  
Extensive resections
No  42 6 90.7  025 7.2 <0.00  64  6.0 0.32 
Yes  45 9.3  5  0.4 29  9.2  
Hosaital factors    
Hosaital Volume    
Low 2680  7.  80 6.7 0.225 38 2 . 0. 62
Medium 846 54.0 653 7.7 99  5.2  
HigC 4525 28.9 343 7.6  56  6.3  
leak-related mortality
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the patients being treated in a low-volume center, 55.5 per cent in 
a medium-volume center and 29.2 per cent in a high-volume center.
­anastomotic­leakage
AL leading to re-intervention occurred in 1176 patients (7.5%). The 
re-interventions were laparotomy (82.1%), laparoscopy (2.8%), 
radiological drainage (8.2 %) or other interventions for example 
wound drainages or wound abscesses (6.9 %). During the primary 
operation a defunctioning stoma was made in 606 patients (3.9 %), 
usually after a sigmoid resection. From all anastomoses created after 
a sigmoid resection, 8.7 % was deviated. There was no difference in 
AL rate between the patients with and without defunctioning stoma, 
6.4 vs 7.5 % respectively (P=0.308). Compared to the other types of 
resections, the incidence of AL was significantly higher after resection 
of the transverse colon, left colectomy and subtotal colectomy. In 805 
patients (69 %) requiring a surgical or radiological re-intervention 
for AL, a secondary stoma was created.
risk­factors­for­anastomotic­leakage
Tables 1-3 show univariate analyses of possible risk factors for the 
occurrence of AL. In univariate analyses, patient factors associated 
with an increased risk of AL were male gender, higher ASA classi-
fication and higher Charlson Score. Of the analyzed tumour factors, 
preoperative tumour complications (mostly tumor perforation or 
obstruction) and tumor location were associated with an increased 
risk of AL. Treatment factors associated with a higher risk of AL, 
were preoperative surgical procedures (e.g. preoperative construc-
tion of a defunctioning stoma), extensive resections (resections of 
other organs during surgery), emergency surgery, and type of resec-
tion, especially transverse resection, left colectomy and subtotal 
colectomy. Multivariate analyses confirmed that male gender and 
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table­4:­Risk factors for anastomotic leakage; multivariate analyses of all aatients wCo 
underwent colonic surgery witC a arimary colonic anastomosis
Characteristics ­ or­ 95%­CI p-value
Gender Female Ref  
 Male  ,378  ,2 9- ,558 <0.00 
ASA classification I-II Ref  
 III-IV  ,26  .088- .449 0.002
 Unknown 0,59 0,343- ,0 6 0.075
­Carlson Score 0 Ref  
 I  ,  0,954- ,29 0, 78
 ≥II  , 02 0,944- ,287 0,2 8
Preoaerative surgical arocedures None Ref  
 Stoma  ,52 0,873-2,647 0, 39
 OtCer  ,209 0,805- ,8 4 0,36 
Surgical Resection RigCt colectomy Ref  
 Ileocecal resection  , 29 0,690- ,848 0,63
 Transverse resection  ,689  ,262-2,26 <0.00 
 Left colectomy  ,69  ,404-2,034 <0.00 
 Sigmoid resection  ,276  , 09- ,468 0.00 
 Subtotal colectomy 2,28  ,42 -3,66 0.00 
Extensive resection No Ref  
 Yes  ,43  , 9 - ,720 <0,00 
Stoma No stoma Ref  
 Defunctioning stoma 0,682 0,486-0,956 0,026
Time of surgery Elective Ref  
 Emergency  ,327  , 07- ,592 0,002
 Unknown  ,553  ,232- ,957 <0,00 
ASA= American Society of AnestCesiologists
leak-related mortality
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a high ASA classification remained independent risk factors for AL 
(table 4). Treatment factors that remained associated with a higher 
AL risk were types of resection (mainly transverse resection, left 
colectomy and subtotal colectomy compared to right colectomy as 
reference group), extensive resections during surgery and surgery in 
emergency setting. On clinical grounds, the variable ‘defunctioning 
stoma’ was added to the model and adjusted data also showed less AL 
in patients with a defunctioning stoma (OR 0.682). In order to check 
for the presence of colinearity between the two clinical associated 
variables ‘timing of surgery (elective/emergency)’ and ‘preoperative 
tumor complications’, the variance inflation factor was computed. 
Results indicated no colinearity between these variables.
Repeated analysis of our multivariate model including the variable 
‘preoperative complication’ instead of ‘time of surgery’ showed a 
significant higher risk for AL in patients with preoperative tumor 
complications as perforation or obstruction (OR 1.684 and 1.629 
respectively). 
Mortality
Of all included patients, 648 (4.1 %) died within 30 days postopera-
tively (3.4 % after elective surgery vs 7.2 % after emergency surgery 
P<0.001). In 193 of all deceased patients, AL was diagnosed post-
operatively (29.8 %). The mortality in patients with AL was signifi-
cantly higher than in patients without AL (16.4 vs 3.1 %, P<0.001). 
There was no significant association between the number of patients 
treated yearly per hospital and mortality after AL (P=0.162). 
risk­factors­for­mortality­after­anastomotic­leakage
Univariate analyses revealed that patient factors associated with 































































































































































































































Charlson score (table 1). Moreover, surgery in emergency setting and 
type of surgical resection were associated with a higher risk.
Especially patients undergoing a right colectomy, transverse 
resection or ileocecal resection, had high mortality rates after oc-
currence of AL (figure 2). After adjustment for possible confounders, 
multivariate analyses showed that higher age, high ASA classification, 
higher Charlson score and surgery in an emergency setting were 
independent risk factors for mortality in patients diagnosed with AL. 
Multivariate analysis also showed lower mortality associated with 
AL after left colectomy compared to other surgical resection types 
(table 5).
table­5:­Risk factors for mortality after anastomotic leakage, multivariate analyses of all 
aatients diagnosed witC anastomotic leakage
Characteristics ­ or­ 95%­CI p-value
Age <65 Ref  
 65-80 3. 54  .887-5.27 <0.00 
 >80 5. 62 2.976-8.956 <0.00 
ASA classification I-II Ref  
 III-IV  .77  .244-2.52 0.002
 Unknown  .89 0.479-7.473 0.363
­Carlson Score 0 Ref  
 I  .764  . 56-2.693 0.008
 ≥II 2.23  .474-3.373 <0.00 
Surgical resection RigCt colectomy Ref  
 Ileocecal resection  .002 0.254-3.944 0.998
 Transverse resection 0.802 0.377- .706 0.566
 Left colectomy 0.538 0.3 3-0.924 0.025
 Sigmoid resection 0.745 0.5 3- .084 0. 24
 Subtotal colectomy 0.284 0.036-2.235 0.232
Time of surgery Elective Ref  
 Emergency  .749  . 2 -2.730 0.0 4




The present study on risk factors for anastomotic leakage and mor-
tality following colon cancer resection with an anastomosis showed a 
7.5 % leak rate for all patients. There was an overall mortality rate of 
4.1 %, which was significantly higher for patients with anastomotic 
leakage than in those without (16.4 vs 3.1 %).
The leak rate found in the present study is higher than the leak rate 
reported in recent literature (3-6.4 %)6-8. This might be attributed to 
the complete registration in a clinical audit. Reported results from 
a nationwide study on leak in Denmark also showed a rather high 
percentage of 6.4 %7. Other publications with lower percentages 
usually are from dedicated centers. Adjusted data for confounding 
factors indicated male gender and high ASA classification as inde-
pendent risk factors for anastomotic leakage, which is consistent 
with the literature7,23,24. Other reported predictors for anastomotic 
leakage such as previous abdominal surgery24 or high BMI3,25, could 
not be confirmed in our analysis. Another well-known risk factor 
for anastomotic leakage is co-morbidity8,11,24, in the present study 
reflected in the Charlson score and ASA classification. Both scores 
were associated with anastomotic leakage in univariate analyses and 
ASA score remained a significant predictor for anastomotic leakage 
in multivariate analyses.
Adjusted analysis in the present study indicated that treatment fac-
tors such as extensive resections and type of surgical resection were 
independent risk factors for anastomotic leakage. The incidence of 
anastomotic leakage differs per tumour location and subsequent 
type of surgical resection. Right-sided colectomy is associated with 
a lower leakage rate compared to left sided colectomy3,26, and the 
occurrence of anastomotic leakage is higher after transversectomy11. 
Vascularization of the anastomotic site may be explanatory in this as 
leak-related mortality
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in a right-sided hemicolectomy a well-vascularized ileal bowel loop 
is anastomosed to an adequately vascularized transverse colon loop. 
While in transverse or left colic resection, where the middle colic 
artery or inferior mesenteric artery is divided, vascularization of the 
anastomotic site might be compromised27,28. Another explanation 
is the lack of full mobilization of one or both flexures. The poorer 
outcome after a transverse resection in the present study, emphasize 
the importance of careful surgical decision-making.
In patients requiring a transverse resection, an extended colectomy 
could be a better alternative than a transverse resection.
Data of other known risk factors as loss of weight26, intraoperative 
complications, operative time, blood loss and fecal contamination8,11 
were not available in our database. 
The overall mortality of 4.1 % in the present analysis is in range 
with population based studies in the literature (3.0-7.4 per cent)6,29,30. 
The 16.4 per cent mortality following AL is high and related to old 
age and co-morbidity, as is also known from the literature (12.0-18.6 
%)6,11. The mortality rate after AL is described to be much higher 
after a colon resection compared to patients undergoing a rectal 
resection (0.7-4 per cent)9,31,32. This dissimilarity might be explained 
by differences in anatomy. Anastomotic leakage after colon resection 
often results in a generalized peritonitis, compared to more local, 
extra peritoneal abscess formation after a rectum resection. For early 
detection of anastomotic leakage after rectal surgery, leakage scores 
are developed29,33. It is of upmost interest to validate these scores also 
for colonic resections, since severity of the consequences of leakage 
from a colonic anastomosis is underestimated. 
To reduce incidence of anastomotic leakage or its clinical sequelae, 
a defunctioning stoma could be constructed. In rectal anastomoses, 
temporary defunctioning stomas are made to reduce the clinical 
consequences of anastomotic leakage10,34. In our series most of the 
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defunctioning stomas were constructed after a sigmoid resection. 
The present analysis showed no significant decrease of anastomotic 
leakage in univariate analysis, but after adjustments for patient and 
tumour characteristics, multivariate analysis showed a protective 
effect of a defunctioning stoma for anastomotic leakage. Apparently, 
there was a good patient selection for fecal diversion, based on the 
preoperative or intraoperative surgeons’ judgment concerning the 
risk for anastomotic leakage. Emergency surgery is also considered 
as a risk factor for both anastomotic leakage12,35 and postoperative 
mortality12.30,36. A poor general condition and nutritional state, 
is associated with higher morbidity and mortality risks in these 
patients36,37. In the present study, emergency surgery was an inde-
pendent risk factor for both anastomotic leakage and mortality fol-
lowing anastomotic leakage. Our repeated multivariate analysis also 
confirmed that patients with preoperative complications as tumour 
perforation and obstruction had a higher odds for postoperative 
anastomotic leakage occurrence.
Emergency surgery is frequently performed in evening and night 
shifts. Studies from different medical fields also reported worse 
postoperative outcome after surgeries performed in late hours38-40. 
Surgical procedures in late hours are sometimes performed by sur-
geons with a lower disease-specific caseload. Some studies suggested 
that experience and caseload of the individual surgeon are predictors 
for postoperative mortality9,41. Unfortunately, our database does not 
contain individual data of surgeons.
The strength of this study is that results are based on a complete 
and large nationwide dataset, which contained registered data from 
all Dutch hospitals performing colorectal surgery. Validation of the 
registered data showed a high concordance against the national 
cancer registry. Therefore a valid analysis of colon cancer surgery 
in the Netherlands could be made. However, several limitations are 
leak-related mortality
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worth mentioning. A somewhat heterogeneous study population is 
included for analysis. All colon cancer patients undergoing resec-
tion are included, including patients with stage IV disease, who may 
represent both curative and palliative resections and operations in 
emergency setting. Though the analysis of such a complete cohort 
leads to fair results, the heterogeneity is also accompanied by con-
founding factors and might lead to bias. In order to control for bias 
we also performed a multivariate analysis model stratified for time of 
surgery (elective and emergency). The main results of the analysis for 
the subgroups did not differ significantly, compared to the presented 
results of the total study population (data not shown). Therefore, we 
used ‘time of surgery’ as possible risk factor for anastomotic leakage 
and subsequent mortality in our multivariate model. Another limita-
tion of this dataset is that only patients treated for malignancy could 
be analyzed, while there are also benign indications for colon sur-
gery. Furthermore, little intraoperative information is recorded. The 
dataset contains no data regarding duration of operation, blood loss 
and surgical techniques. Intraoperative information could be a valu-
able contribution for the identification of risk factors for anastomotic 
leakage. The same also applies to information regarding caseload per 
surgeon. Colon cancer resections are common surgical procedures. 
Although for the individual patient the exact mechanism leading to 
the development of anastomotic leakage is often unknown, and the 
clinical risk assessment by the operating surgeon is of low predictive 
value44, it is important to understand that tumour and treatment fac-
tors may play an important role.
Mortality rates after the occurrence of anastomotic leakage are 
high, and mainly determined by patient factors as high age and co-
morbidity. Therefore, it is important to monitor patients postopera-
tively according to standardized postoperative surveillance, perhaps 
incorporating colon leakage scores designed for left sided colorectal 
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surgeries29,33. Future research projects should be focused on further 
evaluation of these leakage scores in colon resections, and on con-
tinuous monitoring through clinical auditing.
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aBstraCt
Background: Mortality following severe complications (failure to 
rescue, FTR) is targeted in surgical quality improvement projects. 
Rates may differ between colon- and rectal cancer resections.
Methods: Analysis of patients undergoing elective colon and rectal 
cancer resections registered in the Dutch Surgical Colorectal Audit 
in 2011 – 2012. Severe complication- and FTR rates were compared 
between the groups in univariate and multivariate analysis.
Results: Colon cancer (CC) patients (n=10184) were older and had 
more comorbidity. Rectal cancer (RC) patients (n=4906) less often 
received an anastomosis and had more diverting stomas. Complica-
tion rates were higher in RC patients (24.8% vs. 18.3%, P<0.001). 
However, FTR rates were higher in CC patients (18.6% vs 9.4% 
p<0.001). Particularly, FTR associated with anastomotic leakage, 
postoperative bleeding and infections was higher in CC patients. 
Adjusted for casemix, CC patients had a two-fold risk of FTR com-
pared to RC patients (OR 1.89, 95% CI 1.06-3.37).
Conclusions: Severe complication rates were lower in CC patients 
than in RC patients; however, the risk of dying following a severe 
complication was twice as high in CC patients, regardless of dif-
ferences in characteristics between the groups. Efforts should be 
made to improve recognition and management of postoperative 




Ever since the Institute of Medicines report ‘to err is human’, patient 
safety is a number one priority in many western health care systems. 
Colorectal cancer surgery is performed commonly, though it remains 
associated with relatively high morbidity and mortality rates1,2, in 
part because colorectal cancer patients often have a high age and 
comorbid illnesses3. As a result, colorectal cancer surgery is the 
subject of many national quality improvement programs in Europe4 
and the United States5, with complication- and mortality rates being 
widely used outcomes for comparisons of quality of surgical care. 
Failure to rescue (FTR) - the mortality rate in patients with a severe 
complication - is another outcome measure that indicates the ability 
of a surgical team to keep patients alive when severe complications 
occur6-8. FTR is seen as a good quality indicator as it evaluates both 
complication recognition and treatment.
Following the example of audits in other European countries, the 
nationwide Dutch Surgical Colorectal Audit (DSCA) was introduced 
in the Netherlands in 20099. One of the main objectives of these audit 
programs is to reduce morbidity and mortality after colorectal sur-
gery. To reach this objective, it is important to understand the mecha-
nisms behind the development of adverse events and the way they 
lead to fatal outcomes. In the DSCA, postoperative mortality appears 
to be higher after colon cancer resections than after rectal cancer 
resections, despite higher complication rates in the latter9, suggest-
ing higher FTR rates in colon cancer surgery. These differences in 
FTR may be partly due to a higher proportion of non-elective sur-
gery in colon cancer patients, which carries a higher risk of adverse 
events10, though may also exist in elective cases. A similar pattern 
was observed in the British National Bowel Cancer Audit Program, 
with higher postoperative mortality rates after colon resections than 
safety of elective colorectal surgery
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after rectal cancer resections, both in elective and non-elective cases, 
despite higher reoperation rates in rectal cancer patients11. 
Differences in patient characteristics, such as age, comorbidity, and 
tumor stage between colon and rectal cancer patients may also play 
a role in the differences in outcomes between the two patient groups. 
Moreover, possible differences in treatment characteristics, such as 
neoadjuvant therapy, fecal diversion and minimally invasive surgery 
may play a role.  
The purpose of this study was to evaluate differences in FTR rates 
between elective colon and rectal cancer resections in relation to the 
characteristics of these patient groups and differences in treatment 
patterns between colon and rectal cancer patients. 
patIents­and­Methods
data­source
A retrospective review of prospectively collected clinical data was 
undertaken. Data were provided by the DSCA, a national quality 
improvement project in which all hospitals performing colorectal 
cancer surgery participate and in which a variety of characteristics 
concerning patient demographics, comorbidity, diagnostics, disease-
specific details, treatment and outcomes are collected prospectively. 
Inclusion criteria for registration are patients undergoing a resection 
for primary colorectal cancer. External data verification with the 
dataset of the Netherlands Cancer Registry (NCR), showed a 95% 





For this study, no ethical approval was required under Dutch law. 
Patients undergoing any surgical resection for primary colorectal 
cancer between the 1st of January 2011 and 31st of December 2012, 
and registered in the DSCA before March 15th 2013, were evaluated. 
Minimal data requirements to consider a patient eligible for analyses 
were information on tumor location, date of surgery, complications 
and mortality. Patients undergoing non-elective surgery were ex-
cluded since these patients represent a subgroup of patients with 
other treatment perspectives and subsequent different expected out-
comes13. Finally, patients treated for multiple synchronous colorectal 
tumors were excluded to make sure a clear distinction between colon 
and rectal cancer patients could be made.
outcomes
Postoperative complications were defined as all surgical or non-
surgical postoperative complications. In the DSCA, surgical complica-
tions (e.g. anastomotic leak, hemorrhage) are only registered when a 
reintervention was performed.
Failure to rescue was, in accordance with previous publications, 
defined as the mortality rate among patients with a severe com-
plication8,14. Severe complications were defined as complications 
leading to ICU admission (longer than 2 days), to a reintervention, to 
a prolonged hospital stay of more than 14 days, or to postoperative 
mortality. This is consistent with previous publications in which data 
from the DSCA were analyzed8,15, except for the ICU criterion which 
was added for a more precise characterization of severe complica-
tions. The reason this criterion was not used in previous publications 
is that data on ICU admission were lacking from the DSCA database 
before 2011. Patients with a prolonged hospital stay, in which no 
safety of elective colorectal surgery
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complication was registered, were not included in the definition of a 
severe complication.
Anastomotic leakage was defined as clinically apparent leakage or 
an abscess in the proximity of the anastomosis. Intra-abdominal ab-
scesses were registered as such when not evidently associated with 
anastomotic leakage. Infectious/septic complications were all infec-
tions not meeting other (pulmonary, urinary tract, intra-abdominal 
etc.) criteria, for instance central venous catheter related infections, 
or wound infections.
Postoperative mortality was defined as death within 30 days from 
surgery or within the same hospital admission as the resection.
statistical­analysis
Categorical variables were compared between colon cancer and rec-
tal cancer patients by Chi-square tests, while 2-sample t tests were 
used for continuous variables.
The risk of FTR after severe complications, adjusted for patient- and 
tumor related risk factors, was calculated with multivariable logistic 
regression with addition of patient category (colon or rectal cancer 
patients) as a variable in the model. A random effects model adjusted 
for the presence of variability in outcomes between hospitals.
To assess whether differences in hospital characteristics of hospi-
tals treating colon- and rectal cancer patients influenced differences 
in outcomes between colon- and rectal cancer patients, we repeated 
our analysis in a fixed effects model with the addition of the variables 
teaching status, hospital volume, and level of ICU facilities according 
to a previous study14.
A 2-sided P ≤ 0.05 was considered statistically significant. Statis-
tical analyses were performed in PASW Statistics version 20 (SPSS 
inc., Chicago, Il, USA) and R 2-14 (The R Project for Statistical Com-
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A total of 15,090 patients undergoing elective colon or rectal cancer 
resections in 92 hospitals were included. Patient characteristics are 
displayed in table 1. 
Colon cancer patients were less often male, were older and had 
higher Charlson comorbidity scores and ASA classifications com-
pared to rectal cancer patients. TNM stage was also higher in colon 
cancer patients. A primary anastomosis was constructed less often 
in rectal cancer patients, with more often fecal diversion in case of 
an anastomosis, compared to colon cancer patients. Laparoscopic 
resection rates were quite similar in both patient groups.
outcomes
The overall postoperative complication and reintervention rates 
were lower in colon cancer patients than in rectal cancer patients. 
Median length of stay was one day longer in rectal cancer patients 
with a higher proportion of patients with a length of stay longer than 
14 days compared to colon cancer patients. Duration of postoperative 
ICU admission did not differ much between colon and rectal cancer 
patients.
Severe complication (see definitions in the methods section) rates 
were higher in rectal cancer patients than in colon cancer patients 
(p<0.001) (table 2). Colon cancer patients with a severe complication 
met the ICU criterion more often. The majority of colon and rectal 
cancer patients with a severe complication had a prolonged hospital 
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table­2:­Outcomes in colon and rectal cancer aatients.
 ­olon cancer Rectal cancer
 n (aatients) % n (aatients) %
Any comalication 2760 27.4%*  775 36.5%*
Reintervention  075  0.6%* 687  4.0%*
LengtC of stay   
   Median 7 days 8 days  
   > 4 days  553  5.4%*  075 22. %*
I­U admission   
   0-  day 8624 84.7%* 4 2 84.0%*
   2 days 328 3.2%* 2 3 4.3%*
   3-7 days 405 4.0%*  96 4.0%*
   8- 4 days  50  .5%* 58  .2%*
   >  4 days  38  .4%* 53  . %*
   unknown 539 5.3%* 265 5.4%*
   
Severe comalication  863  8,3%*          2 8 24,8%*
   Reason:   
   Postoaerative mortality 347  8,6%**   4 9,4%**
   I­U admission > 2 d 693 37,2%** 307 25,2%**
   Reintervention  075 57,7%** 687 56,4%**
   ­omalication + Cosaital stay > 4 d  268 68,8%** 834 68,5%**
   
Number of severe comalications   
  2 7  2.0%* 902  8.4%*
2 437 4.3%* 22 4.5%*
3  64  .6%* 73  .5%*
4 or more 44 0.4%* 22 0.4%*






Postoaerative mortality 3,4%* 2,3%*
 *aercentage  of all aatients ** aercentage of all aatients witC a severe comalication. Note tCat 
aatients may Cave met multiale criteria for a severe comalication
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stay but only in 20 and 27% of patients with a severe complication, 
respectively, a prolonged hospital stay following a complication was 
the sole reason for inclusion in the severe complication group.
FTR from severe complications – the mortality rate among the pa-
tients defined as having a severe complication – was higher in colon 
cancer patients, resulting in a higher overall postoperative mortality 
rate in colon cancer patients (p<0.001 for both outcomes).
Table 3 shows the most important severe complications for colon 
and rectal cancer patients. In colon cancer patients, the most frequent 
complications were anastomotic leakage (5.6% of all colon cancer 
patients and 6.1% of colon cancer patients with an anastomosis), 
pulmonary complications (4.8%) and cardiac complications (2.6%). 
In rectal cancer patients, the most common severe complications 
were anastomotic leak (4.4% of all rectal cancer patients and 8.7% of 
rectal cancer patients with anastomosis), pulmonary complications 
(4.1%) and infections/septic complications (2.9%).
table­3:­incidence of and failure to rescue (FTR) from serious comalications, disalayed aer 
comalication tyae. Note tCat aatients may Cave Cad more tCan one comalication and tCat 










anastomotic leakage 576 72 ( 2,5%) 2 5    (5, %) a=0.003
intra-abdominal abscess  6 2 ( 2,5%) 80 3 (3,8%) n.s.
aostoaerative bleeding 5    (2 ,6%) 35   (2,9%) a=0.0 4
ileus 84 9 ( 0,7%) 84 3 (3,6%) n.s.
fascial deCiscence  05 7 (6,7%) 59 4 (6,8%) n.s.
aulmonary comalication 448   5 (25,7%)  99 45 (22,6%) n.s.
cardiac comalication 262 97 (37%)    3  (27,9%) n.s.
infection/seatic 
comalication
235 49 (20,9%)  40  4 ( 0%) a=0.007
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Overall, FTR from severe complications was highest in both patient 
groups when associated with pulmonary and cardiac complications. 
FTR was higher in colon cancer patients than in rectal cancer patients 
when associated with anastomotic leakage (12.5% vs 5.1% p=0.003), 
postoperative bleeding (21.6% vs. 2.9%, p=0.014) and infections/
septic complications (20.9% vs. 10.0%, p=0.007). FTR rates associ-
ated with other complication types were not significantly different 
between the two patient groups.  
Most patients had one severe complication, but some had several 
(table 2). FTR rates increased with the number of severe complica-
tions that a patient experienced postoperatively. In colon cancer 
patients this increased from 15.7% in patients that had one severe 


























4 or more severe complications
figure­1:­Failure to rescue rates according to tCe number of severe comalications 
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table­4:­Multivariate analysis for tCe risk of failure to rescue in aatients witC a severe 
comalication. 
Variable ­ ­ odds­ratio 95%­CI
Gender male  ref
female 0.84 0.66- .08
Age <=70 years  ref
>70­years 2.86 2.09-3.89








2  .03 0.7 - .48
3­or­higher 1.97 1.38-2.82
ASA classification I  ref
II 1.97 1.51-2.58
III­or­higher 4.07 2.26-7.32
TNM stage I  ref
II 0.87 0.64- . 9
III 0.94 0.86- .3 
IV  .23 0.79- .92
Neoadjuvant tCeraay none  ref
sCort course RT  .28 0.7 -2.3 
cCemoradiotCeraay 0.80 0.40 - .60
AaaroacC oaen  ref
laaaroscoaic  .04 0.80 - .36
Additional resections none  ref
limited* 0.89 0.50 –  .58
extensive** 0.94 0.56 –  .58
Anastomosis arimary anastomosis  ref
anastomosis witC defunctioning 
stoma
0.74 0.47 - . 7
no anastomosis  .07 0.74- .55
Resection tyae rectal cancer resection  ref
colon­cancer­resection 1.89 1.06-3.37
ASA=American Society of AnestCesiologists ­I=confidence interval. Bold arinted numbers are 
significant associations (P<0.05). *abdominal wall, omentum, aosterior  vaginal  wall, ovaries. 
**organ resection  (aancreas, small bowel, saleen, kidney, liver, stomacC, sacrum, bladder/ure-
tCra/ureters/arostate, uterus)
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severe complications. In rectal cancer patients this increased from 
6.8% to 41% (figure 1).
risk­factors
Table 4 displays the results of the multivariable regression analysis 
for the association between patient-, tumor-, and treatment factors 
and the association with FTR in patients who had a severe complica-
tion. Adjusted for these variables, colon cancer patients had an almost 
two-fold higher risk of dying secondary to a severe complication than 
rectal cancer patients.
Other independent predictors of FTR were advanced age and 
higher Charlson comorbidity and ASA scores. Higher body mass 
index was associated with a lower risk of FTR. Gender, neoadjuvant 
therapy, additional organ resections, laparoscopic resections and 
stoma construction were not significantly associated with outcome. 
In a repeated analysis with adjustment for the hospital character-
istics in the model, the difference in FTR between colon and rectal 
cancer patients remained the same (colon vs. rectal cancer resection: 
adjusted OR 1.88; 95% CI 1.04 – 3.39). There was no significant effect 
of volume or teaching status on FTR rates but better ICU facilities 
were associated with better FTR rates (level 2 vs. level 1; OR 0.54, 
95% CI 0.35 – 0. 84 and level 3 vs. level 1; OR 0.83, 95% CI 0.53 – 
1.31). 
dIsCussIon
This is the first study comparing FTR rates between patients under-
going a resection for colon cancer and rectal cancer. FTR was higher 
in colon cancer patients than in rectal cancer patients. This was partly 
because colon cancer patients were older, and had more comorbidity 
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­Caater 9
and higher ASA classifications; although adjusted for the differences 
in patient- and treatment characteristics, the risk of FTR remained 
twice as high in colon cancer patients.
Schilling et al. described that colectomies account for a dispropor-
tionate share of morbidity, mortality and excess length of stay among 
all general surgical procedures. Colectomies account for 24% of all 
adverse events in general surgery with an adverse event rate of 29%1. 
In a Dutch study with data from the Eindhoven Cancer registry, it was 
shown that patient characteristics differ between colon- and rectal 
cancer patients, and that rectal cancer patients have a higher risk of 
postoperative complications, even though they are younger and less 
often have comorbid diseases than colon cancer patients3. Our study 
confirms the relatively high adverse event rate in colorectal surgery, 
and confirms that this rate is higher in rectal cancer surgery than in 
colon cancer surgery. Our study adds that the risk of dying given a 
severe complication is higher following a colon cancer resection than 
after a rectal cancer resection, even after adjustment for other rel-
evant factors. Due to the nature of the database, our study provides a 
realistic image of outcomes of everyday practice in elective colorectal 
cancer surgery in the Netherlands.
Our study has some limitations. Firstly, as data are self-reported, 
registration bias cannot be excluded. However the dataset is validated 
against the independently collected data of the Netherlands Cancer 
Registry, showing a high rate of case-ascertainment, completeness 
and accuracy12. The direct involvement of clinicians in the registra-
tion leads to a robust database and avoids coding problems that may 
occur when using an administrative database. Secondly, although the 
definition of a severe complication we used is arbitrary, it excludes 
the less severe complications that did not hinder the postoperative 
course. Since ICU admission, reinterventions and prolonged hospital 
stay are objective criteria, FTR rates are not influenced by differences 
safety of elective colorectal surgery
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in the way hospitals register minor complications. However, it cannot 
be excluded that some patients with a serious complication were not 
included in the definition. All (complications leading to) mortality 
cases were considered severe complications, regardless of reinter-
ventions, ICU admission or prolonged hospital stay. We performed a 
sub analysis in only those patients who underwent a reintervention, 
had ICU admission or a complication with a prolonged hospital stay, 
and the difference in FTR rates between rectal and colon cancer 
patients remained the same (adjusted OR 2.1; 95% CI 1.06-4.37). 
Finally, with regards to the analysis of FTR rates associated with dif-
ferent complication types, we cannot exclude that patients who were 
registered as having experienced non-surgical complications might 
also have had undiscovered underlying surgical complications. 
Anastomotic leakage is considered the most dreadful complication 
in colorectal surgery and accounts for a large proportion of overall 
postoperative mortality16. Indeed, in our study anastomotic leak was 
the most common severe complication. The proportion of leaks that 
lead to mortality was significantly higher in colon cancer patients, 
although the anastomotic leak rate was higher in rectal cancer pa-
tients (given an anastomosis was constructed). A part of the expla-
nation may be found in the larger proportion of anastomoses with 
a defunctioning stoma in rectal cancer patients compared to colon 
cancer patients. Also, a large proportion of rectal cancer patients 
did not receive a primary anastomosis, and therefore the group of 
colon cancer patients was a priori more susceptible for mortality fol-
lowing anastomotic leak as well as possible associated non-surgical 
complications.  However, diverting stomas and end-colostomies were 
not significantly associated with FTR. Moreover, adjusted for stoma 
rates, FTR remained higher in colon cancer patients. Early recogni-
tion and treatment of anastomotic leak may be associated with lower 
mortality associated with leakage17. Arguably, as the anastomosis 
190
­Caater 9
following rectal resections lies in the pelvic region, anastomotic leaks 
following rectal cancer resections often will have a more chronic 
course, developing a presacral sinus or pelvic abscess18, whereas 
colonic anastomotic leaks might have a higher risk of fecal peritonitis 
due to the intra-abdominal location. Whether a longer delay or a 
more fulminant course of anastomotic leak in colon cancer patients 
has contributed to the differences in FTR between the two patients 
groups cannot be retrieved from the DSCA dataset, but should be the 
focus of future in-depth studies as a reduction in delay of diagnosing 
anastomotic leak may prove a potential target for improvement19.
Cone et al. reported a high risk of mortality following postoperative 
non-surgical complications such as pneumonia and renal insufficiency 
in colorectal surgery patients20. Friese et al. described mortality rates 
and their relation with complications in 25,957 patients that under-
went a surgical resection for colorectal- and other types of cancer21. 
Mortality was most frequently secondary to respiratory compromise 
(37% of postoperative mortality) and pneumonia (26%). Our study 
confirms that cardiopulmonary complications are often associated 
with postoperative mortality, although it is not possible to make a 
clear distinction between surgical and non-surgical complications 
as surgical complications may start a chain of non-surgical adverse 
events, leading to clinical deterioration and eventually death. It does 
however underline the importance of a high postoperative vigilance 
for non-surgical complications besides the intuitively important sur-
gical complications such as anastomotic leak. Aggressive, multidisci-
plinary treatment of complications such as pneumonia, arrhythmias 
or central venous catheter sepsis may prevent postoperative death 
from non-surgical complications. Arguably, adequate preoperative 
optimization of the patient’s condition may be an even more im-
portant step in reducing mortality from non-surgical complications. 
Fuchshuber et al. describe how a hospital drastically improved the 
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number of patients on a ventilator for >48 hours, and achieved a 
zero postoperative pneumonia rate in patients undergoing thora-
coabdominal surgery during seven months by strictly adhering to a 
few perioperative steps22. Similar achievements have been published 
about reducing the number of acute bloodstream infections related 
to central venous catheters23. A recent meta-analysis showed that 
measuring the C-reactive protein on postoperative day 4 has a pooled 
negative predictive value of 89% for predicting postoperative infec-
tious complications after colorectal surgery, allowing safe discharge 
of patients not at risk24.
In the last decade, improvement of clinical outcomes for complex, 
low-volume gastrointestinal cancer surgery such as pancreatic, 
esophageal and rectal cancer resections has received much atten-
tion in the western world25-30. In the Netherlands, specialization of 
caregivers, focused improvements to infrastructure, specific inter-
ventions to perioperative management and selective referral have 
led to dramatic improvements in outcomes of patients undergoing 
these particular procedures31-35. In contrast, CC surgery received 
less attention and is, as a result, often performed in a non-focused 
setting. In a previous study, we found no association between FTR 
and hospital volume or teaching status in colorectal cancer patients, 
but better FTR rates in patients operated in hospitals with better 
ICU facilities14. We therefore repeated our analyses including these 
hospital characteristics, confirming the association between ICU fa-
cilities and FTR rates. However, the difference in FTR between colon 
and rectal cancer patients remained the same in this second analysis 
and we cannot conclude that the difference in FTR between colon 
and rectal cancer patients can be attributed to differences in hospital 
characteristics in which colon- and rectal cancer patients are treated. 
Surgeons’ differentiation may play a role- rectal cancer resections 
are usually performed by specialized gastrointestinal surgeons, 
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whereas colon cancer resections are often performed by surgeons 
without gastrointestinal specialization- but our study has no data on 
a surgeon level to support this. Recently, the Association of Surgeons 
of the Netherlands started with certification of surgeons performing 
colon cancer procedures.
In conclusion, the incidence of severe postoperative complications 
was lower in colon cancer patients than in rectal cancer patients; 
however, the risk of dying when a severe complication had occurred 
(FTR) was twice as high in colon cancer patients, even after adjust-
ment for differences in patient-, tumor-, and treatment characteristics 
between the two patient groups. In particular, FTR associated with 
anastomotic leak, postoperative bleeding and non-surgical infectious 
complications was higher in colon cancer patients than in rectal can-
cer patients. Given the results of our study, efforts should be made to 
improve recognition and management of postoperative surgical and 
non-surgical complications in order to reduce postoperative mor-
tality. Especially patients undergoing colon cancer surgery should 
receive full attention. 
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With the ever-expanding technological advances, the boundaries 
of healthcare continue to be moved. Especially, oncological care 
is developing rapidly. As staging methods, surgical-, medical- and 
non-medical care evolve, the patient with cancer is increasingly 
approached in a multidisciplinary fashion. The ageing population 
leads to a higher proportion of cancer patients that is susceptible for 
complications secondary to cancer treatment, as a result of prevalent 
comorbid illnesses. 
In this era of expanding indications and increasing complexity of 
treatments, healthcare providers are more and more conscious of the 
need for evaluating the processes and outcomes of the care they pro-
vide.  These developments are accelerated by the fact that doctors are 
progressively confronted with payers and policy makers demanding 
information that should enable them to allocate resources towards 
cost-efficient providers with the best outcomes. Patients, nowadays 
increasingly organized in- and represented by- patient associations, 
also call for information concerning safety and effectiveness of treat-
ments in different hospitals.
CoMparInG­hospItals
With the growing societal demand for quality information on 
healthcare providers, the lay press increasingly publishes reports 
on presumed quality of health care of providers. For instance, in the 
Netherlands, everyone is familiar with the league tables provided 
each year by some journals (Elsevier’s best hospitals, AD hospital 
top 100). Focusing on outcome, the hospital standardized mortality 
rate (HSMR) is calculated annually. In 2014, it became mandatory 
for Dutch hospitals to publish their HSMR. The HSMR comprises of 
an average mortality in-hospital rate from 50 main diagnoses. These 
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rates are merged into one hospital-wide mortality rate, adjusted 
for secondary diagnosis codes. A problem with this method is that 
secondary diagnosis codes are insufficient for a comprehensive and 
reliable risk adjustment, as they do not allow procedure-specific 
risk-adjustment1. Moreover, the mortality rate itself is an average 
hospital-wide mortality rate, and not procedure- or diagnosis specif-
ic. HSMRs are often displayed as simple rankings, which are unsubtle 
and arguably unreliable2. 
Both the lay press league tables as well as the HSMR lack face valid-
ity for doctors3,4.  
This lack of face validity with doctors is important, because without 
it, it is less likely to result in actual improvement of quality of care. 
Recent studies from the Netherlands show that patients so far aren’t 
using available quality information for choosing a hospital5,6. 
MeasurInG­QualIty­of­Care
Measuring quality of care classically comprises three overlapping 
aspects; structure (the environment in which the provision of care 
takes place), process, and outcomes. This triad is referred to as the 
‘Donabedian paradigm’7. Measuring quality of care information in 
a comprehensive manner, and feeding this back to the participating 
healthcare providers can enhance the quality of delivered care8. 
In 2010 and 2011, the Boston Consulting Group published two 
reports elaborating on a comparison between the Dutch and Swed-
ish healthcare systems9,10. The main conclusion was that the quality 
of care is generally high in the Netherlands, but that costs can be 
reduced and outcomes improved when compared to Sweden. The 
main recommendation was to initiate nationwide clinical registries, 
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with a focus on generation of meaningful outcome indicators, which 
is common practice in Sweden for years.
dutch­surgical­Colorectal­audit
Initiated by the Association of Surgeons of the Netherlands, the 
Dutch Surgical Colorectal Audit (DSCA) started in 2009 as a nation-
wide quality improvement program auditing the surgical treatment 
of patients with primary colorectal cancer in the Netherlands. One 
of the main focus points of this initiative is reduction of adverse 
event rates. Colorectal cancer surgery was considered a logical start-
ing point: colorectal surgery accounts for a disproportionate share 
of morbidity, mortality and excess length of stay among all general 
surgical procedures. It accounts for roughly a quarter of all adverse 
events in general surgery11. 
In contrast to other initiatives and registrations, the DSCA is char-
acterized as doctor-driven with a high face-validity among surgeons. 
This is important, as it assures a high participation rate, case-ascer-
tainment and accuracy of data, as well as a smooth implementation 
of improvement projects once targets for improvement have been 
signalled. A main feature is a quick feedback loop to the participating 
surgeons, enabling quality assurance and improvement. This is done 
through web-based feedback of outcomes with the national average 
as a benchmark to participating clinics12. Importantly, the audit was 
designed to capture many patient- and disease related risk factors 
that may add to hospital variation in outcomes when they would be 
unevenly distributed among hospitals13. Where possible, outcomes 
are adjusted for these factors so comparisons are as fair as possible. 
Accumulative evidence shows the benefits of such a program8. A well-
known example of improvement through measurement and feedback 
is from Canada: in 1999, pancreatic cancer surgery was centralized 
in two Canadian provinces. In Quebec, the regionalization was ac-
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companied by an audit cycle, feeding back mortality data to hospitals, 
whereas Ontario did not have an additional audit program. As a 
result, mortality decreased dramatically in Quebec (from 10 to 2%) 
but remained constant in Ontario14. Similarly, the American National 
Quality Improvement Project (NSQIP) is a large-scale clinical registry 
that provides feedback of outcomes to participating hospitals. Initi-
ated in Veteran’s Affairs hospitals and later adopted by the American 
College of Surgeons, the project has led to a significant decrease in 
postoperative adverse events15,16.
In the DSCA improvement cycle, a team of experts led by the As-
sociation of Surgeons of the Netherlands helps clinics with morbidity 
or mortality rates that are significantly higher than the national aver-
age (‘outlier hospitals’) to initiate targeted improvement projects. 
Already after a few years of auditing, the first improvements in terms 
of higher standards and reduced variation in guideline adherence, as 
well as a reduction in the number of adverse outcomes are becoming 
apparent12. After the example of the DSCA, various (surgical) clinical 
audits were initiated in the Netherlands: the Dutch Upper GI Cancer 
Audit (DUCA; 2011), the NABON Breast Cancer Audit (NBCA, 2011) 
and the Dutch Lung Surgery Audit (DLSA, 2012). Quite recently, this 
number has increased even more.  After Swedish example, the As-
sociation of Surgeons of the Netherlands has set the goal to make 
outcomes of the audits publicly available. To reach this goal, a process 
in which outcomes of the audits will become publicly available in a 
stepwise fashion throughout the years was initiated. 
outCoMes­researCh
In programs like these audits, determining outcomes that measure 
and represent actual quality of care remains challenging and depends 
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on the condition of interest and the patient population. In surgical 
oncology, outcomes can be roughly divided into ‘achieving goal’, i.e. 
performing a resection with tumor-free margins and harvesting 
enough lymph nodes; and ‘avoiding adverse events’ on the other 
hand. With a good performance on both aspects, the ultimate goal of 
long-term survival and quality of life can be pursued. Quality of care 
for procedures that are relatively high-risk, as is the case with surgery 
for cancer of the digestive tract, is often assessed using adverse event 
outcome measures such as morbidity or mortality rates. 
In order to identify good and bad performers, outcomes reflecting 
hospital performance must be investigated. The specific value or 
usability of such outcome indicators is not always clear.  Outcome 
indicators should represent meaningful differences between care-
givers. This thesis, focusing on clinical adverse event outcomes 
associated with surgical oncological procedures, should be seen in 
the light of the recent developments around the Dutch nationwide 
outcome registries. The studies contribute to the knowledge about 
the meaning of, and interaction between certain clinical outcome in-
dicators that are used in hospital comparisons. This may contribute 
to more targeted feedback to hospitals and a better understanding 
of results from the audits, which is especially important when out-
comes become publicly available. Moreover, these studies add to the 
knowledge concerning risk factors and outcomes, which may aid in 
directing improvement efforts for the care of surgical patients on a 





Postoperative mortality is considered a very important outcome in 
major oncological surgical procedures like colorectal cancer surgery. 
It also may be considered one of the most delicate outcomes. Re-
cently, in the United Kingdom, postoperative mortality rates per hos-
pital and per surgeon became publicly available from the internet17. 
This development is laudable from a societal perspective. However, 
transparency of this kind of information should be well thought of. It 
is crucial that comparisons of caregivers are reliable as this informa-
tion may influence the patients’ trust and choice, as well as allocation 
of reimbursements by insurers and certification by policy makers. 
Unjustly stigmatizing a hospital as having a high mortality rate may 
have great impact on hospital reputation. Simple mortality league 
tables that may arise from this data may not be reliable18,19.
One of the drawbacks of rankings on this measure is that differ-
ences between hospitals may be influenced by the fact that hospitals 
treat patients with different characteristics 
(“ casemix”), associated with a different a priori risk of mortality 
(e.g., a hospital treating many elderly patients is likely to have a higher 
operative mortality rate because of this)13. Secondly, chance variation 
may play an important role. For hospitals with a small number of 
cases, it is difficult to know whether extremely high or low mortal-
ity rates are due to chance or caused by actual differences in quality 
of care. In this thesis, we showed the importance of adjustment for 
case-mix as well as statistical reliability adjustment20 in rankings on 
postoperative mortality. Moreover, we found that 62% of variation 
between hospitals in mortality after colorectal cancer resections is 
due to chance (a ‘rankability’21 of 38%) [chapter 2] which can be at-
tributed to a relatively low ‘event rate’ from a statistical point of view. 
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This implies that great caution should be used when interpreting 
hospital rankings on this outcome. Outcomes with a higher event rate 
may have a higher rankability.  Lingsma et al. suggest that rankings 
are meaningless when rankability is lower than 50%22. Should rank-
ings be attempted anyway, we suggest the percentile expected rank 
(PCER) should be used: the chance that the selected hospital has a 
better outcome than a randomly selected hospital [chapter 2]23. This 
way, the uncertainty concerning the outcome is included in the single 
percentage ascribed to each hospital. Future work will focus on inclu-
sion of confidence intervals in displaying of ranks and on assessing 
the possibility to predict a hospital’ s future rank based on previous 
years. The rankability of other outcomes should be determined. 
Moreover, in the context of outcome indicators becoming public, it 
should be investigated whether measures like the PCER are compre-
hensible and usable for the general public.
anastomotic­leakage
The abovementioned study underlines the need for case-mix adjust-
ment in hospital comparisons on postoperative mortality. This is 
achievable, but it requires a substantial registration effort to collect 
all possible confounding factors. Hence, it would be valuable to find 
outcomes that reflect differences in quality of care rather than differ-
ences in casemix. One of the most dreadful complications in colorectal 
surgery is anastomotic leakage24. The findings of this thesis suggest 
that hospital variation in anastomotic leak rates is relatively indepen-
dent of patient- and tumor characteristics, and may be more related 
to treatment factors and in-hospital care processes when compared 
to mortality as an outcome indicator [chapter 3]. A drawback of us-
ing anastomotic leak rates as an outcome indicator is that it is only 




Another often suggested outcome indicator in colorectal surgery 
is ‘unplanned reoperations’. The indicator, a compulsory indicator 
collected by the Dutch Healthcare Inspectorate, is said to be useful 
because it discriminates more than mortality rates, especially in 
elective surgery where mortality rates are lower. It correlates with 
postoperative surgical complications, a prolonged hospital stay and 
mortality25-27. Not unimportant, it may be relatively easily obtained, 
for example from financial data or procedure codes. The problem 
is that most of the abovementioned evidence is based upon studies 
performed on a patient level. This thesis sought to determine the 
value of reoperation rates after colorectal cancer resections on a 
hospital level. It turns out that high reoperation rate outlier institu-
tions (significantly higher rates than average) have similar outcomes 
as the hospitals with average reoperation rates [chapter 4]. The 
group of hospitals with lower reoperation rates had low mortality 
rates. Interestingly, when all hospitals are compared on an individual 
basis, results may be the other way around: high reoperation rates 
combined with low mortality or vice versa. 
defensive­behaviour
Benchmarking hospitals on outcome indicators such as anastomotic 
leakage or reoperation rates to compare hospital performance may 
potentially lead to defensive behaviour among surgeons. For instance, 
surgeons may increasingly decide to construct a defunctioning ileos-
tomy or colostomy proximal to the large bowel anastomosis in order 
to limit the rate of clinically relevant anastomotic leaks and subse-
quent reoperations. In the Netherlands, the number of defunctioning 
stomas after rectal resection with anastomosis has already increased 
over the last decade to more than 70%28. As such a stoma itself 
causes short-term but also longer-term morbidity for the patient29,30, 
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there is increasing evidence that a more critical application of faecal 
diversion may be warranted. Auditing short-term outcomes such 
as anastomotic leakage may maintain a certain defensive attitude 
among surgeons, which may not always be in the interest of patients.
‘Reoperation rate’ as an outcome indicator has a similar ambigu-
ity. A reoperation is a marker for surgical complications and has, by 
itself, a high impact on a patient. However, using reoperation rates 
as an outcome indicator may theoretically raise the threshold for a 
reoperation in case of a suspected surgical complication- while in 
fact, a surgical team that recognizes complications early in the pro-
cess may save patients’ lives by adequately performing reoperations. 
In a publication by Almoudaris et al., hospitals with low mortality 
rates after upper gastrointestinal cancer surgery were the ones with 
higher reoperation rates31.
So, reoperation rates are discriminative but do not tell the whole 
story when used in isolation [chapter 4]. A surgical team with high 
reoperation rates but a low mortality rate is at least able to rescue a 
patient with a surgical complication. The same thing applies to ana-
lyzing mortality rates in isolation: if mortality rates are low, though 
come at the cost of very high rates of reoperations, there is probably 
room for improvement. 
failure­to­rescue
An outcome indicator that may be of additional value is failure to res-
cue (FTR): the mortality rate among patients with a severe complica-
tion32. This outcome indicator reflects the ability of a surgical team to 
manage postoperative complications once they have occurred. This 
thesis explored the applicability of FTR as an outcome measure, find-
ing a wide variation between hospitals [chapter 5]. Hospitals with 
high mortality rates will intuitively have higher complication rates. 
Although rates of severe complications differed between low- and 
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high-mortality hospitals, this difference was too small to explain the 
large difference in mortality. Instead, high- and low-mortality hos-
pitals were distinguished by high and low FTR rates: their ability to 
treat and save patients with severe complications. These findings are 
consistent with recent international literature33-35. Hence, an impor-
tant area for improvement of mortality rates may be found in early 
detection and aggressive treatment of postoperative complications.  
So, FTR reflects processes in the perioperative care. It may explain 
why some teams or centers are able to prevent serious complications 
to lead to mortality. The rationale of using FTR is to help institutions 
understand and prevent this. Intuitively, using FTR as an outcome 
indicator would remove any hesitations to reintervene in case of a 
complication, as a successful reoperation will merely lower FTR 
rates. A limitation of this outcome indicator is that event rates are 
relatively low, as is the denominator: only complicated cases are 
used for calculation. This may increase chance variation and lower 
the strength of statistical modelling (and thus risk adjustment) in 
smaller datasets. 
hospItal­CharaCterIstICs­and­outCoMes
Surgical teams differ in their ability to save patient’s lives once 
complications occur. Why do FTR rates differ? Identification of the 
processes that account for superior results remains challenging36. 
Therefore, some argue to focus on exploring which hospital char-
acteristics are associated with better outcomes.  For instance, it has 
been suggested that a higher caseload per hospital is associated with 
lower FTR rates37. Similarly, in Anglo-Saxon literature, university hos-
pitals or teaching hospitals have been described to have lower FTR 
rates than non-teaching hospitals38, which may very well be related 
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to intensive care (ICU) characteristics. We found that in unadjusted 
analysis, a case volume of >200 patients/year, teaching status and 
higher level of ICU facilities were all associated with favorable FTR 
rates after colorectal cancer resection [chapter 6]. After adjustment 
for each other, as well as for other confounders, only a higher level of 
ICU facilities remained significantly associated with better FTR rates. 
A beneficial effect of a higher standard of ICU care on FTR rates is 
in keeping with the fact that ICU treatment is an essential element 
of postoperative care in high risk patients: 15% of all patients un-
dergoing elective colorectal cancer surgery receive ICU treatment 
postoperatively39. This rate is probably even higher in patients un-
dergoing surgery in an urgent setting. In the Netherlands, standards 
of ICU care have traditionally been divided into three levels. A level 
3 ICU is the highest level, comprising of a closed format ICU, with 
highest number of beds (12 minumum), nurses per bed, number of 
ventilator days per year, among other quality standards. On an ICU 
level 1, responsibility for the patient is not necessarily transferred 
to an intensivist, an intensivist is not exclusively available 24 hours a 
day, has less beds (6 minimum) and no minimum of ventilator days 
per year. A level 2 ICU is a closed format ICU with lower minimum 
standards of ventilator days, treatment days per year compared to a 
level 3 ICU40.
In the study in chapter 6, levels 2 and 3 had a similar beneficial 
odds ratio for FTR when compared to level 1. A main difference be-
tween the levels is the 24-hour availability of an intensivist in levels 
2/3. In the upcoming revised Dutch national ICU guidelines, the level 
classification is abolished and 24-hour intensivist staffing becomes a 
standard element of ICU care. Of note, this research focusing on hospi-
tal characteristics, aims to identify possible mechanisms behind dif-
ferences in outcomes between hospitals. From [chapter 6] it follows 
that one of the possible factors may be a difference in standard of ICU 
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care. These differences in ICU level may reflect differences in clinical 
processes and resources, and further research in ‘best practices’ as 
well as the lesser performing centers should be aimed at unraveling 
the processes leading to better or worse outcomes. Combining data 
from the national Intensive Care registration (NICE) with DSCA data 
may be a valuable first step in this process.
Centralization
There is no consensus for concentration of care for common oncologi-
cal procedures like colorectal cancer surgery41,42.  A Cochrane review 
showed a volume-outcome relationship in colorectal cancer surgery, 
but not between postoperative mortality and hospital volume43. 
The review acknowledges that results vary per country or region. 
In a recent Dutch publication, no differences in mortality were seen 
between high- and low volume hospitals performing colon cancer 
surgery44. The absence of association between hospital volume and 
FTR in this thesis [chapter 6] is in line with this study. 
In contrast, the volume-outcome relationship is more convincing 
for high-complex low-volume procedures like pancreatic or upper 
gastrointestinal cancer surgery45. In esophageal cancer surgery, 
there is compelling evidence that patients have better short- and 
long-term outcomes when operated in a hospital with a high annual 
caseload of esophagectomies, including some evidence from Dutch 
studies46,47,48.  Therefore, around the world there is a growing consen-
sus to centralize esophageal cancer surgery to high-volume centers. 
However, many different definitions of a ‘high-volume hospital’ are 
proposed in the recent literature, ranging from more than 5 to more 
than 86 esophageal cancer resections annually45,46,49-75. No research 
was done to define to what extent the volume-outcome relationship 
remains. Consequently, minimum volume standards for esophagec-
tomies vary per country or region76-78. The current Dutch minimum 
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volume standard, set arbitrarily in 2007, is 20 esophageal cancer 
resections per hospital per year79.  From chapter 7 it follows that 
further centralization of esophagectomies may lead to a decrease in 
postoperative mortality and survival. Better outcomes in hospitals 
with a higher hospital volume may be a reflection of a variety of fac-
tors in the process of care, such as an integrated multidisciplinary 
approach, improved patient selection, and protocols; as well as 
superior resources. 
In contrast to the well-established relationship between hospital 
volume and postoperative mortality, this association is less estab-
lished in colorectal cancer surgery. In a meta-analysis by van Gijn et 
al., non-significant results were found in both rectal cancer surgery 
and colon cancer surgery, although the result became significant in 
favor of high-volume hospitals with exclusion of the study that did 
not adjust for confounders42. This excluded study was the only Dutch 
study in the analysis. Of note, the relationship between hospital 
volume and longer-term survival was in fact significantly in favor of 
high volume. 
An original study from the Netherlands also did demonstrate no 
relationship between volume and postoperative mortality in colon 
cancer surgery44. This notable difference between Upper GI cancer 
surgery and colorectal cancer surgery remains subject of speculation. 
A factor may be that esophagectomy and gastric tube reconstruc-
tion is perhaps technically more challenging and a physically more 
demanding procedure for the patient compared to a segmental colec-
tomy. As (surgically treatable) esophageal  cancer is far less common 
than colon cancer, treatment in a high-volume would then be more 
important for esophageal cancer patients compared to colon cancer 
patients. Contradicting this theory is that postoperative mortality 
rates after colectomies in the Netherlands are comparable to those of 
esophagectomies. Perhaps case volume is less an issue in colorectal 
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cancer surgery, but when compared to esophageal cancer surgery, 
dedication of the team to this type of surgery may be. In esophageal 
cancer, a high degree of dedication came along with the introduc-
tion of the minimum volume standards. Perhaps the introduction of 
the DSCA reflects an increasing awareness in the field of colorectal 
cancer surgery that more dedication with multidisciplinary teams, 
enhanced perioperative care protocols and a smoother run-through 
time from diagnosis to surgery- thereby avoiding surgery in the ur-
gent setting- is the way to go in order to further improve outcomes 
for colorectal cancer patients. Moreover, a drawback of using case 
volume as a proxy for quality of care is that nothing can be learnt 
from it80,81. In both esophageal cancer surgery and colorectal cancer 
surgery, in order to reduce morbidity and mortality, it is important 
to understand the mechanisms behind the development of complica-
tions and the way they lead to fatal outcomes. Nationwide audits have 
the potential to indicate areas for improvement, enabling surgical 
teams to move forward.
outcome­based­referral
Nonetheless, in upper GI cancer surgery in the Netherlands, the cen-
tralization- and thereby case-volume- discussion continues. Patient 
advocates and some opinion leaders plea for further centralization; 
some go as far as advocating centralization towards a maximum of 
5-7 upper GI cancer centers, like is the case in Denmark.
Hospital volume and other structural factors reflect a certain en-
vironment in which the chance that caregivers can achieve optimal 
results for their patients is high.  Maintaining a minimum volume 
standard is therefore likely to be beneficial for the outcomes of the 
whole group of patients. However, hospitals with less favorable 
characteristics or lower annual caseloads may achieve excellent 
results with a similar approach and environment.   Moreover, pure 
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volume-based referral carries the risk that high volume hospitals 
with unfavorable outcomes are selected as referral centers45,76. 
In contrast to volume-based referral, outcome-based referral can 
avoid this problem by selecting hospitals as referral centers based 
on their outcomes. As an example, postoperative mortality after 
esophagectomy dropped from 11.6% to 3.1% in the western part of 
the Netherlands after the region started to selectively refer patients 
to the three best performing hospitals in the region instead of the 
original 11 hospitals82.  The additional benefit of feedback besides 
pure volume based centralization was illustrated in the centraliza-
tion process of pancreatic cancer surgery in Canada, with mortality 
decreasing in the province in which outcomes were monitored; and 
mortality remaining constant in Ontario, where only volume-based 
centralization took place14.
Identification of centers of excellence, which should become the 
referral centers, requires valid, reliable, complete, and adequate risk-
adjusted registration of outcomes through audits. Auditing of upper 
gastrointestinal cancer surgery treatment is for example performed 
in the ACS-NSQIP83 in the US, and various similar projects for upper 
gastrointestinal cancer run in Europe on a national level in Den-
mark84, Sweden, United Kingdom and the Netherlands. An additional 
effect in improvement of outcomes may be expected from such audits, 
which provide insight in care patterns and allows surgical teams to 
benchmark their outcomes85. Further quality improvement through 
centralization may come at the cost of increased waiting times which 
are already a problem for patients undergoing esophageal surgery 
in the Netherlands, with the median waiting time between diagnosis 
and treatment for resectable esophageal cancer being 6 weeks86. It is 
a challenge for the Dutch hospital system to rearrange referral and 




In order to reduce morbidity and mortality, it is important to un-
derstand the mechanisms behind the development of complications 
and the way they lead to fatal outcomes. Besides enabling individual 
hospitals to improve care through benchmarking of outcomes, audits 
help with identification of areas for improvement, enabling surgeons 
nationwide to move forward. From the DSCA for example, it became 
evident that elderly patients undergoing colon cancer surgery in an 
emergency setting for colonic obstruction or tumor perforation have 
a risk of postoperative mortality as high as 41%87. Fortunately, the 
majority of patients are operated in an elective setting; but also elec-
tive colorectal cancer surgery is not without risks11. 
In a detailed analysis of patients undergoing colon cancer resec-
tions, we found lower anastomotic leak rates in patients undergoing 
left-sided resection compared to right sided colectomies. However, 
the risk of dying when a leak has occurred is twice as high following 
a right-sided leak [chapter 8].  Additionally, in this thesis, a further 
investigation into the differences in postoperative events between 
patients undergoing rectal and colonic resections was performed. 
Even though severe postoperative complications occured more often 
in rectal cancer patients than in colon cancer patients, the chance 
of dying secondary to a severe complication is twice as high in the 
latter group [chapter 9]. Part of the explanation for this is the fact 
that colon cancer patients are on average four years older and have 
more comorbidity, though adjusted for these factors the difference 
remained. 
Importantly, non-surgical complications such as cardiac and pul-
monary events appear to have a great impact on mortality. Friese et 
al. described mortality rates and their relation with complications in 
25,957 patients that underwent a surgical resection for colorectal- 
and other types of cancer88. Mortality was most frequently secondary 
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to respiratory compromise (37% of postoperative mortality) and 
pneumonia (26%). Surgical complications may start a chain of non-
surgical adverse events, leading to quick clinical deterioration of pa-
tients. Failure to rescue rates increased drastically with the number 
of postoperative complications [chapter 9]. It seems that a further 
reduction in mortality may come from prevention of, and aggres-
sive treatment of cardiopulmonary complications and non-surgical 
infections besides the already intuitive vigilance for anastomotic 
leak. Fuchshuber et al. describe how a hospital drastically decreased 
the number of patients on a ventilator for >48 hours, and achieved 
a zero postoperative pneumonia rate in patients undergoing thora-
coabdominal surgery during seven months by strictly adhering to a 
few perioperative steps89. Similar achievements have been published 
about reducing the number of acute bloodstream infections related 
to central venous catheters90.  
perioperative­care
Unraveling the mechanisms leading to complications and mortality 
as well as perioperative care processes associated with best practice 
should be investigated in-depth and shared in order to initiate im-
provement widely.
Adequate patient selection and preoperative optimization of the 
patient’s condition may be an important step. Carlisle et al. analyzed 
the effect of a specialized, anesthesiologist-led preoperative high-
risk clinic in colorectal cancer patients91. The introduction of this 
high-risk clinic led to a drastic improvement of 1-year mortality in 
patients that were older and had more comorbidity. The authors 
emphasize that part of the success may be explained by the higher 
percentage of patients with planned ICU admissions postoperatively.
Furthermore, factors associated with timely recognition of compli-
cations should be explored92.  Higher nurse-to-patient ratios, associ-
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ated with lower FTR rates, may be related to this93. Although some 
patient-related risk factors for anastomotic leak were identified 
[chapter 8], for the individual patient the exact mechanism leading 
to the development of leakage is mostly unknown. As the clinical as-
sessment by the surgeon is of low predictive value for leakage94, dif-
ferent algorithms to detect anastomotic leakage have been developed 
for left-sided large bowel anastomoses95-97. These algorithms may aid 
in standardized postoperative monitoring of patients and in selecting 
patients for defunctioning stoma creation at the end of the procedure. 
As this thesis underlines the higher risk of mortality associated with 
right-sided leakage, future studies should focus on further evaluation 
of these leakage scores in right-sided colectomies.
Also, less specific clinical scoring systems such as the early warn-
ing score (EWS) may improve clinical detection of postoperative 
complications98. Furthermore, measuring the C-reactive protein on 
postoperative day 4 has a pooled negative predictive value of 89% 
for predicting postoperative infectious complications after colorectal 
surgery, allowing safe discharge of patients not at risk24.
Further in-depth studies in high and low performing centers 
concerning factors reflecting differences concerning in-hospital pro-
cesses should be performed. This is probably a complex interaction 
between many factors e.g. the daily ward rounds, responsibility for 
the ward patients, staffing outside office hours, vital sign collection 
and reporting, the level of experience in a surgical team, team com-
munication, guideline adherence and quality of care from nurses. 
The apparently large burden of non-surgical complications may 
be sought in improvement of intra-operative factors such as intra-
operative volume load, hypotension, ventilator techniques, blood 
loss, and duration of surgery. So far, the clinical audits contain little 
intra-operative factors but linking postoperative outcomes to intra-
operative data may reveal new opportunities for improvement.
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 Secondly, hospital differences in FTR rates may be sought in differ-
ences in delay until the start of treatment of a complication. For in-
stance, early reintervention for a surgical complication may prevent 
clinical deterioration and death. Alves et al. found lower mortality 
after reoperations performed before postoperative day five, although 
this difference was not significant99. Almoudaris et al. did not find 
a difference in time interval to reoperation between low- and high-
mortality hospitals but the median day of reoperation was late, being 
posotoperative day 8 in both groups34.  Ideally, improvement of (sur-
gical) FTR rates would not imply higher reoperation rates, but earlier 
reoperations. However, slightly higher reoperation rates in order to 
prevent postoperative mortality secondary to surgical complications 
may prove acceptable. 
The presence of rapid response teams100 in a hospital may influence 
failure to rescue after colorectal surgery and should be investigated 
in this context.
With identification of specific care processes that account for differ-
ences in hospital FTR rates, local and national quality improvement 
initiatives can aim at reducing postoperative mortality by addressing 
the most important factors in the postoperative care process.  
MoVInG­forward
The introduction of the DSCA reflects a change in mind-set among 
colorectal surgeons in the Netherlands, characterized by – more than 
ever- increasing efforts to learn, to improve and to share in order to 
assure quality throughout the field. Already, within a few years after 
initiation, it has brought many improvements in the outcomes of 
surgical care for colorectal cancer patients12, and continues to do so. 
In other gastrointestinal tumours, much attention still goes to case 
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volume, which historically has brought along many improvements. 
However, in order to take the next step in quality improvement, a 
change in paradigm- from volume-based to outcome-based quality 
assurance- is essential. Focus on ‘best practice’ should play a pivotal 
role. 
Following the DSCA, clinical audits have been introduced in, among 
others, the fields of gastro-oesophageal and pancreatic cancer, aim-
ing at further improving outcomes of care for these patients.
selecting­outcomes
This thesis has explored outcome indicators concerning adverse 
events. We showed that these outcomes, when used in isolation, do 
not entirely reflect quality of care (for instance, when assessing anas-
tomotic leakage rates, stoma rates should not be ignored [chapter 
3]).  Moreover, indicators like surgical resection margins or lymph 
node yield are important predictors for long term survival but do 
not necessarily correlate with clinical outcomes101. Therefore, sum-
marizing measures for outcome indicators, representing the number 
of patients in which all desired (short-term) goals are achieved may 
better reflect quality of surgical care. Kolfschoten et al. found that 
only half of colorectal cancer patients have a so-called ‘ textbook 
outcome’  (hospital survival, radical resection, no reintervention, 
no ostomy, no adverse event, hospital stay <14 days) with a marked 
hospital variation. A quality measure like this may be an impetus for 
improvement on all separate components of the indicator. 
Finally, medium term outcomes (90 days, 1 year) instead of the 
traditional in-hospital or 30-day outcomes may improve sensitivity 
for adverse events102-105. As medium-term events are less likely to 





Ultimately, with transparency of outcomes comes the possibility for 
patients to use outcome information for selecting the hospital of 
choice for a certain treatment. So far there is little evidence that pa-
tients actually use such information. A survey among Dutch surgical 
patients revealed that quality information is not often used for choos-
ing a hospital. Most mentioned reasons were ‘hospital reputation’, ‘ 
friendly atmosphere’ and ‘ease of access by (public) transportation’6. 
Only 3% of patients had used quality information. In another study, it 
was shown that even patients who had actively compared quality in-
formation of hospitals, mostly relied on their own and other peoples’ 
experiences5. For future reference, patients most often (52%) would 
prefer a summary measure (textbook outcome) over more detailed, 
procedure-specific outcome measures6. 
The Dutch clinical audits bring together all stakeholders, including 
patients, doctors and payers in order to facilitate all with meaningful 
information. Importantly, this includes patient-related outcome mea-
surements (PROMS). The DSCA is currently running a pilot project 
involving patients reporting their (functional) outcomes. With defini-
tive incorporation of PROMS, a big step will be taken in participation 
of patients in monitoring quality of care, with potentially meaningful 
information for patients being generated. 
ConClusIons
The recent introduction of clinical audits in the Netherlands has al-
ready brought many improvements in the field of surgical oncology, 
reflecting the beginning of a new era of quality measurement and 
improvement. With tangible results after the first few years, they are 
promising tools for further nationwide quality improvement. With 
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consolidation of their role in quality policy of individual hospitals 
and the Association of Surgeons of the Netherlands, and increasing 
participation of patients and other stakeholders, further refinement 
of outcome measures is warranted.
This thesis explored the value of clinical outcome indicators in gas-
trointestinal cancer surgery on a hospital level. Interactions between 
outcome indicators are complex and measuring single outcomes in 
isolation do not seem to adequately reflect quality of care as related 
areas remain underexposed. 
Rankings are not suitable for displaying hospital postoperative 
mortality rates in colorectal cancer surgery. Ranking caregivers on 
outcomes should only be done when rankability is high. Adjustments 
for casemix and reliability (sample size) should be made and prefer-
ably, rankings should be displayed as PCERs as this takes into account 
the uncertainty of the rank. The rankability of other outcomes should 
be explored. Measuring and comparing certain outcomes such as 
anastomotic leakage or reoperations between surgical teams may 
induce defensive behaviour, which is not always in the patient’s 
interest. The indicator ‘failure to rescue’ is an interesting outcome 
measure that reflects the ability of a surgical team to detect and 
treat complications, thereby keeping patients alive.  Identification of 
related hospital characteristics like procedural volume or level of ICU 
facilities, as well as identification of patient groups at risk may aid 
in further understanding the mechanisms leading to adverse events. 
Guided by clinical data, further in-depth research should focus on 
the differences in the perioperative care process between hospitals, 
accounting for superior results in some hospitals and suboptimal 
outcomes in others, ultimately leading identification and sharing of 
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Met de toenemende mogelijkheden en groeiende complexiteit van 
behandelingen is de medische wereld in toenemende mate bewust 
van het belang van het evalueren en verbeteren van de processen en 
uitkomsten van geleverde zorg. Dat is bij uitstek het geval in de onco-
logische zorg. Dit is niet in de laatste plaats vanwege de toenemende 
behoefte aan kwaliteitsinformatie vanuit patiënten, tegenwoordig 
toenemend verenigd in patiëntenverenigingen, en vanuit instanties 
zoals zorgverzekeraars en beleidsmakers. Het bekendste voorbeeld 
van de behoefte aan kwaliteitsinformatie is wel de ranglijstjes van-
uit de Elseviers beste ziekenhuizen en de AD ziekenhuis top-100; 
een ander bekend voorbeeld is het cijfer over (ziekenhuisbrede) 
sterftecijfers die Nederlandse ziekenhuizen tegenwoordig moeten 
publiceren (de hospital standardized mortality rates, HSMR). Het 
probleem is dat deze initiatieven voor medici onvoldoende beteke-
nisvolle informatie over kwaliteit van zorg genereren waardoor de 
beroepsgroepen geen instrument hebben om kwaliteit van zorg wer-
kelijk te evalueren en verbeteren1,2. In het eerste geval gaat het veelal 
over subjectieve zaken en over processen, maar wordt er weinig op 
uitkomsten gefocusd. In het geval van de HSMR is het getal dermate 
overkoepelend voor het gehele ziekenhuis, dat de uitkomst weinig 
zegt over individuele behandelteams in dat ziekenhuis. Tot slot zijn 
veel specialisten van mening dat de correctie voor verschillen in zorg-
zwaarte tussen ziekenhuizen inadequaat is. Ook bij patiënten sluit 
deze informatie niet aan: patiënten gebruiken nog steeds nauwelijks 
dergelijke informatie bij de keuze voor een bepaalde zorgverlener3,4.
In navolging van Zweden5,6  werd in Nederland begonnen met het 
opzetten van klinische uitkomstregistraties, met als doel kwaliteit 
van zorg inzichtelijk te maken door naast structurele factoren (type 
ziekenhuis, aantal verrichtte procedures) en processen (bijvoorbeeld 
verschillende vlakken van richtlijnnaleving) te focussen op uitkom-
sten van zorg (tumor radicaal verwijderd, complicaties, sterfte etc.) 
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volgens het paradigma van Donabedian7.  Het doel hiervan is een 
kwaliteitsimpuls te initiëren. De chirurgen lopen in Nederland hierin 
voorop, met de Dutch Surgical Colorectal Audit die in 2009 als eerste 
succesvolle klinische registratie van start ging8. Hierin worden van 
alle chirurgisch behandelde patiënten met colorectaal carcinoom ge-
gevens met betrekking tot het zorgproces en de uitkomsten hiervan 
geregistreerd. Een ruime hoeveelheid geregistreerde gegevens over 
onder andere comorbiditeit waarborgen uitgebreide correcties voor 
zorgzwaarte9, waardoor uitkomsten van verschillende ziekenhuizen 
eerlijker vergeleken kunnen worden.
Een van de doelen van de DSCA is het reduceren van postopera-
tieve complicaties en mortaliteit door middel van terugkoppelen van 
spiegelinformatie aan de participerende centra. Hierdoor kunnen op 
lokaal zowel als landelijk niveau verbeterpunten worden gesigna-
leerd en aangepakt. Omdat de audit door chirurgen zelf is bedacht en 
opgezet, heeft deze bij hen meer ‘face validity’ dan andere projecten, 
waardoor het uiteindelijke kwaliteitsbevorderende potentieel veel 
groter is.
De uitkomsten in de DSCA leveren veel informatie op over de pres-
taties van de Nederlandse colorectale chirurgie. In hoeverre de 
uitkomstindicatoren daadwerkelijk iets over de geleverde zorg zeg-
gen en wat we er mee kunnen, is echter niet altijd even duidelijk. Dit 
proefschrift draagt bij aan kennis over de betekenis van, en de (on)
mogelijkheden van diverse klinische uitkomsten die gebruikt worden 
in de gastrointestinale oncologische chirurgie. Bovendien zoomen 
een aantal studies in op de risico’s op ongewenste uitkomsten in een 
aantal verschillende patiëntengroepen. Dit alles om tot gerichtere en 
betere feedback binnen de klinische registraties te komen, om een 
maximaal kwaliteit bevorderend effect te behouden. Bovendien is 
samenvatting en discussie
231
meer inzicht in hoe de uitkomsten gebruikt kunnen worden essenti-
eel wanneer deze openbaar zullen worden.
In hoofdstuk 2 wordt onderzocht wat de invloed van correctie voor 
zorgzwaarte en correctie voor toeval (“reliability adjstment”)10,11 is 
op rangorde van 92 ziekenhuizen op postoperatieve mortaliteit na 
colorectale chirurgie. Het belang van beiden wordt onderstreept 
door verandering van rang na toepassing van verschillende model-
len. De ‘rankability’ bleek laag bij deze uitkomst in deze patienten-
groep: 62% van de gevonden ziekenhuisverschillen in rangorde is 
toe te schrijven aan toeval. Rankability moet worden meegenomen 
wanneer ranglijsten worden getoond en in dit geval is het maken van 
een ranglijst niet juist. Indien dit toch wordt gedaan, is het percentiel 
“expected rank”12 een duidelijker alternatief, dat in èèn getal de kans 
aangeeft dat een ziekenhuis beter presteert op deze uitkomst dan 
een willekeurig ander ziekenhuis. 
In hoofdstuk 3 wordt geconcludeerd dat de uitkomst naadlekkage 
na colorectale resectie relatief minder afhankelijk is van patiënt- en 
ziektegebonden factoren zoals leeftijd en comorbiditeit, en meer 
van behandeling gebonden factoren, wanneer vergeleken wordt met 
mortaliteit. Een nadeel van de uitkomst is dat het alleen van toepas-
sing is op patiënten met een anastomose.
Vervolgens wordt in hoofdstuk 4  ingegaan op de wisselwerking 
tussen heroperatie- en mortaliteitscijfers na colorectale chirurgie. 
Hoewel patiënten die een heroperatie moeten ondergaan een ho-
gere kans hebben op overlijden postoperatief, is het niet zo dat de 
ziekenhuizen die meer heropereren dan gemiddeld, ook een hoger 
sterftecijfer hebben dan gemiddeld. De ziekenhuizen met weinig 
heroperaties hadden gemiddeld genomen echter wel lagere sterfte-
cijfers.  Dit is van belang bij de interpretatie van deze indicator, die 
ook door de Inspectie voor gezondheidszorg wordt uitgevraagd.  Bo-
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vendien hebben zowel de uitkomst ‘heroperaties’ als ‘naadlekkages’ 
de potentie om tot meer defensief gedrag (aanleggen van stoma’s om 
naadlekkages en heroperaties te voorkomen) te leiden bij chirurgen, 
wat niet altijd in het belang van de patiënt zal zijn.
Een uitkomst die dit nadeel niet heeft is ‘failure to rescue’: het aan-
tal overleden patiënten binnen de groep patiënten met een (ernstige) 
postoperatieve complicatie. Dit zegt dus iets over het vermogen van 
een chirurgisch team om een patiënt met een complicatie adequaat te 
behandelen, waardoor de complicatie niet fataal afloopt. Hoofdstuk 5 
exploreert de ziekenhuisvariatie op deze uitkomst en concludeert dat 
ziekenhuizen met hoge en lage mortaliteit zich eerder onderscheiden 
door meer of minder ‘failure to rescue’ dan dat er grote verschillen 
in aantal ernstige complicaties zijn. In terugkoppelingen kan deze 
uitkomst dan ook erg inzichtgevend zijn. Een nadeel is dat ook hier 
het toeval een rol speelt wanneer kleinere datasets worden gebruikt, 
omdat zowel de teller (aantal overleden na een complicatie) als de 
noemer (aantal patiënten met een ernstige complicatie) relatief klein 
is vanuit statistisch oogpunt.
Waarom een patiënt in het ene ziekenhuis een grotere kans heeft om 
een ernstige complicatie te overleven dan in het andere ziekenhuis, 
is grotendeels onbekend. In hoofdstuk 6 wordt de correlatie tussen 
‘failure to rescue’ en een drietal ziekenhuisfactoren onderzocht. In 
multivariate analyse blijkt dat ziekenhuizen met een level 2 of 3 Inten-
sive care lagere failure to rescue rates hebben dan ziekenhuizen met 
een intensive care van de laagste categorie. Aantal operaties en type 
ziekenhuis (academisch, opleidings- of sytreekziekenhuis) waren 
niet significant van invloed. De bevindingen zijn slechts een associ-
atie en hangen waarschijnlijk samen met een groot aantal structurele 
en procesmatige factoren, die bij nader onderzoek naar verschillende 
processen bij de goed presterende ziekenhuizen (‘best practices’) en 
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de minder presterende ziekenhuizen, onder loep moeten worden 
genomen. Wel ligt het voor de hand dat dergelijk vervolgonderzoek 
in elk geval ook naar de processen op de IC, en de wisselwerking met 
de rest van het ziekenhuis (bijvoorbeeld de kwaliteit van de spoed 
interventie teams in het ziekenhuis)13-15 zal kijken.
Bij oncologische chirurgie hoger in de tractus digestivus, zoals 
chirurgie bij oesophaguscarcinoom, ligt in de literatuur de nadruk nu 
nog erg op de associatie tussen volume (aantal verrichte procedures) 
en uitkomsten zoals mortaliteit. Bij dit type chirurgie is deze relatie 
dan ook duidelijk aanwezig16,17. In hoofdstuk 7 wordt gezien dat 
verdere centralisatie een verdere daling in postoperatieve mortaliteit 
tot gevolg kan hebben. Hierbij geldt dat het verhogen van de volume-
norm slechts èèn van de middelen is om tot verdere centralisatie te 
komen. Van een volumenorm kan niets geleerd worden en het gevaar 
bestaat dat niet (alleen) ziekenhuizen met goede resultaten worden 
aangezewen als verwijscentrum . Een andere strategie is ‘outcome-
based referral’ , waarbij gecentraliseerd wordt op basis van uitkom-
sten. Een klinische audit heeft de potentie om te laten leren van 
‘best practice’ en de zorg te centraliseren naar die centra die zichzelf 
bewijzen met goede uitkomsten na feedback van de resultaten18. 
In hoofdstuk 8 wordt nader ingegaan op factoren die samenhangen 
met de kans om te overlijden wanneer een naadlekkage optreedt na 
een colonresectie. In linkszijdige colonresecties is de kans op lekkage 
verhoogd, maar de kans om te overlijden wanneer deze complicatie 
is opgetreden, is twee keer zo hoog in rechtszijdige resecties. 
In hoofdstuk 9 wordt vervolgens een gedetailleerde analyse 
gedaan naar het optreden van verschillende complicaties en over-
lijden secundair hieraan, bij patiënten die een rectum- danwel een 
colonresectie ondergingen. Ernstige complicaties komen vaker voor 
bij patiënten met rectumcarcinoom, maar failure to rescue- dus het 
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aantal overleden patiënten  als percentage van het totaal aantal 
patiënten met een ernstige complicatie- was twee keer zo hoog bij 
patiënten die een colonresectie ondergingen in vergelijking met 
patiënten die een rectumresectie ondergingen. Naast naadlekkage 
lijken cardiopulmonale complicaties een groot aandeel in het fatale 
verloop van complicaties te hebben, waarbij de kans op overlijden 
fors toeneemt met het aantal optredende complicaties.
In conclusie kan gesteld worden dat de recente introductie van de 
klinische audits in Nederland de gastrointestinale chirurgische on-
cologie al veel heeft gebracht, met tastbare resultaten na reeds een 
aantal jaar. Het lijkt het begin in te luiden van een nieuw tijdperk 
waarin kwaliteitscontrole door medici zelf, maar ook door middel 
van transparantie naar buiten toe, voorop staat. Met de toenemende 
rol van de uitkomstregistraties is het van belang dat uitkomstindica-
toren worden geëvalueerd en daar waar nodig aangescherpt. Dit zal 
een continu proces zijn, waarbij jaarlijks bruikbaarheid en relevantie 
moet worden beoordeeld. De onderzoeken zoals beschreven in dit 
proefschrift exploreren de waarde en toepasbaarheid van een aantal 
klinische uitkomstindicatoren. Het gevaar van ranglijsten maken 
wordt aangestipt: van belang is dan de rankability om te beoordelen 
in hoeverre toeval een rol speelt.
De interactie tussen uitkomsten onderling kan complex zijn en 
wanneer ze op zichzelf worden bekeken bestaat het risico dat er 
andere aspecten onderbelicht blijven. Bovendien zouden uitkom-
sten als ‘naadlekkage’ en ‘heroperaties’  defensief gedrag, zoals het 
aanleggen van stoma’s, tot gevolg kunnen hebben. Een interessante 
uitkomstmaat is daarom ‘failure to rescue’, die aangeeft in hoeverre 
chirurgische teams in staat zijn patiënten met een ernstige complica-
tie in leven te houden. Associatie tussen uitkomsten en structuurfac-
toren geven richting aan het begrijpen waarom prestaties beter zijn 
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in het ene ziekenhuis dan in het andere. Echter, diepte-onderzoek 
naar verschillen in het zorgproces tussen ziekenhuizen- bijvoorbeeld 
bij ‘best practices’ en bij minder presterende centra- is van belang om 
werkelijk te achterhalen welke mechanismen een rol spelen bij het 
optreden en het fataal aflopen van complicaties. Dergelijke kennis zal 
de gehele chirurgie helpen om ongewenste uitkomsten nog verder te 
reduceren.
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